Disorders characterized by impairment of the ability to initiate or maintain sleep. This may occur as a primary disorder or in association with another medical or psychiatric condition.
An autosomal dominant disorder characterized by degeneration of the THALAMUS and progressive insomnia. It is caused by a mutation in the prion protein (PRIONS).
Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety.
A readily reversible suspension of sensorimotor interaction with the environment, usually associated with recumbency and immobility.
Simultaneous and continuous monitoring of several parameters during sleep to study normal and abnormal sleep. The study includes monitoring of brain waves, to assess sleep stages, and other physiological variables such as breathing, eye movements, and blood oxygen levels which exhibit a disrupted pattern with sleep disturbances.
Bicyclic bridged compounds that contain a nitrogen which has three bonds. The nomenclature indicates the number of atoms in each path around the rings, such as [2.2.2] for three equal length paths. Some members are TROPANES and BETA LACTAMS.
A plant genus of the family VALERIANACEAE, order Dipsacales, subclass Asteridae, class Magnoliopsida. It is best known for the sedative use and valepotriate content of the roots. It is sometimes called Garden Heliotrope but is unrelated to true Heliotrope (HELIOTROPIUM).
A state in which there is an enhanced potential for sensitivity and an efficient responsiveness to external stimuli.
Conditions characterized by disturbances of usual sleep patterns or behaviors. Sleep disorders may be divided into three major categories: DYSSOMNIAS (i.e. disorders characterized by insomnia or hypersomnia), PARASOMNIAS (abnormal sleep behaviors), and sleep disorders secondary to medical or psychiatric disorders. (From Thorpy, Sleep Disorders Medicine, 1994, p187)
A direct form of psychotherapy based on the interpretation of situations (cognitive structure of experiences) that determine how an individual feels and behaves. It is based on the premise that cognition, the process of acquiring knowledge and forming beliefs, is a primary determinant of mood and behavior. The therapy uses behavioral and verbal techniques to identify and correct negative thinking that is at the root of the aberrant behavior.
A series of thoughts, images, or emotions occurring during sleep which are dissociated from the usual stream of consciousness of the waking state.
Cortical vigilance or readiness of tone, presumed to be in response to sensory stimulation via the reticular activating system.
Periods of sleep manifested by changes in EEG activity and certain behavioral correlates; includes Stage 1: sleep onset, drowsy sleep; Stage 2: light sleep; Stages 3 and 4: delta sleep, light sleep, deep sleep, telencephalic sleep.
Disorders characterized by hypersomnolence during normal waking hours that may impair cognitive functioning. Subtypes include primary hypersomnia disorders (e.g., IDIOPATHIC HYPERSOMNOLENCE; NARCOLEPSY; and KLEINE-LEVIN SYNDROME) and secondary hypersomnia disorders where excessive somnolence can be attributed to a known cause (e.g., drug affect, MENTAL DISORDERS, and SLEEP APNEA SYNDROME). (From J Neurol Sci 1998 Jan 8;153(2):192-202; Thorpy, Principles and Practice of Sleep Medicine, 2nd ed, p320)
The measurement and recording of MOTOR ACTIVITY to assess rest/activity cycles.
A broad category of sleep disorders characterized by either hypersomnolence or insomnia. The three major subcategories include intrinsic (i.e., arising from within the body) (SLEEP DISORDERS, INTRINSIC), extrinsic (secondary to environmental conditions or various pathologic conditions), and disturbances of circadian rhythm. (From Thorpy, Sleep Disorders Medicine, 1994, p187)
Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder.
Dyssomnias associated with disruption of the normal 24 hour sleep wake cycle secondary to travel (e.g., JET LAG SYNDROME), shift work, or other causes.
Predetermined sets of questions used to collect data - clinical data, social status, occupational group, etc. The term is often applied to a self-completed survey instrument.
A group of two-ring heterocyclic compounds consisting of a benzene ring fused to a diazepine ring.
The presence of co-existing or additional diseases with reference to an initial diagnosis or with reference to the index condition that is the subject of study. Comorbidity may affect the ability of affected individuals to function and also their survival; it may be used as a prognostic indicator for length of hospital stay, cost factors, and outcome or survival.
A family of fused-ring hydrocarbons isolated from coal tar that act as intermediates in various chemical reactions and are used in the production of coumarone-indene resins.
A disorder characterized by aching or burning sensations in the lower and rarely the upper extremities that occur prior to sleep or may awaken the patient from sleep.
Chronic mental disorders in which there has been an insidious development of a permanent and unshakeable delusional system (persecutory delusions or delusions of jealousy), accompanied by preservation of clear and orderly thinking. Emotional responses and behavior are consistent with the delusional state.
Dyssomnias (i.e., insomnias or hypersomnias) associated with dysfunction of internal sleep mechanisms or secondary to a sleep-related medical disorder (e.g., sleep apnea, post-traumatic sleep disorders, etc.). (From Thorpy, Sleep Disorders Medicine, 1994, p187)
The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time.
The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.
An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent.
A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors.
Depressive states usually of moderate intensity in contrast with major depression present in neurotic and psychotic disorders.
A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. (From AMA Drug Evaluations Annual, 1994, p309)
Treatment of disease by exposure to light, especially by variously concentrated light rays or specific wavelengths.
Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time.
Persistent and disabling ANXIETY.
Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness.
A risk factor for suicide attempts and completions, it is the most common of all suicidal behavior, but only a minority of ideators engage in overt self-harm.
The state of being deprived of sleep under experimental conditions, due to life events, or from a wide variety of pathophysiologic causes such as medication effect, chronic illness, psychiatric illness, or sleep disorder.
Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here.
Marked depression appearing in the involution period and characterized by hallucinations, delusions, paranoia, and agitation.
The application of modern theories of learning and conditioning in the treatment of behavior disorders.
A stage of sleep characterized by rapid movements of the eye and low voltage fast pattern EEG. It is usually associated with dreaming.
Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care. (Dictionary of Health Services Management, 2d ed)
A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment.
Excessive periodic leg movements during sleep that cause micro-arousals and interfere with the maintenance of sleep. This condition induces a state of relative sleep deprivation which manifests as excessive daytime hypersomnolence. The movements are characterized by repetitive contractions of the tibialis anterior muscle, extension of the toe, and intermittent flexion of the hip, knee and ankle. (Adams et al., Principles of Neurology, 6th ed, p387)
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
A systematic collection of factual data pertaining to health and disease in a human population within a given geographic area.
The regular recurrence, in cycles of about 24 hours, of biological processes or activities, such as sensitivity to drugs and stimuli, hormone secretion, sleeping, and feeding.
A plant genus of the family Passifloraceae, order Violales, subclass Dilleniidae, class Magnoliopsida. They are vines with ornamental flowers and edible fruit.
A benzodiazepine that acts as a GAMMA-AMINOBUTYRIC ACID modulator and anti-anxiety agent.
A biogenic amine that is found in animals and plants. In mammals, melatonin is produced by the PINEAL GLAND. Its secretion increases in darkness and decreases during exposure to light. Melatonin is implicated in the regulation of SLEEP, mood, and REPRODUCTION. Melatonin is also an effective antioxidant.
A personality inventory consisting of statements to be asserted or denied by the individual. The patterns of response are characteristic of certain personality attributes.
Feeling or emotion of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS.
Disorders characterized by multiple cessations of respirations during sleep that induce partial arousals and interfere with the maintenance of sleep. Sleep apnea syndromes are divided into central (see SLEEP APNEA, CENTRAL), obstructive (see SLEEP APNEA, OBSTRUCTIVE), and mixed central-obstructive types.
A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral and social environment; the overall condition of a human life.
A plant genus in the CANNABACEAE family. Best known for the buds of Humulus lupulus L. used in BEER.
Movements or behaviors associated with sleep, sleep stages, or partial arousals from sleep that may impair sleep maintenance. Parasomnias are generally divided into four groups: arousal disorders, sleep-wake transition disorders, parasomnias of REM sleep, and nonspecific parasomnias. (From Thorpy, Sleep Disorders Medicine, 1994, p191)
An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.
A melatonin receptor subtype primarily found expressed in the BRAIN and RETINA.
A melatonin receptor subtype that is primarily found in the HYPOTHALAMUS and in the KIDNEY.
Treatment to improve one's health condition by using techniques that can reduce PHYSIOLOGICAL STRESS; PSYCHOLOGICAL STRESS; or both.
A benzodiazepine with anticonvulsant, hypnotic, and muscle relaxant properties. It has been shown in some cases to be more potent than DIAZEPAM or NITRAZEPAM.
Materials or substances used in the composition of traditional medical remedies. The use of this term in MeSH was formerly restricted to historical articles or those concerned with traditional medicine, but it can also refer to homeopathic remedies. Nosodes are specific types of homeopathic remedies prepared from causal agents or disease products.
A plant genus of the genus STRYCHNOS, family LOGANIACEAE that is the source of STRYCHNINE.
A state of consciousness in which the individual eliminates environmental stimuli from awareness so that the mind can focus on a single thing, producing a state of relaxation and relief from stress. A wide variety of techniques are used to clear the mind of stressful outside interferences. It includes meditation therapy. (Mosby's Medical, Nursing, and Allied Health Dictionary, 4th ed)
A province of eastern Canada. Its capital is Quebec. The region belonged to France from 1627 to 1763 when it was lost to the British. The name is from the Algonquian quilibek meaning the place where waters narrow, referring to the gradually narrowing channel of the St. Lawrence or to the narrows of the river at Cape Diamond. (From Webster's New Geographical Dictionary, 1988, p993 & Room, Brewer's Dictionary of Names, 1992, p440)
Recording of electric currents developed in the brain by means of electrodes applied to the scalp, to the surface of the brain, or placed within the substance of the brain.
The feeling-tone accompaniment of an idea or mental representation. It is the most direct psychic derivative of instinct and the psychic representative of the various bodily changes by means of which instincts manifest themselves.
Treatment of disease by inserting needles along specific pathways or meridians. The placement varies with the disease being treated. It is sometimes used in conjunction with heat, moxibustion, acupressure, or electric stimulation.
A benzodiazepine used in the treatment of anxiety, alcohol withdrawal, and insomnia.
Persistent, unwanted idea or impulse which is considered normal when it does not markedly interfere with mental processes or emotional adjustment.
Physiologic period, characterized by endocrine, somatic, and psychic changes with the termination of ovarian function in the female. It may also accompany the normal diminution of sexual activity in the male.
Elements of limited time intervals, contributing to particular results or situations.
A disorder characterized by recurrent apneas during sleep despite persistent respiratory efforts. It is due to upper airway obstruction. The respiratory pauses may induce HYPERCAPNIA or HYPOXIA. Cardiac arrhythmias and elevation of systemic and pulmonary arterial pressures may occur. Frequent partial arousals occur throughout sleep, resulting in relative SLEEP DEPRIVATION and daytime tiredness. Associated conditions include OBESITY; ACROMEGALY; MYXEDEMA; micrognathia; MYOTONIC DYSTROPHY; adenotonsilar dystrophy; and NEUROMUSCULAR DISEASES. (From Adams et al., Principles of Neurology, 6th ed, p395)
Acquired or learned responses which are regularly manifested.
Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
A disorder beginning in childhood whose essential features are persistent impairment in reciprocal social communication and social interaction, and restricted, repetitive patterns of behavior, interests, or activities. These symptoms may limit or impair everyday functioning. (From DSM-5)
Ratio of output to effort, or the ratio of effort produced to energy expended.
Studies in which variables relating to an individual or group of individuals are assessed over a period of time.
Successive and rapid contractions of motor units associated with chronic nerve injury. The discharges arise from the peripheral aspects of regenerating nerves, and clinically impart a nearly continuous undulation of the body surface overlying the muscle. (Adams et al., Principles of Neurology, 6th ed, p1491)
Disruptions of the rhythmic cycle of bodily functions or activities.
Stress wherein emotional factors predominate.
Sleep disorders characterized by impaired arousal from the deeper stages of sleep (generally stage III or IV sleep).
Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.
The burning of a small, thimble sized, smoldering plug of dried leaves on the SKIN at an ACUPUNCTURE point. Usually the plugs contain leaves of MUGWORT or moxa.
Check list, usually to be filled out by a person about himself, consisting of many statements about personal characteristics which the subject checks.
A structurally and mechanistically diverse group of drugs that are not tricyclics or monoamine oxidase inhibitors. The most clinically important appear to act selectively on serotonergic systems, especially by inhibiting serotonin reuptake.
Observable manifestations of impaired psychological functioning.
Rough, noisy breathing during sleep, due to vibration of the uvula and soft palate.
A sudden, temporary sensation of heat predominantly experienced by some women during MENOPAUSE. (Random House Unabridged Dictionary, 2d ed)
Small-scale tests of methods and procedures to be used on a larger scale if the pilot study demonstrates that these methods and procedures can work.
Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.
An autosomal disorder of the peripheral and autonomic nervous systems limited to individuals of Ashkenazic Jewish descent. Clinical manifestations are present at birth and include diminished lacrimation, defective thermoregulation, orthostatic hypotension (HYPOTENSION, ORTHOSTATIC), fixed pupils, excessive SWEATING, loss of pain and temperature sensation, and absent reflexes. Pathologic features include reduced numbers of small diameter peripheral nerve fibers and autonomic ganglion neurons. (From Adams et al., Principles of Neurology, 6th ed, p1348; Nat Genet 1993;4(2):160-4)
Chronic absence from work or other duty.
Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems.
Physiological or psychological effects of periods of work which may be fixed or flexible such as flexitime, work shifts, and rotating shifts.
Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.
Assessment of psychological variables by the application of mathematical procedures.
(Note: I believe there might be some confusion in your question as "Pennsylvania" is a place, specifically a state in the United States, and not a medical term. However, if you're asking for a medical condition or concept that shares a name with the state of Pennsylvania, I couldn't find any specific medical conditions or concepts associated with the name "Pennsylvania." If you have more context or clarification regarding your question, please provide it so I can give a more accurate response.)
A type of massage in which finger pressure on specific body sites is used to promote healing, relieve fatigue, etc. Although the anatomical locations are the same as the ACUPUNCTURE POINTS used in ACUPUNCTURE THERAPY (hence acu-), no needle or other acupuncture technique is employed in acupressure. (From Random House Unabridged Dictionary, 2d ed). Shiatsu is a modern outgrowth that focuses more on prevention than healing.
Computer systems utilized as adjuncts in the treatment of disease.
A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable.
Designated locations along nerves or organ meridians for inserting acupuncture needles.
Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time.
The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases, new or old, in the population at a given time.
I'm sorry for any confusion, but the term "Norway" is a country name and doesn't have a medical definition. If you have any medical or health-related questions, I'd be happy to help!
The term "United States" in a medical context often refers to the country where a patient or study participant resides, and is not a medical term per se, but relevant for epidemiological studies, healthcare policies, and understanding differences in disease prevalence, treatment patterns, and health outcomes across various geographic locations.
An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS.
Common name for several daisy-like plants (MATRICARIA; TRIPLEUROSPERMUM; ANTHEMIS; CHAMAEMELUM) native to Europe and Western Asia, now naturalized in the United States and Australia.
A family of G-protein-coupled receptors that are specific for and mediate the effects of MELATONIN. Activation of melatonin receptors has been associated with decreased intracellular CYCLIC AMP and increased hydrolysis of PHOSPHOINOSITIDES.
A false belief regarding the self or persons or objects outside the self that persists despite the facts, and is not considered tenable by one's associates.
Those disorders that have a disturbance in mood as their predominant feature.
A benzodiazepine derivative used as an anticonvulsant and hypnotic.
Recording of pertinent information concerning patient's illness or illnesses.
Dosage forms of a drug that act over a period of time by controlled-release processes or technology.
The assessment of the functioning of an employee in relation to work.
A primary, chronic disease with genetic, psychosocial, and environmental factors influencing its development and manifestations. The disease is often progressive and fatal. It is characterized by impaired control over drinking, preoccupation with the drug alcohol, use of alcohol despite adverse consequences, and distortions in thinking, most notably denial. Each of these symptoms may be continuous or periodic. (Morse & Flavin for the Joint Commission of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism: in JAMA 1992;268:1012-4)
A progressive advance or delay of bedtime until the desired bedtime is achieved.
A behavior therapy technique in which deep muscle relaxation is used to inhibit the effects of graded anxiety-evoking stimuli.
Use of plants or herbs to treat diseases or to alleviate pain.
Studies comparing two or more treatments or interventions in which the subjects or patients, upon completion of the course of one treatment, are switched to another. In the case of two treatments, A and B, half the subjects are randomly allocated to receive these in the order A, B and half to receive them in the order B, A. A criticism of this design is that effects of the first treatment may carry over into the period when the second is given. (Last, A Dictionary of Epidemiology, 2d ed)
Frequent URINATION at night that interrupts sleep. It is often associated with outflow obstruction, DIABETES MELLITUS, or bladder inflammation (CYSTITIS).
A group of genetic, infectious, or sporadic degenerative human and animal nervous system disorders associated with abnormal PRIONS. These diseases are characterized by conversion of the normal prion protein to an abnormal configuration via a post-translational process. In humans, these conditions generally feature DEMENTIA; ATAXIA; and a fatal outcome. Pathologic features include a spongiform encephalopathy without evidence of inflammation. The older literature occasionally refers to these as unconventional SLOW VIRUS DISEASES. (From Proc Natl Acad Sci USA 1998 Nov 10;95(23):13363-83)
Piperazines are a class of heterocyclic organic compounds containing a seven-membered ring with two nitrogen atoms at positions 1 and 4, often used in pharmaceuticals as smooth muscle relaxants, antipsychotics, antidepressants, and antihistamines, but can also be found as recreational drugs with stimulant and entactogen properties.
A system of traditional medicine which is based on the beliefs and practices of the Chinese culture.
Aching sensation that persists for more than a few months. It may or may not be associated with trauma or disease, and may persist after the initial injury has healed. Its localization, character, and timing are more vague than with acute pain.
The transmission and reception of electric impulses or signals by means of electric waves without a connecting wire, or the use of these waves for the wireless transmission of electric impulses into which sound is converted. (From Webster's 3d)
Method for obtaining information through verbal responses, written or oral, from subjects.
Substances used for their pharmacological actions on GABAergic systems. GABAergic agents include agonists, antagonists, degradation or uptake inhibitors, depleters, precursors, and modulators of receptor function.
Statistical models which describe the relationship between a qualitative dependent variable (that is, one which can take only certain discrete values, such as the presence or absence of a disease) and an independent variable. A common application is in epidemiology for estimating an individual's risk (probability of a disease) as a function of a given risk factor.
The teaching or training of patients concerning their own health needs.
The ratio of two odds. The exposure-odds ratio for case control data is the ratio of the odds in favor of exposure among cases to the odds in favor of exposure among noncases. The disease-odds ratio for a cohort or cross section is the ratio of the odds in favor of disease among the exposed to the odds in favor of disease among the unexposed. The prevalence-odds ratio refers to an odds ratio derived cross-sectionally from studies of prevalent cases.
The vital life force in the body, supposedly able to be regulated by acupuncture. It corresponds roughly to the Greek pneuma, the Latin spiritus, and the ancient Indian prana. The concept of life-breath or vital energy was formulated as an indication of the awareness of man, originally directed externally toward nature or society but later turned inward to the self or life within. (From Comparison between Concepts of Life-Breath in East and West, 15th International Symposium on the Comparative History of Medicine - East and West, August 26-September 3, 1990, Shizuoka, Japan, pp. ix-x)
Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function.
A rare transmissible encephalopathy most prevalent between the ages of 50 and 70 years. Affected individuals may present with sleep disturbances, personality changes, ATAXIA; APHASIA, visual loss, weakness, muscle atrophy, MYOCLONUS, progressive dementia, and death within one year of disease onset. A familial form exhibiting autosomal dominant inheritance and a new variant CJD (potentially associated with ENCEPHALOPATHY, BOVINE SPONGIFORM) have been described. Pathological features include prominent cerebellar and cerebral cortical spongiform degeneration and the presence of PRIONS. (From N Engl J Med, 1998 Dec 31;339(27))
Maleness or femaleness as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or effect of a circumstance. It is used with human or animal concepts but should be differentiated from SEX CHARACTERISTICS, anatomical or physiological manifestations of sex, and from SEX DISTRIBUTION, the number of males and females in given circumstances.
The level of health of the individual, group, or population as subjectively assessed by the individual or by more objective measures.
The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol.
A collective expression for all behavior patterns acquired and socially transmitted through symbols. Culture includes customs, traditions, and language.
A barbiturate that is used as a sedative. Secobarbital is reported to have no anti-anxiety activity.
Small proteinaceous infectious particles which resist inactivation by procedures that modify NUCLEIC ACIDS and contain an abnormal isoform of a cellular protein which is a major and necessary component. The abnormal (scrapie) isoform is PrPSc (PRPSC PROTEINS) and the cellular isoform PrPC (PRPC PROTEINS). The primary amino acid sequence of the two isoforms is identical. Human diseases caused by prions include CREUTZFELDT-JAKOB SYNDROME; GERSTMANN-STRAUSSLER SYNDROME; and INSOMNIA, FATAL FAMILIAL.
A geographical area of the United States comprising the District of Columbia, Delaware, Maryland, New Jersey, New York, and Pennsylvania.
An effect usually, but not necessarily, beneficial that is attributable to an expectation that the regimen will have an effect, i.e., the effect is due to the power of suggestion.
The field of knowledge, theory, and technology dealing with the collection of facts and figures, and the processes and methods involved in their manipulation, storage, dissemination, publication, and retrieval. It includes the fields of COMMUNICATION; PUBLISHING; LIBRARY SCIENCE; and informatics.
Voluntary cooperation of the patient in following a prescribed regimen.
The former British crown colony located off the southeast coast of China, comprised of Hong Kong Island, Kowloon Peninsula, and New Territories. The three sites were ceded to the British by the Chinese respectively in 1841, 1860, and 1898. Hong Kong reverted to China in July 1997. The name represents the Cantonese pronunciation of the Chinese xianggang, fragrant port, from xiang, perfume and gang, port or harbor, with reference to its currents sweetened by fresh water from a river west of it.
A common primary headache disorder, characterized by a dull, non-pulsatile, diffuse, band-like (or vice-like) PAIN of mild to moderate intensity in the HEAD; SCALP; or NECK. The subtypes are classified by frequency and severity of symptoms. There is no clear cause even though it has been associated with MUSCLE CONTRACTION and stress. (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
A system of categories to which morbid entries are assigned according to established criteria. Included is the entire range of conditions in a manageable number of categories, grouped to facilitate mortality reporting. It is produced by the World Health Organization (From ICD-10, p1). The Clinical Modifications, produced by the UNITED STATES DEPT. OF HEALTH AND HUMAN SERVICES, are larger extensions used for morbidity and general epidemiological purposes, primarily in the U.S.
Recording of the average amplitude of the resting potential arising between the cornea and the retina in light and dark adaptation as the eyes turn a standard distance to the right and the left. The increase in potential with light adaptation is used to evaluate the condition of the retinal pigment epithelium.
The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results.
A state of harmony between internal needs and external demands and the processes used in achieving this condition. (From APA Thesaurus of Psychological Index Terms, 8th ed)
A histamine H1 receptor antagonist that is effective in the treatment of chronic urticaria, dermatitis, and histamine-mediated pruritus. Unlike its major metabolite CETIRIZINE, it does cause drowsiness. It is also effective as an antiemetic, for relief of anxiety and tension, and as a sedative.
A form of acupuncture with electrical impulses passing through the needles to stimulate NERVE TISSUE. It can be used for ANALGESIA; ANESTHESIA; REHABILITATION; and treatment for diseases.
The state wherein the person is well adjusted.
Scales, questionnaires, tests, and other methods used to assess pain severity and duration in patients or experimental animals to aid in diagnosis, therapy, and physiological studies.
Chinese herbal or plant extracts which are used as drugs to treat diseases or promote general well-being. The concept does not include synthesized compounds manufactured in China.
A graphic means for assessing the ability of a screening test to discriminate between healthy and diseased persons; may also be used in other studies, e.g., distinguishing stimuli responses as to a faint stimuli or nonstimuli.
I'm sorry for any confusion, but "Taiwan" is not a medical term and does not have a medical definition. It is a country located in East Asia. If you have any questions related to healthcare or medical terms, I would be happy to help with those!
Treatment methods or techniques which are based on the knowledge of mind and body interactions. These techniques can be used to reduce the feeling of tension and effect of stress, and to enhance the physiological and psychological well-being of an individual.
Social and economic factors that characterize the individual or group within the social structure.
G-protein-coupled NEUROPEPTIDE RECEPTORS that have specificity for OREXINS and play a role in appetite control, and sleep-wake cycles. Two principle receptor types exist, each having a specificity for OREXIN A and OREXIN B peptide subtypes.
The transitional period before and after MENOPAUSE. Perimenopausal symptoms are associated with irregular MENSTRUAL CYCLE and widely fluctuated hormone levels. They may appear 6 years before menopause and subside 2 to 5 years after menopause.
Public or private organizations that provide, either directly or through arrangements with other organizations, home health services in the patient's home. (Hospital Administration Terminology, 2d ed)
I'm sorry for any confusion, but "Finland" is not a medical term and does not have a medical definition. It is a country located in Northern Europe, known officially as the Republic of Finland. If you have any questions related to medical topics or definitions, I would be happy to help with those!
A condition characterized by recurrent episodes of daytime somnolence and lapses in consciousness (microsomnias) that may be associated with automatic behaviors and AMNESIA. CATAPLEXY; SLEEP PARALYSIS, and hypnagogic HALLUCINATIONS frequently accompany narcolepsy. The pathophysiology of this disorder includes sleep-onset rapid eye movement (REM) sleep, which normally follows stage III or IV sleep. (From Neurology 1998 Feb;50(2 Suppl 1):S2-S7)
A state of increased receptivity to suggestion and direction, initially induced by the influence of another person.
Discomfort stemming from muscles, LIGAMENTS, tendons, and bones.
A class of chemicals derived from barbituric acid or thiobarbituric acid. Many of these are GABA MODULATORS used as HYPNOTICS AND SEDATIVES, as ANESTHETICS, or as ANTICONVULSANTS.
Instructional materials used in teaching.
A method in which either the observer(s) or the subject(s) is kept ignorant of the group to which the subjects are assigned.
Compounds that specifically inhibit the reuptake of serotonin in the brain.
The symptom of PAIN in the cranial region. It may be an isolated benign occurrence or manifestation of a wide variety of HEADACHE DISORDERS.
The act of "taking account" of an object or state of affairs. It does not imply assessment of, nor attention to the qualities or nature of the object.
A parasomnia characterized by a partial arousal that occurs during stage IV of non-REM sleep. Affected individuals exhibit semipurposeful behaviors such as ambulation and are difficult to fully awaken. Children are primarily affected, with a peak age range of 4-6 years.
Back flow of gastric contents to the LARYNGOPHARYNX where it comes in contact with tissues of the upper aerodigestive tract. Laryngopharyngeal reflux is an extraesophageal manifestation of GASTROESOPHAGEAL REFLUX.
Studies which start with the identification of persons with a disease of interest and a control (comparison, referent) group without the disease. The relationship of an attribute to the disease is examined by comparing diseased and non-diseased persons with regard to the frequency or levels of the attribute in each group.
I'm sorry for any confusion, but the term "Arkansas" is a place name and does not have a medical definition. It is a state located in the southern region of the United States.
The use of electronic equipment to observe or record physiologic processes while the patient undergoes normal daily activities.
Cyclohexanecarboxylic acids are organic compounds consisting of a cyclohexane ring substituted with a carboxylic acid group, typically represented by the structural formula C6H11COOH.
Standardized tests designed to measure abilities, as in intelligence, aptitude, and achievement tests, or to evaluate personality traits.
A generic term for the treatment of mental illness or emotional disturbances primarily by verbal or nonverbal communication.
Care which provides integrated, accessible health care services by clinicians who are accountable for addressing a large majority of personal health care needs, developing a sustained partnership with patients, and practicing in the context of family and community. (JAMA 1995;273(3):192)
Coordinate set of non-specific behavioral responses to non-psychiatric illness. These may include loss of APPETITE or LIBIDO; disinterest in ACTIVITIES OF DAILY LIVING; or withdrawal from social interaction.
Drinking an excessive amount of ALCOHOLIC BEVERAGES in a short period of time.
Azoles with an OXYGEN and a NITROGEN next to each other at the 1,2 positions, in contrast to OXAZOLES that have nitrogens at the 1,3 positions.
Therapeutic practices which are not currently considered an integral part of conventional allopathic medical practice. They may lack biomedical explanations but as they become better researched some (PHYSICAL THERAPY MODALITIES; DIET; ACUPUNCTURE) become widely accepted whereas others (humors, radium therapy) quietly fade away, yet are important historical footnotes. Therapies are termed as Complementary when used in addition to conventional treatments and as Alternative when used instead of conventional treatment.
Cognitive disorders characterized by an impaired ability to perceive the nature of objects or concepts through use of the sense organs. These include spatial neglect syndromes, where an individual does not attend to visual, auditory, or sensory stimuli presented from one side of the body.
Derivatives of acetamide that are used as solvents, as mild irritants, and in organic synthesis.

Recombinant human prion protein mutants huPrP D178N/M129 (FFI) and huPrP+9OR (fCJD) reveal proteinase K resistance. (1/21)

The Semliki-Forest virus (SFV) system was used to overexpress human wild-type and mutant prion proteins as well as FLAG-tagged human and bovine PrP in mammalian cells. The application of recombinant SFV vectors allowed a high-level production of highly glycosylated prion proteins with a molecular weight ranging from 25 to 30 kDa for recombinant wild-type human PrP and from 26 to 32 kDa for wild-type bovine PrP. Further, we report here the generation of recombinant mutant prion proteins that are associated with inherited human prion diseases such as fatal familial insomnia (FFI) and Creutzfeldt-Jakob disease (CJD). Both mutated variants, the FFI-associated PrP carrying a mutation at amino acid position 178 and the CJD-linked form containing an insertion of nine additional octarepeats reveal proteinase K resistance, one of the typical biochemical properties of the infectious scrapie isoform of the prion protein. By contrast, recombinant wild-type PrP was completely proteinase K sensitive when expressed in SFV-transfected BHK cells. The subcellular location of both PrP mutants at the cell surface and in intracellular compartments of transfected BHK cells was similar to that of wild-type PrP. In order to purify recombinant human and bovine PrP from cell lysates, a FLAG-tag was introduced either at the N-terminus behind the signal peptide or at the C-terminus close to the adhesion site of the GPI anchor. N-terminal insertion did not extensively influence the trafficking of the FLAG-tagged protein to the cell surface, whereas insertion close to the GPI attachment site clearly affected the transport of the majority of PrP to the cell membrane, probably resulting in their retention within the secretory pathway. All FLAG-tagged prion proteins were expressed efficiently in BHK cells and showed a typical glycosylation pattern, allowing their rapid and simple purification via anti-FLAG antibody chromatography.  (+info)

Pre-symptomatic diagnosis in fatal familial insomnia: serial neurophysiological and 18FDG-PET studies. (2/21)

Knowing how and when the degenerative process starts is important in neurodegenerative diseases. We have addressed this issue in fatal familial insomnia (FFI) measuring the cerebral metabolic rate of glucose (CMRglc) with 2-[18F]fluoro-2-deoxy-D-glucose PET in parallel with detailed clinical, neuropsychological examinations and polysomnography with EEG spectral analyses. Nine asymptomatic carriers of the D178N mutation, 10 non-carriers belonging to the same family, and 19 age-matched controls were studied over several years. The CMRglc as well as clinical and electrophysiological examinations were normal in all cases at the beginning of the study. Four of the mutation carriers developed typical FFI during the study but CMRglc and the clinical and electrophysiological examinations remained normal 63, 56, 32 and 21 months, respectively before disease onset. The carrier whose tests were normal 32 months before disease onset was re-examined 13 months before the onset. At that time, selective hypometabolism was detected in the thalamus while spectral-EEG analysis disclosed an impaired thalamic sleep spindle formation. Following clinical disease onset, CRMglc was reduced in the thalamus in all 3 patients examined. Our data indicate that the neurodegenerative process associated with FFI begins in the thalamus between 13 and 21 months before the clinical presentation of the disease.  (+info)

The expanding universe of prion diseases. (3/21)

Prions cause fatal and transmissible neurodegenerative disease. These etiological infectious agents are formed in greater part from a misfolded cell-surface protein called PrP(C). Several mammalian species are affected by the diseases, and in the case of "mad cow disease" (BSE) the agent has a tropism for humans, with negative consequences for agribusiness and public health. Unfortunately, the known universe of prion diseases is expanding. At least four novel prion diseases--including human diseases variant Creutzfeldt-Jakob disease (vCJD) and sporadic fatal insomnia (sFI), bovine amyloidotic spongiform encephalopathy (BASE), and Nor98 of sheep--have been identified in the last ten years, and chronic wasting disease (CWD) of North American deer (Odocoileus Specis) and Rocky Mountain elk (Cervus elaphus nelsoni) is undergoing a dramatic spread across North America. While amplification (BSE) and dissemination (CWD, commercial sourcing of cervids from the wild and movement of farmed elk) can be attributed to human activity, the origins of emergent prion diseases cannot always be laid at the door of humankind. Instead, the continued appearance of new outbreaks in the form of "sporadic" disease may be an inevitable outcome in a situation where the replicating pathogen is host-encoded.  (+info)

Prosthesis replacement in a calcified mitral annulus with reconstruction of the intervalvular fibrous body: the value of an alternative repair. (4/21)

A patient with healed prosthetic endocarditis, severe calcification of the mitral annulus, and multiple mitral periprosthetic leaks underwent double-valve replacement, with reconstruction of the intervalvular fibrous body. Placing sutures through healthy autologous tissues from outside the heart enabled secure replacement of the mitral prosthesis. This technique avoids extensive circumferential reconstruction of the mitral annulus.  (+info)

Self management of fatal familial insomnia. Part 1: what is FFI? (5/21)

CONTEXT: Fatal familial insomnia (FFI) is a genetically transmitted neurodegenerative prion disease that incurs great suffering and has neither a treatment nor a cure. The clinical literature is devoid of management plans (other than palliative). Part 1 of this article reviews the sparse literature about FFI, including case descriptions. Part 2 of this paper describes the efforts of 1 patient (with the rapid-course Met-Met subtype) to contend with his devastating symptoms and improve the quality of his life. DESIGN: Interventions were based on the premise that some symptoms may be secondary to insomnia and not a direct result of the disease itself. Strategies (derived by trial and error) were devised to induce sleep and increase alertness. Interventions included vitamin supplementation, narcoleptics, anesthesia, stimulants, sensory deprivation, exercise, light entrainment, growth hormone, and electroconvulsive therapy. RESULTS: The patient exceeded the average survival time by nearly 1 year, and during this time (when most patients are totally incapacitated), he was able to write a book and to successfully drive hundreds of miles. CONCLUSION: Methods to induce sleep may extend and enhance life during the disease, although they do not prevent death. It is hoped that some of his methods might inspire further clinical studies.  (+info)

Self-management of fatal familial insomnia. Part 2: case report. (6/21)

CONTEXT: Fatal familial insomnia (FFI) is a genetically transmitted neurodegenerative prion disease that incurs great suffering and has neither a treatment nor cure. The clinical literature is devoid of management plans (other than palliative). Part 1 of this article reviews the sparse literature about FFI, including case descriptions. Part 2 describes the efforts of one patient (with the rapid-course Met-Met subtype) who contended with his devastating symptoms and improved the quality of his life. DESIGN: Interventions were based on the premise that some symptoms may be secondary to insomnia and not a direct result of the disease itself. Strategies (derived by trial and error) were devised to induce sleep and increase alertness. Interventions included vitamin supplementation, narcoleptics, anesthesia, stimulants, sensory deprivation, exercise, light entrainment, growth hormone, and electroconvulsive therapy (ECT). RESULTS: The patient exceeded the average survival time by nearly 1 year, and during this time (when most patients are totally incapacitated), he was able to write a book and to successfully drive hundreds of miles. CONCLUSION: Methods to induce sleep may extend and enhance life during the disease course, although they do not prevent death. It is hoped that some of his methods will inspire further clinical studies.  (+info)

Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies. (7/21)

 (+info)

Septic shock induced by Lecythophora mutabilis in a patient with mitochondrial encephalomyopathy. (8/21)

 (+info)

Sleep initiation and maintenance disorders are a category of sleep disorders that involve difficulty falling asleep and staying asleep throughout the night. This category includes:

1. Insomnia disorder: A persistent difficulty in initiating or maintaining sleep, or early morning awakening, despite adequate opportunity and circumstances for sleep, which causes clinically significant distress or impairment.
2. Narcolepsy: A chronic neurological disorder characterized by excessive daytime sleepiness, cataplexy (sudden loss of muscle tone triggered by strong emotions), hypnagogic hallucinations (vivid, dream-like experiences that occur while falling asleep) and sleep paralysis (temporary inability to move or speak while falling asleep or waking up).
3. Breathing-related sleep disorders: A group of disorders that involve abnormal breathing patterns during sleep, such as obstructive sleep apnea and central sleep apnea, which can lead to difficulty initiating and maintaining sleep.
4. Circadian rhythm sleep-wake disorders: A group of disorders that involve a misalignment between the individual's internal circadian rhythm and the external environment, leading to difficulty falling asleep and staying asleep at desired times.
5. Parasomnias: A group of disorders that involve abnormal behaviors or experiences during sleep, such as sleepwalking, night terrors, and REM sleep behavior disorder, which can disrupt sleep initiation and maintenance.

These disorders can have significant impacts on an individual's quality of life, daytime functioning, and overall health, and should be evaluated and managed by a healthcare professional with expertise in sleep medicine.

Fatal Familial Insomnia (FFI) is a rare, inherited prion disease characterized by progressive insomnia that leads to death, typically within a year of onset. It is caused by a mutation in the PRNP gene, which encodes the prion protein. The mutation results in an abnormal form of the prion protein that accumulates in the brain and causes damage to nerve cells.

The symptoms of FFI usually begin in middle age and include progressive insomnia, rapid weight loss, hallucinations, confusion, and eventually dementia. As the disease progresses, patients may experience muscle spasms, rigidity, and difficulty swallowing. There is no cure for FFI, and treatment is focused on managing symptoms and providing supportive care.

FFI is inherited in an autosomal dominant manner, meaning that a person has a 50% chance of inheriting the mutated gene from an affected parent. The disease affects both men and women and has been reported in families worldwide.

Hypnotics and sedatives are classes of medications that have depressant effects on the central nervous system, leading to sedation (calming or inducing sleep), reduction in anxiety, and in some cases, decreased awareness or memory. These agents work by affecting the neurotransmitter GABA (gamma-aminobutyric acid) in the brain, which results in inhibitory effects on neuronal activity.

Hypnotics are primarily used for the treatment of insomnia and other sleep disorders, while sedatives are often prescribed to manage anxiety or to produce a calming effect before medical procedures. Some medications can function as both hypnotics and sedatives, depending on the dosage and specific formulation. Common examples of these medications include benzodiazepines (such as diazepam and lorazepam), non-benzodiazepine hypnotics (such as zolpidem and eszopiclone), barbiturates, and certain antihistamines.

It is essential to use these medications under the guidance of a healthcare professional, as they can have potential side effects, such as drowsiness, dizziness, confusion, and impaired coordination. Additionally, long-term use or high doses may lead to tolerance, dependence, and withdrawal symptoms upon discontinuation.

Sleep is a complex physiological process characterized by altered consciousness, relatively inhibited sensory activity, reduced voluntary muscle activity, and decreased interaction with the environment. It's typically associated with specific stages that can be identified through electroencephalography (EEG) patterns. These stages include rapid eye movement (REM) sleep, associated with dreaming, and non-rapid eye movement (NREM) sleep, which is further divided into three stages.

Sleep serves a variety of functions, including restoration and strengthening of the immune system, support for growth and development in children and adolescents, consolidation of memory, learning, and emotional regulation. The lack of sufficient sleep or poor quality sleep can lead to significant health problems, such as obesity, diabetes, cardiovascular disease, and even cognitive decline.

The American Academy of Sleep Medicine (AASM) defines sleep as "a period of daily recurring natural rest during which consciousness is suspended and metabolic processes are reduced." However, it's important to note that the exact mechanisms and purposes of sleep are still being researched and debated among scientists.

Polysomnography (PSG) is a comprehensive sleep study that monitors various body functions during sleep, including brain activity, eye movement, muscle tone, heart rate, respirations, and oxygen levels. It is typically conducted in a sleep laboratory under the supervision of a trained technologist. The data collected during PSG is used to diagnose and manage various sleep disorders such as sleep-related breathing disorders (e.g., sleep apnea), movement disorders (e.g., periodic limb movement disorder), parasomnias, and narcolepsy.

The study usually involves the attachment of electrodes to different parts of the body, such as the scalp, face, chest, and legs, to record electrical signals from the brain, eye movements, muscle activity, and heartbeats. Additionally, sensors may be placed on or near the nose and mouth to measure airflow, and a belt may be worn around the chest and abdomen to monitor breathing efforts. Oxygen levels are also monitored through a sensor attached to the finger or ear.

Polysomnography is often recommended when a sleep disorder is suspected based on symptoms or medical history, and other diagnostic tests have been inconclusive. The results of the study can help guide treatment decisions and improve overall sleep health.

Azabicyclo compounds are a type of organic compound that contain at least one nitrogen atom (azacycle) and two rings fused together (bicyclic). The nitrogen atom can be part of either a saturated or unsaturated ring, and the rings themselves can be composed of carbon atoms only or contain other heteroatoms such as oxygen or sulfur.

The term "azabicyclo" is often followed by a set of three numbers that specify the number of atoms in each of the three rings involved in the fusion. For example, azabicyclo[3.2.1]octane is a compound with two fused rings containing 3 and 2 carbon atoms, respectively, and one nitrogen atom forming the third ring of 1 carbon atom.

These compounds have a wide range of applications in pharmaceuticals, agrochemicals, and materials science due to their unique structures and properties. In particular, azabicyclo compounds are often used as building blocks for the synthesis of complex natural products and bioactive molecules.

Valerian is not a medical term, but rather the name of a plant (Valeriana officinalis) that has been used in herbal medicine. The root of this plant contains several chemical compounds, including valerenic acid and other volatile oils, which are believed to have sedative and anxiolytic effects.

In medical terms, Valerian is sometimes referred to as a "herbal supplement" or "botanical extract" used for the treatment of sleep disorders, anxiety, and stress. It's important to note that while some studies suggest that Valerian may help with these conditions, more research is needed to fully understand its effects and safety. As with any medication or supplement, it should be taken under the guidance of a healthcare provider.

Wakefulness is a state of consciousness in which an individual is alert and aware of their surroundings. It is characterized by the ability to perceive, process, and respond to stimuli in a purposeful manner. In a medical context, wakefulness is often assessed using measures such as the electroencephalogram (EEG) to evaluate brain activity patterns associated with consciousness.

Wakefulness is regulated by several interconnected neural networks that promote arousal and attention. These networks include the ascending reticular activating system (ARAS), which consists of a group of neurons located in the brainstem that project to the thalamus and cerebral cortex, as well as other regions involved in regulating arousal and attention, such as the basal forebrain and hypothalamus.

Disorders of wakefulness can result from various underlying conditions, including neurological disorders, sleep disorders, medication side effects, or other medical conditions that affect brain function. Examples of such disorders include narcolepsy, insomnia, hypersomnia, and various forms of encephalopathy or brain injury.

Sleep disorders are a group of conditions that affect the ability to sleep well on a regular basis. They can include problems with falling asleep, staying asleep, or waking up too early in the morning. These disorders can be caused by various factors such as stress, anxiety, depression, medical conditions, or substance abuse.

The American Academy of Sleep Medicine (AASM) recognizes over 80 distinct sleep disorders, which are categorized into the following major groups:

1. Insomnia - difficulty falling asleep or staying asleep.
2. Sleep-related breathing disorders - abnormal breathing during sleep such as obstructive sleep apnea.
3. Central disorders of hypersomnolence - excessive daytime sleepiness, including narcolepsy.
4. Circadian rhythm sleep-wake disorders - disruption of the internal body clock that regulates the sleep-wake cycle.
5. Parasomnias - abnormal behaviors during sleep such as sleepwalking or night terrors.
6. Sleep-related movement disorders - repetitive movements during sleep such as restless legs syndrome.
7. Isolated symptoms and normal variants - brief and occasional symptoms that do not warrant a specific diagnosis.

Sleep disorders can have significant impacts on an individual's quality of life, productivity, and overall health. If you suspect that you may have a sleep disorder, it is recommended to consult with a healthcare professional or a sleep specialist for proper evaluation and treatment.

Cognitive Therapy (CT) is a type of psychotherapeutic treatment that helps patients understand the thoughts and feelings that influence behaviors. It is a form of talk therapy where the therapist and the patient work together to identify and change negative or distorted thinking patterns and beliefs, with the goal of improving emotional response and behavior.

Cognitive Therapy is based on the idea that our thoughts, feelings, and behaviors are all interconnected, and that negative or inaccurate thoughts can contribute to problems like anxiety and depression. By identifying and challenging these thoughts, patients can learn to think more realistically and positively, which can lead to improvements in their mood and behavior.

In cognitive therapy sessions, the therapist will help the patient identify negative thought patterns and replace them with healthier, more accurate ways of thinking. The therapist may also assign homework or exercises for the patient to practice between sessions, such as keeping a thought record or challenging negative thoughts.

Cognitive Therapy has been shown to be effective in treating a wide range of mental health conditions, including depression, anxiety disorders, eating disorders, and post-traumatic stress disorder (PTSD). It is often used in combination with other forms of treatment, such as medication, and can be delivered individually or in group settings.

Dreams are a series of thoughts, images, and sensations occurring in a person's mind during sleep. They can be vivid or vague, positive or negative, and may involve memories, emotions, and fears. The scientific study of dreams is called oneirology. While the exact purpose and function of dreams remain a topic of debate among researchers, some theories suggest that dreaming may help with memory consolidation, problem-solving, emotional processing, and learning.

Dreams usually occur during the rapid eye movement (REM) stage of sleep, although they can also happen in non-REM stages. They are typically associated with complex brain activities, involving areas such as the amygdala, hippocampus, and the neocortex. The content of dreams can be influenced by various factors, including a person's thoughts, experiences, emotions, physical state, and environmental conditions.

It is important to note that dreaming is a natural and universal human experience, and understanding dreams can provide insights into our cognitive processes, emotional well-being, and mental health.

In a medical or physiological context, "arousal" refers to the state of being awake and responsive to stimuli. It involves the activation of the nervous system, particularly the autonomic nervous system, which prepares the body for action. Arousal levels can vary from low (such as during sleep) to high (such as during states of excitement or stress). In clinical settings, changes in arousal may be assessed to help diagnose conditions such as coma, brain injury, or sleep disorders. It is also used in the context of sexual response, where it refers to the level of physical and mental awareness and readiness for sexual activity.

Sleep stages are distinct patterns of brain activity that occur during sleep, as measured by an electroencephalogram (EEG). They are part of the sleep cycle and are used to describe the different types of sleep that humans go through during a normal night's rest. The sleep cycle includes several repeating stages:

1. Stage 1 (N1): This is the lightest stage of sleep, where you transition from wakefulness to sleep. During this stage, muscle activity and brain waves begin to slow down.
2. Stage 2 (N2): In this stage, your heart rate slows, body temperature decreases, and eye movements stop. Brain wave activity becomes slower, with occasional bursts of electrical activity called sleep spindles.
3. Stage 3 (N3): Also known as deep non-REM sleep, this stage is characterized by slow delta waves. It is during this stage that the body undergoes restorative processes such as tissue repair, growth, and immune function enhancement.
4. REM (Rapid Eye Movement) sleep: This is the stage where dreaming typically occurs. Your eyes move rapidly beneath closed eyelids, heart rate and respiration become irregular, and brain wave activity increases to levels similar to wakefulness. REM sleep is important for memory consolidation and learning.

The sleep cycle progresses through these stages multiple times during the night, with REM sleep periods becoming longer towards morning. Understanding sleep stages is crucial in diagnosing and treating various sleep disorders.

Disorders of excessive somnolence (DES) are a group of medical conditions characterized by an increased tendency to fall asleep or experience excessive daytime sleepiness (EDS), despite having adequate opportunity and circumstances for sleep. These disorders are typically classified as central disorders of hypersomnolence according to the International Classification of Sleep Disorders (ICSD-3).

The most common DES is narcolepsy, a chronic neurological disorder caused by the brain's inability to regulate sleep-wake cycles normally. Other DES include idiopathic hypersomnia, Kleine-Levin syndrome, and recurrent hypersomnia. These disorders can significantly impact an individual's daily functioning, quality of life, and overall health.

Narcolepsy is further divided into two types: narcolepsy type 1 (NT1) and narcolepsy type 2 (NT2). NT1 is characterized by the presence of cataplexy, a sudden loss of muscle tone triggered by strong emotions, while NT2 does not include cataplexy. Both types of narcolepsy involve excessive daytime sleepiness, sleep paralysis, hypnagogic/hypnopompic hallucinations, and fragmented nighttime sleep.

Idiopathic hypersomnia is a DES without the presence of REM-related symptoms like cataplexy or sleep paralysis. Individuals with idiopathic hypersomnia experience excessive daytime sleepiness and prolonged nighttime sleep, often lasting 10 to 14 hours, but do not feel refreshed upon waking.

Kleine-Levin syndrome is a rare DES characterized by recurrent episodes of excessive sleepiness, often accompanied by cognitive impairment, altered perception, hyperphagia (excessive eating), and hypersexuality during the episodes. These episodes can last days to weeks and typically occur multiple times per year.

Recurrent hypersomnia is another rare DES with recurring episodes of excessive sleepiness lasting for several days, followed by a period of normal or reduced sleepiness. The episodes are not as predictable or consistent as those seen in Kleine-Levin syndrome.

Treatment for DES typically involves pharmacological interventions to manage symptoms and improve daytime alertness. Modafinil, armodafinil, and traditional stimulants like amphetamine salts are commonly used to treat excessive daytime sleepiness. Additionally, antidepressants may be prescribed to manage REM-related symptoms like cataplexy or sleep paralysis. Non-pharmacological interventions, such as scheduled napping and good sleep hygiene practices, can also help improve symptoms.

Actigraphy is a non-invasive method used to estimate sleep-wake patterns and physical activity levels over extended periods, typically ranging from several days to weeks. It involves the use of a small device called an actigraph, which is usually worn on the wrist like a watch.

The actigraph contains an accelerometer that detects movement and records the intensity and duration of motion. This data is then analyzed using specialized software to provide information about sleep and wake times, as well as patterns of physical activity.

Actigraphy can be useful in assessing various sleep disorders, such as insomnia, circadian rhythm disorders, and sleep-related breathing disorders. It can also help evaluate the effectiveness of treatments for these conditions. However, it is important to note that actigraphy is not a substitute for a formal sleep study (polysomnography) and should be used in conjunction with other assessment tools and clinical evaluations.

Dyssomnias are a category of sleep disorders that involve problems with the amount, quality, or timing of sleep. They can be broken down into several subcategories, including:

1. Insomnia: This is characterized by difficulty falling asleep or staying asleep, despite adequate opportunity and circumstances to do so. It can result in distress, impairment in social, occupational, or other areas of functioning, and/or feelings of dissatisfaction with sleep.
2. Hypersomnias: These are disorders that involve excessive sleepiness during the day, even after having adequate opportunity for sleep. Narcolepsy is an example of a hypersomnia.
3. Sleep-related breathing disorders: These include conditions such as obstructive sleep apnea, in which breathing is repeatedly interrupted during sleep, leading to poor sleep quality and excessive daytime sleepiness.
4. Circadian rhythm sleep-wake disorders: These involve disruptions to the body's internal clock, which can result in difficulty falling asleep or staying asleep at desired times. Jet lag and shift work disorder are examples of circadian rhythm sleep-wake disorders.
5. Parasomnias: These are disruptive sleep-related events that occur during various stages of sleep, such as sleepwalking, night terrors, and REM sleep behavior disorder.

Dyssomnias can have significant impacts on a person's quality of life, and it is important to seek medical evaluation if you are experiencing symptoms. Treatment may involve lifestyle changes, medication, or other interventions depending on the specific type of dyssomnia.

A Severity of Illness Index is a measurement tool used in healthcare to assess the severity of a patient's condition and the risk of mortality or other adverse outcomes. These indices typically take into account various physiological and clinical variables, such as vital signs, laboratory values, and co-morbidities, to generate a score that reflects the patient's overall illness severity.

Examples of Severity of Illness Indices include the Acute Physiology and Chronic Health Evaluation (APACHE) system, the Simplified Acute Physiology Score (SAPS), and the Mortality Probability Model (MPM). These indices are often used in critical care settings to guide clinical decision-making, inform prognosis, and compare outcomes across different patient populations.

It is important to note that while these indices can provide valuable information about a patient's condition, they should not be used as the sole basis for clinical decision-making. Rather, they should be considered in conjunction with other factors, such as the patient's overall clinical presentation, treatment preferences, and goals of care.

A Circadian Rhythm Sleep Disorder (CRSD) is a condition in which a person's sleep-wake cycle is out of sync with the typical 24-hour day. This means that their internal "body clock" that regulates sleep and wakefulness does not align with the external environment, leading to difficulties sleeping, staying awake, or functioning at appropriate times.

CRSDs can be caused by a variety of factors, including genetic predisposition, environmental influences, and medical conditions. Some common types of CRSDs include Delayed Sleep Phase Syndrome (DSPS), Advanced Sleep Phase Syndrome (ASPS), Non-24-Hour Sleep-Wake Rhythm Disorder, and Shift Work Disorder.

Symptoms of CRSDs may include difficulty falling asleep or staying asleep at the desired time, excessive sleepiness during the day, difficulty concentrating or functioning at work or school, and mood disturbances. Treatment for CRSDs may involve lifestyle changes, such as adjusting sleep schedules or exposure to light at certain times of day, as well as medications or other therapies.

A questionnaire in the medical context is a standardized, systematic, and structured tool used to gather information from individuals regarding their symptoms, medical history, lifestyle, or other health-related factors. It typically consists of a series of written questions that can be either self-administered or administered by an interviewer. Questionnaires are widely used in various areas of healthcare, including clinical research, epidemiological studies, patient care, and health services evaluation to collect data that can inform diagnosis, treatment planning, and population health management. They provide a consistent and organized method for obtaining information from large groups or individual patients, helping to ensure accurate and comprehensive data collection while minimizing bias and variability in the information gathered.

Benzodiazepines are a class of psychoactive drugs that have been widely used for their sedative, hypnotic, anxiolytic, anticonvulsant, and muscle relaxant properties. They act by enhancing the inhibitory effects of gamma-aminobutyric acid (GABA), the major inhibitory neurotransmitter in the central nervous system.

Benzodiazepines are commonly prescribed for the treatment of anxiety disorders, insomnia, seizures, and muscle spasms. They can also be used as premedication before medical procedures to produce sedation, amnesia, and anxiolysis. Some examples of benzodiazepines include diazepam (Valium), alprazolam (Xanax), clonazepam (Klonopin), lorazepam (Ativan), and temazepam (Restoril).

While benzodiazepines are effective in treating various medical conditions, they can also cause physical dependence and withdrawal symptoms. Long-term use of benzodiazepines can lead to tolerance, meaning that higher doses are needed to achieve the same effect. Abrupt discontinuation of benzodiazepines can result in severe withdrawal symptoms, including seizures, hallucinations, and anxiety. Therefore, it is important to taper off benzodiazepines gradually under medical supervision.

Benzodiazepines are classified as Schedule IV controlled substances in the United States due to their potential for abuse and dependence. It is essential to use them only as directed by a healthcare provider and to be aware of their potential risks and benefits.

Comorbidity is the presence of one or more additional health conditions or diseases alongside a primary illness or condition. These co-occurring health issues can have an impact on the treatment plan, prognosis, and overall healthcare management of an individual. Comorbidities often interact with each other and the primary condition, leading to more complex clinical situations and increased healthcare needs. It is essential for healthcare professionals to consider and address comorbidities to provide comprehensive care and improve patient outcomes.

I'm sorry for any confusion, but "Indenes" is not a recognized medical term or concept in the field of medicine or healthcare. It may be that there is a spelling mistake or typo in your question. If you are referring to "Indenes" as a chemical compound, it is a polycyclic aromatic hydrocarbon (PAH) with the molecular formula C9H8. However, I would recommend consulting a chemistry or toxicology resource for information on its non-medical uses and properties.

Restless Legs Syndrome (RLS) is a neurological disorder characterized by an irresistible urge to move one's body to stop uncomfortable or odd sensations. It most commonly affects the legs. The condition worsens during periods of rest, particularly when lying or sitting.

The symptoms typically include:

1. An uncontrollable need or urge to move the legs to relieve uncomfortable sensations such as crawling, creeping, tingling, pulling, or painful feelings.
2. Symptoms begin or intensify during rest or inactivity.
3. Symptoms are partially or totally relieved by movement, such as walking or stretching, at least as long as the activity continues.
4. Symptoms are worse in the evening or night, often leading to disturbed sleep.

The exact cause of RLS is unknown, but it may be related to abnormalities in the brain's dopamine pathways that control muscle movements. It can also be associated with certain medical conditions like iron deficiency, kidney disease, diabetes, and pregnancy. Treatment often involves addressing any underlying conditions and using medications to manage symptoms.

Paranoid disorders are a category of mental disorders characterized by the presence of paranoia, which is defined as a persistent and unfounded distrust or suspicion of others. This can include beliefs that others are trying to harm you, deceive you, or are plotting against you. These beliefs are not based in reality and are firmly held despite evidence to the contrary.

The Diagnostic and Statistical Manual of Mental Disorders (DSM-5), which is used by mental health professionals to diagnose mental conditions, includes two paranoid disorders: Delusional Disorder and Paranoid Personality Disorder.

Delusional disorder is characterized by the presence of one or more delusions for a month or longer, with no significant hallucinations, disorganized speech, or grossly disorganized or catatonic behavior. The individual's functioning is not markedly impaired and behavior is not obviously odd or bizarre.

Paranoid personality disorder is characterized by a pervasive distrust and suspiciousness of others such that their motives are interpreted as malevolent, beginning in early adulthood and present in a variety of contexts. The individual may appear cold and aloof or may be explosively angry if they feel threatened.

It's important to note that these disorders can cause significant distress and impairment in social, occupational, and other areas of functioning. If you or someone you know is experiencing symptoms of a paranoid disorder, it's important to seek help from a qualified mental health professional.

Sleep disorders, intrinsic, refer to a group of sleep disorders that are caused by underlying medical conditions within an individual's body. These disorders originate from internal physiological or psychological factors and can significantly impact the quality, duration, and timing of sleep. The most common types of intrinsic sleep disorders include insomnia, sleep-related breathing disorders (such as sleep apnea), central hypersomnias (like narcolepsy), circadian rhythm sleep-wake disorders, and parasomnias (including nightmares and sleepwalking).

Intrinsic sleep disorders can lead to various negative consequences, such as excessive daytime sleepiness, impaired cognitive function, reduced quality of life, and increased risk of accidents or injuries. Proper diagnosis and management of these disorders typically involve addressing the underlying medical condition and implementing appropriate treatment strategies, which may include lifestyle modifications, pharmacological interventions, or medical devices.

Prevalence, in medical terms, refers to the total number of people in a given population who have a particular disease or condition at a specific point in time, or over a specified period. It is typically expressed as a percentage or a ratio of the number of cases to the size of the population. Prevalence differs from incidence, which measures the number of new cases that develop during a certain period.

Fatigue is a state of feeling very tired, weary, or exhausted, which can be physical, mental, or both. It is a common symptom that can be caused by various factors, including lack of sleep, poor nutrition, stress, medical conditions (such as anemia, diabetes, heart disease, or cancer), medications, and substance abuse. Fatigue can also be a symptom of depression or other mental health disorders. In medical terms, fatigue is often described as a subjective feeling of tiredness that is not proportional to recent activity levels and interferes with usual functioning. It is important to consult a healthcare professional if experiencing persistent or severe fatigue to determine the underlying cause and develop an appropriate treatment plan.

A depressive disorder is a mental health condition characterized by persistent feelings of sadness, hopelessness, and loss of interest or pleasure in activities. It can also include changes in sleep, appetite, energy levels, concentration, and self-esteem, as well as thoughts of death or suicide. Depressive disorders can vary in severity and duration, with some people experiencing mild and occasional symptoms, while others may have severe and chronic symptoms that interfere with their ability to function in daily life.

There are several types of depressive disorders, including major depressive disorder (MDD), persistent depressive disorder (PDD), and postpartum depression. MDD is characterized by symptoms that interfere significantly with a person's ability to function and last for at least two weeks, while PDD involves chronic low-grade depression that lasts for two years or more. Postpartum depression occurs in women after childbirth and can range from mild to severe.

Depressive disorders are thought to be caused by a combination of genetic, biological, environmental, and psychological factors. Treatment typically involves a combination of medication, psychotherapy (talk therapy), and lifestyle changes.

Doxepin is a tricyclic antidepressant (TCA) medication that is primarily used to treat depression and anxiety disorders. It works by increasing the levels of certain neurotransmitters, such as serotonin and norepinephrine, in the brain. Doxepin is also used in the treatment of insomnia, as it can help to improve sleep quality and reduce nighttime awakenings.

In addition to its antidepressant and sedative effects, doxepin has anti-inflammatory properties and is sometimes used off-label to treat chronic itching associated with various skin conditions, such as eczema and psoriasis.

Like other TCAs, doxepin can cause a range of side effects, including dry mouth, blurred vision, constipation, dizziness, and drowsiness. It may also cause weight gain, sexual dysfunction, and orthostatic hypotension (a drop in blood pressure upon standing). In rare cases, doxepin can cause more serious side effects, such as seizures, irregular heart rhythms, and serotonin syndrome (a potentially life-threatening condition caused by excessive levels of serotonin in the body).

Doxepin is available in immediate-release and extended-release forms, and is typically taken orally once or twice a day. The dosage may vary depending on the individual's age, weight, and medical history, as well as the specific condition being treated. It is important to follow the prescribing physician's instructions carefully when taking doxepin, and to report any unusual symptoms or side effects promptly.

Depression is a mood disorder that is characterized by persistent feelings of sadness, hopelessness, and loss of interest in activities. It can also cause significant changes in sleep, appetite, energy level, concentration, and behavior. Depression can interfere with daily life and normal functioning, and it can increase the risk of suicide and other mental health disorders. The exact cause of depression is not known, but it is believed to be related to a combination of genetic, biological, environmental, and psychological factors. There are several types of depression, including major depressive disorder, persistent depressive disorder, postpartum depression, and seasonal affective disorder. Treatment for depression typically involves a combination of medication and psychotherapy.

Trazodone is an antidepressant medication that belongs to the class of drugs called serotonin antagonist and reuptake inhibitors (SARIs). It works by increasing the levels of the neurotransmitter serotonin in the brain, which helps to improve mood and reduce symptoms of depression.

Trazodone is primarily used to treat major depressive disorder, but it may also be prescribed for anxiety, insomnia, and other conditions. The medication comes in various forms, including tablets and an extended-release formulation, and is typically taken orally one to three times a day. Common side effects of trazodone include dizziness, dry mouth, and sedation.

It's important to note that trazodone can interact with other medications and substances, so it's essential to inform your healthcare provider about all the drugs you are taking before starting treatment. Additionally, trazodone may increase the risk of suicidal thoughts or behavior in some people, particularly during the initial stages of treatment, so close monitoring is necessary.

Phototherapy is a medical treatment that involves the use of light to manage or improve certain conditions. It can be delivered in various forms, such as natural light exposure or artificial light sources, including lasers, light-emitting diodes (LEDs), or fluorescent lamps. The wavelength and intensity of light are carefully controlled to achieve specific therapeutic effects.

Phototherapy is most commonly used for newborns with jaundice to help break down bilirubin in the skin, reducing its levels in the bloodstream. This type of phototherapy is called bilirubin lights or bili lights.

In dermatology, phototherapy can be applied to treat various skin conditions like psoriasis, eczema, vitiligo, and acne. Narrowband ultraviolet B (UVB) therapy, PUVA (psoralen plus UVA), and blue or red light therapies are some examples of dermatological phototherapies.

Phototherapy can also be used to alleviate symptoms of seasonal affective disorder (SAD) and other mood disorders by exposing patients to bright artificial light, which helps regulate their circadian rhythms and improve their mood. This form of phototherapy is called light therapy or bright light therapy.

It's essential to consult a healthcare professional before starting any phototherapy treatment, as inappropriate use can lead to adverse effects.

A cross-sectional study is a type of observational research design that examines the relationship between variables at one point in time. It provides a snapshot or a "cross-section" of the population at a particular moment, allowing researchers to estimate the prevalence of a disease or condition and identify potential risk factors or associations.

In a cross-sectional study, data is collected from a sample of participants at a single time point, and the variables of interest are measured simultaneously. This design can be used to investigate the association between exposure and outcome, but it cannot establish causality because it does not follow changes over time.

Cross-sectional studies can be conducted using various data collection methods, such as surveys, interviews, or medical examinations. They are often used in epidemiology to estimate the prevalence of a disease or condition in a population and to identify potential risk factors that may contribute to its development. However, because cross-sectional studies only provide a snapshot of the population at one point in time, they cannot account for changes over time or determine whether exposure preceded the outcome.

Therefore, while cross-sectional studies can be useful for generating hypotheses and identifying potential associations between variables, further research using other study designs, such as cohort or case-control studies, is necessary to establish causality and confirm any findings.

Anxiety disorders are a category of mental health disorders characterized by feelings of excessive and persistent worry, fear, or anxiety that interfere with daily activities. They include several different types of disorders, such as:

1. Generalized Anxiety Disorder (GAD): This is characterized by chronic and exaggerated worry and tension, even when there is little or nothing to provoke it.
2. Panic Disorder: This is characterized by recurring unexpected panic attacks and fear of experiencing more panic attacks.
3. Social Anxiety Disorder (SAD): Also known as social phobia, this is characterized by excessive fear, anxiety, or avoidance of social situations due to feelings of embarrassment, self-consciousness, and concern about being judged or viewed negatively by others.
4. Phobias: These are intense, irrational fears of certain objects, places, or situations. When a person with a phobia encounters the object or situation they fear, they may experience panic attacks or other severe anxiety responses.
5. Agoraphobia: This is a fear of being in places where it may be difficult to escape or get help if one has a panic attack or other embarrassing or incapacitating symptoms.
6. Separation Anxiety Disorder (SAD): This is characterized by excessive anxiety about separation from home or from people to whom the individual has a strong emotional attachment (such as a parent, sibling, or partner).
7. Selective Mutism: This is a disorder where a child becomes mute in certain situations, such as at school, but can speak normally at home or with close family members.

These disorders are treatable with a combination of medication and psychotherapy (cognitive-behavioral therapy, exposure therapy). It's important to seek professional help if you suspect that you or someone you know may have an anxiety disorder.

Psychiatric Status Rating Scales are standardized assessment tools used by mental health professionals to evaluate and rate the severity of a person's psychiatric symptoms and functioning. These scales provide a systematic and structured approach to measuring various aspects of an individual's mental health, such as mood, anxiety, psychosis, behavior, and cognitive abilities.

The purpose of using Psychiatric Status Rating Scales is to:

1. Assess the severity and improvement of psychiatric symptoms over time.
2. Aid in diagnostic decision-making and treatment planning.
3. Monitor treatment response and adjust interventions accordingly.
4. Facilitate communication among mental health professionals about a patient's status.
5. Provide an objective basis for research and epidemiological studies.

Examples of Psychiatric Status Rating Scales include:

1. Clinical Global Impression (CGI): A brief, subjective rating scale that measures overall illness severity, treatment response, and improvement.
2. Positive and Negative Syndrome Scale (PANSS): A comprehensive scale used to assess the symptoms of psychosis, including positive, negative, and general psychopathology domains.
3. Hamilton Rating Scale for Depression (HRSD) or Montgomery-Ã…sberg Depression Rating Scale (MADRS): Scales used to evaluate the severity of depressive symptoms.
4. Young Mania Rating Scale (YMRS): A scale used to assess the severity of manic or hypomanic symptoms.
5. Brief Psychiatric Rating Scale (BPRS) or Symptom Checklist-90 Revised (SCL-90-R): Scales that measure a broad range of psychiatric symptoms and psychopathology.
6. Global Assessment of Functioning (GAF): A scale used to rate an individual's overall psychological, social, and occupational functioning on a hypothetical continuum of mental health-illness.

It is important to note that Psychiatric Status Rating Scales should be administered by trained mental health professionals to ensure accurate and reliable results.

Suicidal ideation is a medical term used to describe thoughts about, or an unusual preoccupation with, suicide. The range of suicidal ideation varies greatly from fleeting thoughts, to extensive thoughts, to detailed planning, role playing, and incomplete attempts, which may be deliberately constructed to not complete or to be discovered, or may be fully intended to result in death.

It's important to take any mention of suicide seriously and seek immediate help from a healthcare professional if someone is experiencing suicidal ideation. Mental health conditions such as depression, bipolar disorder, schizophrenia, borderline personality disorder, and substance abuse are commonly associated with an increased risk of suicidal thoughts.

If you or someone you know is struggling with suicidal thoughts, please reach out to a mental health professional or trusted person immediately. In the US, contact the National Suicide Prevention Lifeline at 1-800-273-TALK (1-800-273-8255) or use the Crisis Text Line by texting HOME to 741741.

Sleep deprivation is a condition that occurs when an individual fails to get sufficient quality sleep or the recommended amount of sleep, typically 7-9 hours for adults. This can lead to various physical and mental health issues. It can be acute, lasting for one night or a few days, or chronic, persisting over a longer period.

The consequences of sleep deprivation include:

1. Fatigue and lack of energy
2. Difficulty concentrating or remembering things
3. Mood changes, such as irritability or depression
4. Weakened immune system
5. Increased appetite and potential weight gain
6. Higher risk of accidents due to decreased reaction time
7. Health problems like high blood pressure, diabetes, and heart disease over time

Sleep deprivation can be caused by various factors, including stress, shift work, sleep disorders like insomnia or sleep apnea, poor sleep hygiene, and certain medications. It's essential to address the underlying causes of sleep deprivation to ensure proper rest and overall well-being.

Anti-anxiety agents, also known as anxiolytics, are a class of medications used to manage symptoms of anxiety disorders. These drugs work by reducing the abnormal excitement in the brain and promoting relaxation and calmness. They include several types of medications such as benzodiazepines, azapirone, antihistamines, and beta-blockers.

Benzodiazepines are the most commonly prescribed anti-anxiety agents. They work by enhancing the inhibitory effects of a neurotransmitter called gamma-aminobutyric acid (GABA) in the brain, which results in sedative, hypnotic, anxiolytic, anticonvulsant, and muscle relaxant properties. Examples of benzodiazepines include diazepam (Valium), alprazolam (Xanax), lorazepam (Ativan), and clonazepam (Klonopin).

Azapirones are a newer class of anti-anxiety agents that act on serotonin receptors in the brain. Buspirone (Buspar) is an example of this type of medication, which has fewer side effects and less potential for abuse compared to benzodiazepines.

Antihistamines are medications that are primarily used to treat allergies but can also have anti-anxiety effects due to their sedative properties. Examples include hydroxyzine (Vistaril, Atarax) and diphenhydramine (Benadryl).

Beta-blockers are mainly used to treat high blood pressure and heart conditions but can also help manage symptoms of anxiety such as rapid heartbeat, tremors, and sweating. Propranolol (Inderal) is an example of a beta-blocker used for this purpose.

It's important to note that anti-anxiety agents should be used under the guidance of a healthcare professional, as they can have side effects and potential for dependence or addiction. Additionally, these medications are often used in combination with psychotherapy and lifestyle modifications to manage anxiety disorders effectively.

Major Depressive Disorder (MDD), also simply referred to as depression, is a serious mental health condition characterized by the presence of one or more major depressive episodes. A major depressive episode is a period of at least two weeks during which an individual experiences a severely depressed mood and/or loss of interest or pleasure in nearly all activities, accompanied by at least four additional symptoms such as significant changes in appetite or weight, sleep disturbances, psychomotor agitation or retardation, fatigue or loss of energy, feelings of worthlessness or excessive guilt, difficulty thinking, concentrating, or making decisions, and recurrent thoughts of death or suicide.

MDD can significantly impair an individual's ability to function in daily life, and it is associated with increased risks of suicide, substance abuse, and other mental health disorders. The exact cause of MDD is not fully understood, but it is believed to result from a complex interplay of genetic, biological, environmental, and psychological factors. Treatment typically involves a combination of psychotherapy (such as cognitive-behavioral therapy) and medication (such as selective serotonin reuptake inhibitors or tricyclic antidepressants).

Behavior therapy is a type of psychotherapy that focuses on modifying harmful or unhealthy behaviors, thoughts, and emotions by applying learning principles derived from behavioral psychology. The goal of behavior therapy is to reinforce positive behaviors and eliminate negative ones through various techniques such as systematic desensitization, aversion therapy, exposure therapy, and operant conditioning.

Systematic desensitization involves gradually exposing the individual to a feared situation or stimulus while teaching them relaxation techniques to reduce anxiety. Aversion therapy aims to associate an undesirable behavior with an unpleasant stimulus to discourage the behavior. Exposure therapy exposes the individual to a feared situation or object in a controlled and safe environment to help them overcome their fear. Operant conditioning uses reinforcement and punishment to encourage desirable behaviors and discourage undesirable ones.

Behavior therapy has been found to be effective in treating various mental health conditions, including anxiety disorders, phobias, depression, obsessive-compulsive disorder, post-traumatic stress disorder, and substance use disorders. It is often used in combination with other forms of therapy and medication to provide a comprehensive treatment plan for individuals seeking help for mental health concerns.

REM sleep, or Rapid Eye Movement sleep, is a stage of sleep characterized by rapid eye movements, low muscle tone, and active brain activity. It is one of the two main types of sleep along with non-REM sleep and is marked by vivid dreaming, increased brain metabolism, and altered brain wave patterns. REM sleep is often referred to as "paradoxical sleep" because of the seemingly contradictory nature of its characteristics - an active brain in a state of relaxation. It is thought to play a role in memory consolidation, learning, and mood regulation. A typical night's sleep cycle includes several episodes of REM sleep, with each episode becoming longer as the night progresses.

A chronic disease is a long-term medical condition that often progresses slowly over a period of years and requires ongoing management and care. These diseases are typically not fully curable, but symptoms can be managed to improve quality of life. Common chronic diseases include heart disease, stroke, cancer, diabetes, arthritis, and COPD (chronic obstructive pulmonary disease). They are often associated with advanced age, although they can also affect children and younger adults. Chronic diseases can have significant impacts on individuals' physical, emotional, and social well-being, as well as on healthcare systems and society at large.

The double-blind method is a study design commonly used in research, including clinical trials, to minimize bias and ensure the objectivity of results. In this approach, both the participants and the researchers are unaware of which group the participants are assigned to, whether it be the experimental group or the control group. This means that neither the participants nor the researchers know who is receiving a particular treatment or placebo, thus reducing the potential for bias in the evaluation of outcomes. The assignment of participants to groups is typically done by a third party not involved in the study, and the codes are only revealed after all data have been collected and analyzed.

Nocturnal Myoclonus Syndrome, also known as Periodic Limb Movement Disorder (PLMD), is a condition characterized by recurring involuntary jerking movements of the limbs during sleep, particularly the legs. These movements typically occur every 20-40 seconds and can last for an hour or more throughout the night. They often disrupt normal sleep patterns, causing insomnia or excessive daytime sleepiness.

The movements are usually jerky, rapid, and rhythmic, involving extension of the big toe and flexion of the ankle, knee, or hip. In some cases, these movements can be so forceful that they cause the person to wake up, although often individuals with this condition may not be aware of their nighttime leg movements.

Nocturnal Myoclonus Syndrome is different from another common sleep disorder called Restless Legs Syndrome (RLS), as RLS primarily causes discomfort or an irresistible urge to move the legs while awake and still, whereas Nocturnal Myoclonus Syndrome involves involuntary movements during sleep. However, up to 80% of people with RLS also have PLMD.

The exact cause of Nocturnal Myoclonus Syndrome is not fully understood, but it may be associated with abnormalities in the brain's regulation of muscle activity during sleep. Certain medications, neurological conditions, and iron deficiency anemia have been linked to an increased risk of developing this disorder. Treatment options include medication, lifestyle changes, and addressing any underlying medical conditions that may contribute to the development or worsening of symptoms.

Treatment outcome is a term used to describe the result or effect of medical treatment on a patient's health status. It can be measured in various ways, such as through symptoms improvement, disease remission, reduced disability, improved quality of life, or survival rates. The treatment outcome helps healthcare providers evaluate the effectiveness of a particular treatment plan and make informed decisions about future care. It is also used in clinical research to compare the efficacy of different treatments and improve patient care.

Health surveys are research studies that collect data from a sample population to describe the current health status, health behaviors, and healthcare utilization of a particular group or community. These surveys may include questions about various aspects of health such as physical health, mental health, chronic conditions, lifestyle habits, access to healthcare services, and demographic information. The data collected from health surveys can be used to monitor trends in health over time, identify disparities in health outcomes, develop and evaluate public health programs and policies, and inform resource allocation decisions. Examples of national health surveys include the National Health Interview Survey (NHIS) and the Behavioral Risk Factor Surveillance System (BRFSS).

A circadian rhythm is a roughly 24-hour biological cycle that regulates various physiological and behavioral processes in living organisms. It is driven by the body's internal clock, which is primarily located in the suprachiasmatic nucleus (SCN) of the hypothalamus in the brain.

The circadian rhythm controls many aspects of human physiology, including sleep-wake cycles, hormone secretion, body temperature, and metabolism. It helps to synchronize these processes with the external environment, particularly the day-night cycle caused by the rotation of the Earth.

Disruptions to the circadian rhythm can have negative effects on health, leading to conditions such as insomnia, sleep disorders, depression, bipolar disorder, and even increased risk of chronic diseases like cancer, diabetes, and cardiovascular disease. Factors that can disrupt the circadian rhythm include shift work, jet lag, irregular sleep schedules, and exposure to artificial light at night.

"Passiflora" is a genus of flowering plants, commonly known as passion flowers or passion vines. While it is not a medical term itself, certain species of Passiflora are used in herbal medicine. The most common medicinal use of Passiflora is Passiflora incarnata, also known as maypop or purple passionflower. This plant is used as a natural sedative and anxiety reliever due to its calming effects on the nervous system. It contains various chemical compounds such as flavonoids, indole alkaloids, and glycosides which contribute to its medicinal properties. It's often used in teas, supplements, and tinctures for promoting relaxation, reducing insomnia, and treating symptoms of anxiety and stress.

Temazepam is a benzodiazepine medication that is primarily used for the treatment of insomnia. It has a depressant effect on the central nervous system and helps to slow down brain activity, allowing for relaxation and promoting sleep. Temazepam works by binding to specific receptors in the brain called GABA-A receptors, which are involved in regulating nerve impulses in the brain. This action increases the activity of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), resulting in sedative, hypnotic, anxiolytic, anticonvulsant, and muscle relaxant effects.

Temazepam is available in immediate-release and controlled-release formulations, with the former typically taken just before bedtime and the latter taken at bedtime to help people stay asleep throughout the night. It is important to note that temazepam can be habit-forming and should only be used under the supervision of a healthcare provider. Common side effects include drowsiness, dizziness, weakness, and coordination problems.

Melatonin is a hormone that is produced by the pineal gland in the brain. It helps regulate sleep-wake cycles and is often referred to as the "hormone of darkness" because its production is stimulated by darkness and inhibited by light. Melatonin plays a key role in synchronizing the circadian rhythm, the body's internal clock that regulates various biological processes over a 24-hour period.

Melatonin is primarily released at night, and its levels in the blood can rise and fall in response to changes in light and darkness in an individual's environment. Supplementing with melatonin has been found to be helpful in treating sleep disorders such as insomnia, jet lag, and delayed sleep phase syndrome. It may also have other benefits, including antioxidant properties and potential uses in the treatment of certain neurological conditions.

It is important to note that while melatonin supplements are available over-the-counter in many countries, they should still be used under the guidance of a healthcare professional, as their use can have potential side effects and interactions with other medications.

The MMPI, or Minnesota Multiphasic Personality Inventory, is a psychological assessment tool that is widely used in clinical and research settings to help evaluate an individual's personality, emotional state, and behavior. It consists of a series of true-false questions that are designed to measure various aspects of an individual's psychological functioning, including their attitudes, beliefs, and behaviors.

The MMPI was first developed in the 1930s and has undergone several revisions over the years. The current version, the MMPI-2, consists of 567 items and takes approximately 60-90 minutes to complete. The test is typically administered by a trained professional, such as a psychologist or counselor, who uses the results to help diagnose mental health conditions, develop treatment plans, and make recommendations about an individual's care.

It is important to note that while the MMPI can be a useful tool in assessing psychological functioning, it should not be used as the sole basis for making diagnostic or treatment decisions. It is typically used in conjunction with other assessment methods, such as clinical interviews and other tests, to provide a comprehensive picture of an individual's psychological state.

Anxiety: A feeling of worry, nervousness, or unease, typically about an imminent event or something with an uncertain outcome. In a medical context, anxiety refers to a mental health disorder characterized by feelings of excessive and persistent worry, fear, or panic that interfere with daily activities. It can also be a symptom of other medical conditions, such as heart disease, diabetes, or substance abuse disorders. Anxiety disorders include generalized anxiety disorder, panic disorder, social anxiety disorder, and phobias.

Sleep apnea syndromes refer to a group of disorders characterized by abnormal breathing patterns during sleep. These patterns can result in repeated pauses in breathing (apneas) or shallow breaths (hypopneas), causing interruptions in sleep and decreased oxygen supply to the body. There are three main types of sleep apnea syndromes:

1. Obstructive Sleep Apnea (OSA): This is the most common form, caused by the collapse or obstruction of the upper airway during sleep, often due to relaxation of the muscles in the throat and tongue.

2. Central Sleep Apnea (CSA): This type is less common and results from the brain's failure to send proper signals to the breathing muscles. It can be associated with conditions such as heart failure, stroke, or certain medications.

3. Complex/Mixed Sleep Apnea: In some cases, a person may experience both obstructive and central sleep apnea symptoms, known as complex or mixed sleep apnea.

Symptoms of sleep apnea syndromes can include loud snoring, excessive daytime sleepiness, fatigue, morning headaches, difficulty concentrating, and mood changes. Diagnosis typically involves a sleep study (polysomnography) to monitor breathing patterns, heart rate, brain activity, and other physiological factors during sleep. Treatment options may include lifestyle modifications, oral appliances, positive airway pressure therapy, or even surgery in severe cases.

Quality of Life (QOL) is a broad, multidimensional concept that usually includes an individual's physical health, psychological state, level of independence, social relationships, personal beliefs, and their relationship to salient features of their environment. It reflects the impact of disease and treatment on a patient's overall well-being and ability to function in daily life.

The World Health Organization (WHO) defines QOL as "an individual's perception of their position in life in the context of the culture and value systems in which they live and in relation to their goals, expectations, standards and concerns." It is a subjective concept, meaning it can vary greatly from person to person.

In healthcare, QOL is often used as an outcome measure in clinical trials and other research studies to assess the impact of interventions or treatments on overall patient well-being.

"Humulus" is a term that refers to a genus of plants, specifically the hop plant. The hop plant belongs to the Cannabaceae family and is native to Europe, western Asia, and North America. The humulus plant has climbing or trailing stems and produces separate male and female flowers on different plants.

The female flowers, known as hops, are used in the brewing industry to add flavor, aroma, and preservative qualities to beer. Hops contain resins and essential oils that contribute to the bitter taste and floral or citrusy notes of beer. They also have antibacterial properties that help to stabilize and preserve the beverage.

In a medical context, hops are sometimes used in herbal medicine for their sedative and calming effects. They may be prepared as teas, tinctures, or extracts and can be used to treat anxiety, insomnia, restlessness, and other conditions related to nervous tension. However, it's important to note that the scientific evidence supporting these uses is limited, and hops should not be used as a substitute for medical treatment without consulting a healthcare professional.

Parasomnias are a category of sleep disorders that involve unwanted physical events or experiences that occur while falling asleep, sleeping, or waking up. These behaviors can include abnormal movements, talk, emotions, perceptions, or dreams. Parasomnias can be caused by various factors such as stress, alcohol, certain medications, or underlying medical conditions. Some examples of parasomnias are sleepwalking, night terrors, sleep talking, and REM sleep behavior disorder. These disorders can disrupt sleep and cause distress to the individual and their bed partner.

Medical Definition:

"Risk factors" are any attribute, characteristic or exposure of an individual that increases the likelihood of developing a disease or injury. They can be divided into modifiable and non-modifiable risk factors. Modifiable risk factors are those that can be changed through lifestyle choices or medical treatment, while non-modifiable risk factors are inherent traits such as age, gender, or genetic predisposition. Examples of modifiable risk factors include smoking, alcohol consumption, physical inactivity, and unhealthy diet, while non-modifiable risk factors include age, sex, and family history. It is important to note that having a risk factor does not guarantee that a person will develop the disease, but rather indicates an increased susceptibility.

A melatonin receptor is a type of G protein-coupled receptor (GPCR) that binds to the hormone melatonin, which is primarily involved in regulating sleep-wake cycles. There are two main subtypes of melatonin receptors, MT1 and MT2, which are encoded by the genes MTNR1A and MTNR1B, respectively.

MT2 receptor, also known as Mel1b or MTNR1B, is a subtype of melatonin receptor that is widely expressed in various tissues, including the retina, brain, heart, and gastrointestinal tract. MT2 receptors are involved in several physiological functions, such as circadian rhythm regulation, sleep onset and duration, and neuroprotection.

MT2 receptor activation has been shown to promote sleep onset and consolidation, reduce anxiety and depressive-like behaviors, and improve cognitive function. Additionally, MT2 receptors have been implicated in the regulation of glucose metabolism, insulin secretion, and energy homeostasis, suggesting a potential role in the treatment of metabolic disorders such as diabetes.

Overall, melatonin receptors, particularly the MT2 subtype, are important targets for developing therapies for sleep disorders, neuropsychiatric conditions, and metabolic diseases.

A melatonin receptor is a type of G protein-coupled receptor (GPCR) that binds to the hormone melatonin, which plays a crucial role in regulating sleep-wake cycles and other physiological functions. There are two main types of melatonin receptors: MT1 (also known as Mel1a or MTNR1A) and MT2 (also known as Mel1b or MTNR1B).

MT1 receptor, specifically, is a gene that encodes for the MT1 melatonin receptor protein. This receptor is primarily expressed in the suprachiasmatic nucleus (SCN) of the hypothalamus, which is the body's central circadian pacemaker, as well as in various other tissues such as the retina, pineal gland, and peripheral blood vessels. The activation of MT1 receptors by melatonin can lead to a variety of downstream effects, including the regulation of sleep onset and duration, circadian rhythm entrainment, and the modulation of mood and cognitive function. Additionally, MT1 receptors have been implicated in the regulation of several other physiological processes such as blood pressure, body temperature, and immune function.

Relaxation therapy is not a specific type of therapy with its own distinct medical definition. Rather, relaxation is a common element that is incorporated into many types of therapies and techniques aimed at reducing stress, anxiety, and promoting physical and mental relaxation. These techniques can include various forms of mind-body interventions such as deep breathing exercises, progressive muscle relaxation, guided imagery, meditation, yoga, tai chi, and biofeedback.

The goal of relaxation therapy is to help individuals learn to control their physiological responses to stress and anxiety, leading to a reduction in muscle tension, lower heart rate and blood pressure, and an overall sense of calm and well-being. While relaxation therapy is not typically used as a standalone treatment for medical conditions, it can be a useful adjunctive therapy when combined with other treatments for a variety of physical and mental health concerns.

Estazolam is a benzodiazepine medication that is primarily used for the treatment of insomnia. It has a sedative, hypnotic, and muscle relaxant effect. Estazolam works by enhancing the activity of gamma-aminobutyric acid (GABA), a neurotransmitter in the brain that inhibits nerve impulses, thereby producing a calming effect.

The medication is available in tablet form and is typically taken orally before bedtime. It has a rapid onset of action and its effects can last for several hours. Estazolam is generally considered to be safe and effective when used as directed, but like all benzodiazepines, it carries a risk of dependence and withdrawal symptoms if used for prolonged periods or in high doses.

It's important to note that estazolam should only be taken under the supervision of a healthcare provider, and that its use may be contraindicated in certain individuals, such as those with respiratory problems, liver disease, or a history of substance abuse. Additionally, estazolam can interact with other medications, so it's important to inform your doctor of all medications you are taking before starting this drug.

"Materia Medica" is a term that comes from the Latin language, where "materia" means "substance" or "material," and "medica" refers to "medical." In a medical context, Materia Medica historically refers to a collection of detailed descriptions of substances that are used for medicinal purposes.

It is essentially a comprehensive reference book that describes the properties, actions, uses, dosages, potential side effects, and contraindications of various drugs or medicinal agents. The information in a Materia Medica is typically based on historical use, experimental pharmacological data, clinical trials, and other scientific research.

Modern Materia Medica has evolved to become more specialized, with separate references for different types of medicinal substances, such as botanical (herbal) medicine, homeopathic remedies, or conventional pharmaceuticals. These resources are often used by healthcare professionals, including physicians, pharmacists, and nurses, to guide their prescribing decisions and ensure the safe and effective use of medications for their patients.

'Strychnos nux-vomica' is a plant species also known as the poison nut tree or strychnine tree. Its seeds, known as nux vomica, contain several alkaloids including strychnine and brucine, which have been used in medicine for their stimulant and convulsant properties. However, due to the high toxicity and narrow therapeutic index of these compounds, the use of 'Strychnos nux-vomica' in modern medicine is very limited and generally not recommended.

It's important to note that while some alkaloids found in 'Strychnos nux-vomica' have been used in homeopathy, there is a lack of scientific evidence supporting their efficacy, and they should only be used under the guidance of a qualified healthcare professional.

Meditation is not a medical term, but it is often used in the context of mental and physical health. The National Center for Complementary and Integrative Health (NCCIH) defines meditation as "a mind and body practice where an individual uses a technique – such as mindfulness, or focusing the mind on a particular object, thought, or activity – to train attention and awareness, and achieve a mentally clear and emotionally calm and stable state."

Meditation can be used as a means of reducing stress and improving overall health and well-being. Some research suggests that meditation may have beneficial effects on conditions such as anxiety, depression, high blood pressure, and chronic pain. However, more rigorous studies are needed to fully understand the potential benefits and risks of meditation as a medical intervention.

I'm sorry for any confusion, but "Quebec" is not a medical term. It is a place name, referring to the Canadian province of Quebec. If you have any questions about medical terms or concepts, I would be happy to help answer those!

Electroencephalography (EEG) is a medical procedure that records electrical activity in the brain. It uses small, metal discs called electrodes, which are attached to the scalp with paste or a specialized cap. These electrodes detect tiny electrical charges that result from the activity of brain cells, and the EEG machine then amplifies and records these signals.

EEG is used to diagnose various conditions related to the brain, such as seizures, sleep disorders, head injuries, infections, and degenerative diseases like Alzheimer's or Parkinson's. It can also be used during surgery to monitor brain activity and ensure that surgical procedures do not interfere with vital functions.

EEG is a safe and non-invasive procedure that typically takes about 30 minutes to an hour to complete, although longer recordings may be necessary in some cases. Patients are usually asked to relax and remain still during the test, as movement can affect the quality of the recording.

In medical and psychological terms, "affect" refers to a person's emotional or expressive state, mood, or dispositions that are outwardly manifested in their behavior, facial expressions, demeanor, or speech. Affect can be described as being congruent or incongruent with an individual's thoughts and experiences.

There are different types of affect, including:

1. Neutral affect: When a person shows no apparent emotion or displays minimal emotional expressiveness.
2. Positive affect: When a person exhibits positive emotions such as happiness, excitement, or enthusiasm.
3. Negative affect: When a person experiences and displays negative emotions like sadness, anger, or fear.
4. Blunted affect: When a person's emotional response is noticeably reduced or diminished, often observed in individuals with certain mental health conditions, such as schizophrenia.
5. Flat affect: When a person has an almost complete absence of emotional expressiveness, which can be indicative of severe depression or other mental health disorders.
6. Labile affect: When a person's emotional state fluctuates rapidly and frequently between positive and negative emotions, often observed in individuals with certain neurological conditions or mood disorders.

Clinicians may assess a patient's affect during an interview or examination to help diagnose mental health conditions, evaluate treatment progress, or monitor overall well-being.

Acupuncture therapy is a form of traditional Chinese medicine that involves the insertion of thin needles into specific points on the body to stimulate the flow of energy (Qi), balance the vital force (Chi), and promote healing. It is based on the concept of meridians, or pathways, through which this energy flows. Acupuncture therapy is used to treat a variety of conditions, including pain, stress, anxiety, insomnia, digestive disorders, and reproductive health issues. According to Western medicine, acupuncture may work by stimulating the nervous system, increasing blood flow, and releasing natural pain-relieving chemicals called endorphins. It is generally considered safe when performed by a qualified practitioner using sterile needles.

Oxazepam is a benzodiazepine medication that is primarily used to treat anxiety disorders and symptoms such as sleeplessness and irritability. It works by enhancing the activity of gamma-aminobutyric acid (GABA), a neurotransmitter that inhibits the activity of certain neurons in the brain, producing a calming effect.

In medical terms, oxazepam can be defined as follows:

Oxazepam is a Schedule IV controlled substance, indicating that it has a potential for abuse and dependence. It is available in tablet form and is typically taken two to four times per day. Common side effects of oxazepam include drowsiness, dizziness, and weakness. More serious side effects can include memory problems, confusion, and difficulty breathing.

It's important to note that oxazepam should only be used under the supervision of a healthcare provider, as it can have significant risks and interactions with other medications. It is not recommended for use in pregnant women or those with a history of substance abuse.

Obsessive behavior is defined in the medical context as repetitive, persistent, and intrusive thoughts, images, or urges that cause distress or anxiety. These obsessions are not simply excessive worries about real-life problems, but rather they are irrational and uncontrollable. Often, individuals with obsessive behavior attempt to ignore or suppress their obsessions, which can lead to increased distress and anxiety. In some cases, the obsessions may become so overwhelming that they interfere with a person's daily life and ability to function.

Obsessive behavior is a key feature of several mental health conditions, including obsessive-compulsive disorder (OCD), body dysmorphic disorder (BDD), and hoarding disorder. In these conditions, the obsessions are often accompanied by compulsive behaviors that are performed in an attempt to alleviate the anxiety or distress caused by the obsessions.

It is important to note that everyone experiences unwanted thoughts or urges from time to time. However, when these thoughts become so frequent and distressing that they interfere with a person's daily life, it may be indicative of an underlying mental health condition. In such cases, it is recommended to seek professional help from a qualified mental health provider.

The climacteric, also known as perimenopause or menopausal transition, is a phase in a woman's reproductive life characterized by various physiological and hormonal changes that occur as she approaches menopause. The term "climacteric" comes from the Greek word "klimakter," which means "ladder" or "rung of a ladder."

During this phase, which typically begins in a woman's mid-to-late 40s and can last for several years, the production of estrogen and progesterone by the ovaries starts to decline. This decline in hormone levels can lead to a variety of symptoms, including:

* Irregular menstrual cycles
* Hot flashes and night sweats
* Sleep disturbances
* Mood changes
* Vaginal dryness and discomfort during sexual activity
* Decreased libido
* Urinary frequency or urgency
* Memory and cognitive changes

The climacteric is a natural phase of a woman's life, and while some women may experience significant symptoms, others may have few or no symptoms at all. Hormone replacement therapy (HRT) and other treatments are available to help manage the symptoms of the climacteric for those who find them disruptive or bothersome.

In the field of medicine, "time factors" refer to the duration of symptoms or time elapsed since the onset of a medical condition, which can have significant implications for diagnosis and treatment. Understanding time factors is crucial in determining the progression of a disease, evaluating the effectiveness of treatments, and making critical decisions regarding patient care.

For example, in stroke management, "time is brain," meaning that rapid intervention within a specific time frame (usually within 4.5 hours) is essential to administering tissue plasminogen activator (tPA), a clot-busting drug that can minimize brain damage and improve patient outcomes. Similarly, in trauma care, the "golden hour" concept emphasizes the importance of providing definitive care within the first 60 minutes after injury to increase survival rates and reduce morbidity.

Time factors also play a role in monitoring the progression of chronic conditions like diabetes or heart disease, where regular follow-ups and assessments help determine appropriate treatment adjustments and prevent complications. In infectious diseases, time factors are crucial for initiating antibiotic therapy and identifying potential outbreaks to control their spread.

Overall, "time factors" encompass the significance of recognizing and acting promptly in various medical scenarios to optimize patient outcomes and provide effective care.

Obstructive Sleep Apnea (OSA) is a sleep-related breathing disorder that occurs when the upper airway becomes partially or completely blocked during sleep, leading to pauses in breathing or shallow breaths. These episodes, known as apneas or hypopneas, can last for 10 seconds or longer and may occur multiple times throughout the night, disrupting normal sleep patterns and causing oxygen levels in the blood to drop.

The obstruction in OSA is typically caused by the relaxation of the muscles in the back of the throat during sleep, which allows the soft tissues to collapse and block the airway. This can result in snoring, choking, gasping for air, or awakening from sleep with a start.

Contributing factors to OSA may include obesity, large neck circumference, enlarged tonsils or adenoids, alcohol consumption, smoking, and use of sedatives or muscle relaxants. Untreated OSA can lead to serious health consequences such as high blood pressure, heart disease, stroke, diabetes, and cognitive impairment. Treatment options for OSA include lifestyle changes, oral appliances, positive airway pressure therapy, and surgery.

In the context of medical terminology, a "habit" refers to a regular, repeated behavior or practice that is often performed automatically or subconsciously. Habits can be physical (such as biting nails) or mental (such as worrying). They can be harmless, beneficial (like regularly brushing your teeth), or harmful (like smoking cigarettes).

Habits are different from instincts or reflexes because they involve a learned behavior that has been repeated and reinforced over time. Breaking a habit can often be challenging due to the deeply ingrained nature of the behavior.

Substance Withdrawal Syndrome is a medically recognized condition that occurs when an individual who has been using certain substances, such as alcohol, opioids, or benzodiazepines, suddenly stops or significantly reduces their use. The syndrome is characterized by a specific set of symptoms that can be physical, cognitive, and emotional in nature. These symptoms can vary widely depending on the substance that was being used, the length and intensity of the addiction, and individual factors such as genetics, age, and overall health.

The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), published by the American Psychiatric Association, provides the following diagnostic criteria for Substance Withdrawal Syndrome:

A. The development of objective evidence of withdrawal, referring to the specific physiological changes associated with the particular substance, or subjective evidence of withdrawal, characterized by the individual's report of symptoms that correspond to the typical withdrawal syndrome for the substance.

B. The symptoms cause clinically significant distress or impairment in social, occupational, or other important areas of functioning.

C. The symptoms are not better explained by co-occurring mental, medical, or other substance use disorders.

D. The withdrawal syndrome is not attributable to another medical condition and is not better accounted for by another mental disorder.

The DSM-5 also specifies that the diagnosis of Substance Withdrawal Syndrome should be substance-specific, meaning that it should specify the particular class of substances (e.g., alcohol, opioids, benzodiazepines) responsible for the withdrawal symptoms. This is important because different substances have distinct withdrawal syndromes and require different approaches to management and treatment.

In general, Substance Withdrawal Syndrome can be a challenging and potentially dangerous condition that requires professional medical supervision and support during the detoxification process. The specific symptoms and their severity will vary depending on the substance involved, but they may include:

* For alcohol: tremors, seizures, hallucinations, agitation, anxiety, nausea, vomiting, and insomnia.
* For opioids: muscle aches, restlessness, lacrimation (tearing), rhinorrhea (runny nose), yawning, perspiration, chills, mydriasis (dilated pupils), piloerection (goosebumps), nausea or vomiting, diarrhea, and abdominal cramps.
* For benzodiazepines: anxiety, irritability, insomnia, restlessness, confusion, hallucinations, seizures, and increased heart rate and blood pressure.

It is essential to consult with a healthcare professional if you or someone you know is experiencing symptoms of Substance Withdrawal Syndrome. They can provide appropriate medical care, support, and referrals for further treatment as needed.

Asperger Syndrome is a developmental disorder that is part of the autism spectrum disorders (ASDs). It is characterized by significant difficulties in social interaction and nonverbal communication, as well as restricted and repetitive patterns of behavior and interests. However, people with Asperger Syndrome usually have normal or above-average intelligence and language development.

The following are some of the diagnostic criteria for Asperger Syndrome according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5):

1. Persistent deficits in social communication and social interaction across multiple contexts, including:
* Deficits in social-emotional reciprocity;
* Deficits in nonverbal communicative behaviors used for social interaction;
* Deficits in developing, maintaining, and understanding relationships.
2. Restricted, repetitive patterns of behavior, interests, or activities, as manifested by at least two of the following:
* Stereotyped or repetitive motor movements, use of objects, or speech;
* Insistence on sameness, inflexible adherence to routines, or ritualized patterns of verbal or nonverbal behavior;
* Highly restricted, fixated interests that are abnormal in intensity or focus;
* Hyper- or hyporeactivity to sensory input or unusual interest in sensory aspects of the environment.
3. Symptoms must be present in early childhood but may not become fully manifest until social demands exceed limited capacities or may be masked by learned strategies in later life.
4. Symptoms cause clinically significant impairment in social, occupational, or other important areas of functioning.
5. These disturbances are not better explained by intellectual disability (intellectual developmental disorder) or global developmental delay.

It's worth noting that the term "Asperger Syndrome" is no longer used in the DSM-5, and it has been subsumed under the broader category of autism spectrum disorder. However, many people still use the term to describe a particular presentation of ASD with normal language development and intelligence.

In a medical context, efficiency generally refers to the ability to achieve a desired outcome with minimal waste of time, effort, or resources. It can be applied to various aspects of healthcare, including the delivery of clinical services, the use of medical treatments and interventions, and the operation of health systems and organizations. High levels of efficiency can help to improve patient outcomes, increase access to care, and reduce costs.

Longitudinal studies are a type of research design where data is collected from the same subjects repeatedly over a period of time, often years or even decades. These studies are used to establish patterns of changes and events over time, and can help researchers identify causal relationships between variables. They are particularly useful in fields such as epidemiology, psychology, and sociology, where the focus is on understanding developmental trends and the long-term effects of various factors on health and behavior.

In medical research, longitudinal studies can be used to track the progression of diseases over time, identify risk factors for certain conditions, and evaluate the effectiveness of treatments or interventions. For example, a longitudinal study might follow a group of individuals over several decades to assess their exposure to certain environmental factors and their subsequent development of chronic diseases such as cancer or heart disease. By comparing data collected at multiple time points, researchers can identify trends and correlations that may not be apparent in shorter-term studies.

Longitudinal studies have several advantages over other research designs, including their ability to establish temporal relationships between variables, track changes over time, and reduce the impact of confounding factors. However, they also have some limitations, such as the potential for attrition (loss of participants over time), which can introduce bias and affect the validity of the results. Additionally, longitudinal studies can be expensive and time-consuming to conduct, requiring significant resources and a long-term commitment from both researchers and study participants.

Myokymia is a medical term that refers to the involuntary, fine, worm-like muscle fasciculations or contractions, often described as "bag of worms" movement, seen beneath the skin. These rhythmic, persistent muscle twitches typically occur in small areas of a muscle and can be visible under the skin. Myokymia is generally not painful but can cause cosmetic concerns or discomfort due to the continuous movement.

Myokymia can result from various factors, including nerve injury, nerve compression, metabolic disorders, vitamin deficiencies, or certain medications. In some cases, it may be a symptom of neurological conditions like multiple sclerosis, motor neuron disease, or brainstem tumors. However, isolated myokymia is often idiopathic and not associated with any underlying medical condition.

It's essential to consult a healthcare professional if you experience persistent or worsening myokymia, as they can help determine the cause and recommend appropriate treatment options.

Chronobiology disorders are a group of conditions that involve disruptions in the body's internal biological clock, which regulates various physiological processes such as sleep-wake cycles, hormone release, and metabolism. These disorders can result in a variety of symptoms, including difficulty sleeping, changes in mood and energy levels, and problems with cognitive function.

Some common examples of chronobiology disorders include:

1. Delayed Sleep Phase Syndrome (DSPS): This condition is characterized by a persistent delay in the timing of sleep, so that an individual's preferred bedtime is significantly later than what is considered normal. As a result, they may have difficulty falling asleep and waking up at socially acceptable times.
2. Advanced Sleep Phase Syndrome (ASPS): In this condition, individuals experience an earlier-than-normal timing of sleep, so that they become sleepy and wake up several hours earlier than most people.
3. Non-24-Hour Sleep-Wake Rhythm Disorder: This disorder is characterized by a persistent mismatch between the individual's internal biological clock and the 24-hour day, resulting in irregular sleep-wake patterns that can vary from day to day.
4. Irregular Sleep-Wake Rhythm Disorder: In this condition, individuals experience a lack of consistent sleep-wake patterns, with multiple periods of sleep and wakefulness throughout the 24-hour day.
5. Shift Work Sleep Disorder: This disorder is caused by the disruption of normal sleep-wake patterns due to working irregular hours, such as night shifts or rotating schedules.
6. Jet Lag Disorder: This condition occurs when an individual travels across time zones and experiences a temporary mismatch between their internal biological clock and the new local time.

Treatment for chronobiology disorders may include lifestyle changes, such as adjusting sleep schedules and exposure to light, as well as medications that can help regulate sleep-wake cycles. In some cases, cognitive-behavioral therapy (CBT) may also be helpful in managing these conditions.

Psychological stress is the response of an individual's mind and body to challenging or demanding situations. It can be defined as a state of emotional and physical tension resulting from adversity, demand, or change. This response can involve a variety of symptoms, including emotional, cognitive, behavioral, and physiological components.

Emotional responses may include feelings of anxiety, fear, anger, sadness, or frustration. Cognitive responses might involve difficulty concentrating, racing thoughts, or negative thinking patterns. Behaviorally, psychological stress can lead to changes in appetite, sleep patterns, social interactions, and substance use. Physiologically, the body's "fight-or-flight" response is activated, leading to increased heart rate, blood pressure, muscle tension, and other symptoms.

Psychological stress can be caused by a wide range of factors, including work or school demands, financial problems, relationship issues, traumatic events, chronic illness, and major life changes. It's important to note that what causes stress in one person may not cause stress in another, as individual perceptions and coping mechanisms play a significant role.

Chronic psychological stress can have negative effects on both mental and physical health, increasing the risk of conditions such as anxiety disorders, depression, heart disease, diabetes, and autoimmune diseases. Therefore, it's essential to identify sources of stress and develop effective coping strategies to manage and reduce its impact.

Sleep arousal disorders are a category of sleep disorders that involve the partial or complete awakening from sleep, often accompanied by confusion and disorientation. These disorders are characterized by an abnormal arousal process during sleep, which can result in brief periods of wakefulness or full awakenings. The most common types of sleep arousal disorders include sleepwalking (somnambulism), sleep talking (somniloquy), and night terrors (pavor nocturnus).

In sleepwalking, the individual may get out of bed and walk around while still asleep, often with a blank stare and without any memory of the event. Sleep talking can occur in various levels of sleep and may range from simple sounds to complex conversations. Night terrors are episodes of intense fear and agitation during sleep, often accompanied by screams or cries for help, rapid heart rate, and sweating.

These disorders can be caused by a variety of factors, including stress, anxiety, fever, certain medications, alcohol consumption, and underlying medical conditions such as sleep apnea or restless leg syndrome. They can also occur as a result of genetic predisposition. Sleep arousal disorders can have significant impacts on an individual's quality of life, leading to fatigue, daytime sleepiness, impaired cognitive function, and decreased overall well-being. Treatment options may include behavioral therapy, medication, or addressing any underlying medical conditions.

Prospective studies, also known as longitudinal studies, are a type of cohort study in which data is collected forward in time, following a group of individuals who share a common characteristic or exposure over a period of time. The researchers clearly define the study population and exposure of interest at the beginning of the study and follow up with the participants to determine the outcomes that develop over time. This type of study design allows for the investigation of causal relationships between exposures and outcomes, as well as the identification of risk factors and the estimation of disease incidence rates. Prospective studies are particularly useful in epidemiology and medical research when studying diseases with long latency periods or rare outcomes.

Moxibustion is a traditional Chinese medicine (TCM) practice involving the burning of a mugwort-based herb called "moxa" close to or on specific points on the body, with the intention of stimulating chi (vital energy), encouraging healing, and preventing/treating diseases. The heat generated by moxa sticks or cones is believed to warm the meridians, dispel cold and dampness, and improve circulation. Practitioners may apply moxibustion directly on the skin, through an insulating material, or indirectly above the skin. It's often used in conjunction with acupuncture for various health issues, such as arthritis, digestive disorders, and gynecological conditions.

A Personality Inventory is a standardized test used in psychology to assess an individual's personality traits and characteristics. It typically consists of a series of multiple-choice questions or statements that the respondent must rate according to their level of agreement or disagreement. The inventory measures various aspects of an individual's behavior, attitudes, and temperament, providing a quantifiable score that can be compared to normative data to help diagnose personality disorders, assess personal strengths and weaknesses, or provide insights into an individual's likely responses to different situations. Examples of well-known personality inventories include the Minnesota Multiphasic Personality Inventory (MMPI) and the California Psychological Inventory (CPI).

Second-generation antidepressants (SGAs) are a class of medications used primarily for the treatment of depression, although they are also used for other psychiatric and medical conditions. They are called "second-generation" because they were developed after the first generation of antidepressants, which include tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs).

SGAs are also known as atypical antidepressants or novel antidepressants. They work by affecting the levels of neurotransmitters in the brain, such as serotonin, norepinephrine, and dopamine. However, they have a different chemical structure and mechanism of action than first-generation antidepressants.

Some examples of second-generation antidepressants include:

* Selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine (Prozac), sertraline (Zoloft), and citalopram (Celexa)
* Serotonin-norepinephrine reuptake inhibitors (SNRIs) such as venlafaxine (Effexor) and duloxetine (Cymbalta)
* Norepinephrine and dopamine reuptake inhibitors (NDRIs) such as bupropion (Wellbutrin)
* Atypical antidepressants such as mirtazapine (Remeron), trazodone, and vortioxetine (Brintellix)

SGAs are generally considered to have a more favorable side effect profile than first-generation antidepressants. They are less likely to cause anticholinergic effects such as dry mouth, constipation, and blurred vision, and they are less likely to cause cardiac conduction abnormalities or orthostatic hypotension. However, SGAs may still cause side effects such as nausea, insomnia, sexual dysfunction, and weight gain.

It's important to note that the choice of antidepressant medication should be individualized based on the patient's specific symptoms, medical history, and other factors. It may take some trial and error to find the most effective and well-tolerated medication for a given patient.

Behavioral symptoms refer to changes or abnormalities in a person's behavior, which may be indicative of an underlying medical or psychological condition. These symptoms can manifest as a wide range of observable behaviors that are unusual, disruptive, or distressing for the individual experiencing them or those around them. Examples of behavioral symptoms include:

1. Agitation: A state of irritability, restlessness, or excitement, often accompanied by aggressive or disruptive behavior.
2. Aggression: Hostile or violent behavior directed towards others, including verbal or physical attacks.
3. Apathy: A lack of interest, motivation, or emotion, often leading to social withdrawal and decreased activity levels.
4. Changes in appetite or sleep patterns: Significant fluctuations in the amount or frequency of food intake or sleep, which can be indicative of various medical or psychological conditions.
5. Disinhibition: A loss of restraint or impulse control, leading to inappropriate behavior in social situations.
6. Hallucinations: Perception of sensory stimuli (such as sight, sound, touch) without an external source, often associated with certain mental illnesses or neurological disorders.
7. Hyperactivity: Increased activity levels, often accompanied by impulsivity and difficulty focusing attention.
8. Impaired judgment: Poor decision-making abilities, often resulting in risky or harmful behavior.
9. Inattention: Difficulty focusing or sustaining attention on a task or activity.
10. Mood changes: Fluctuations in emotional state, such as depression, anxiety, or euphoria.
11. Psychosis: A severe mental disorder characterized by detachment from reality, hallucinations, and disorganized thinking or behavior.
12. Repetitive behaviors: Engaging in repetitive actions or movements, often associated with certain developmental disorders or neurological conditions.
13. Social withdrawal: Avoidance of social interactions or activities, often indicative of depression, anxiety, or other mental health concerns.
14. Thought disturbances: Disorganized or disrupted thinking patterns, such as racing thoughts, tangential thinking, or loose associations between ideas.

Behavioral symptoms can be caused by various factors, including medical conditions (such as infections, brain injuries, or neurodegenerative diseases), mental health disorders (such as depression, anxiety, bipolar disorder, or schizophrenia), substance abuse, and environmental factors (such as stress or trauma). Accurate assessment and diagnosis are crucial for determining appropriate treatment interventions.

Snoring is defined as the vibration of respiratory structures and the resulting sound, due to obstructed air movement during breathing while sleeping. It occurs when the tissues at the back of the throat relax and narrow during sleep, partially blocking the airway. The airflow causes these tissues to vibrate, leading to the snoring sound. Snoring can be a sign of various conditions such as obstructive sleep apnea or other respiratory disorders. It can also be influenced by factors such as alcohol consumption, obesity, and sleeping position.

A hot flash is a sudden, intense feeling of heat, particularly in the face, neck and chest regions, which is often accompanied by perspiration, reddening of the skin (flush or blush), and rapid heartbeat. It is a common symptom experienced by individuals, especially women during menopause or perimenopause, although it can also occur in other medical conditions or as a side effect of certain medications. The exact cause of hot flashes is not fully understood, but they are thought to be related to changes in hormone levels and the body's regulation of temperature.

I'm sorry for any confusion, but "pilot projects" is not a medical term per se. Instead, it is a general term used in various fields, including healthcare and medicine, to describe a small-scale initiative that is implemented on a temporary basis to evaluate its feasibility, effectiveness, or impact before deciding whether to expand or continue it.

In the context of healthcare, pilot projects might involve testing new treatment protocols, implementing innovative care models, or introducing technology solutions in a limited setting to assess their potential benefits and drawbacks. The results of these projects can help inform decisions about broader implementation and provide valuable insights for improving the quality and efficiency of healthcare services.

Follow-up studies are a type of longitudinal research that involve repeated observations or measurements of the same variables over a period of time, in order to understand their long-term effects or outcomes. In medical context, follow-up studies are often used to evaluate the safety and efficacy of medical treatments, interventions, or procedures.

In a typical follow-up study, a group of individuals (called a cohort) who have received a particular treatment or intervention are identified and then followed over time through periodic assessments or data collection. The data collected may include information on clinical outcomes, adverse events, changes in symptoms or functional status, and other relevant measures.

The results of follow-up studies can provide important insights into the long-term benefits and risks of medical interventions, as well as help to identify factors that may influence treatment effectiveness or patient outcomes. However, it is important to note that follow-up studies can be subject to various biases and limitations, such as loss to follow-up, recall bias, and changes in clinical practice over time, which must be carefully considered when interpreting the results.

Familial dysautonomia (FD) is a genetic disorder that affects the autonomic nervous system (ANS), which controls automatic functions such as heart rate, blood pressure, body temperature, and digestion. It is also known as Riley-Day syndrome or Hereditary Sensory and Autonomic Neuropathy Type III (HSAN III).

FD is caused by a mutation in the IKBKAP gene, which provides instructions for making a protein that is essential for the development and function of certain nerves. The condition is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene (one from each parent) to have the disease.

The symptoms of familial dysautonomia can vary widely, but often include:

* Difficulty regulating blood pressure and heart rate, leading to fluctuations in blood pressure, dizziness, and fainting spells
* Poor temperature regulation, causing episodes of sweating or flushing
* Difficulty swallowing and poor muscle tone in the face and tongue
* Absent or reduced deep tendon reflexes
* Delayed growth and development
* Reduced sensitivity to pain and temperature changes
* Emotional lability and behavioral problems

There is no cure for familial dysautonomia, but treatment can help manage symptoms and improve quality of life. Treatment may include medications to regulate blood pressure and heart rate, physical therapy to improve muscle tone and coordination, and feeding tubes or special diets to ensure adequate nutrition.

Absenteeism is a term used in the medical and occupational health fields to describe the habitual pattern of absence from work or school. It refers to an employee or student's repeated failure to show up for scheduled work or classes without a valid reason or excuse. Absenteeism can have various causes, including physical illness or injury, mental health issues, stress, burnout, disengagement, and poor job or school satisfaction. Chronic absenteeism can lead to negative consequences such as decreased productivity, increased healthcare costs, and reduced academic performance.

Antidepressive agents are a class of medications used to treat various forms of depression and anxiety disorders. They act on neurotransmitters, the chemical messengers in the brain, to restore the balance that has been disrupted by mental illness. The most commonly prescribed types of antidepressants include selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), and monoamine oxidase inhibitors (MAOIs). These medications can help alleviate symptoms such as low mood, loss of interest in activities, changes in appetite and sleep patterns, fatigue, difficulty concentrating, and thoughts of death or suicide. It is important to note that antidepressants may take several weeks to reach their full effectiveness and may cause side effects, so it is essential to work closely with a healthcare provider to find the right medication and dosage.

I'm sorry for any confusion, but "Work Schedule Tolerance" is not a recognized term in the medical field. It may be a term used in occupational health or human resources to refer to an employee's ability to adapt to different work schedules, such as night shifts, rotating shifts, or irregular hours. However, it is not a medical diagnosis or condition. If you have any concerns about your work schedule and how it affects your health, I would recommend speaking with a healthcare provider or occupational health professional.

I'm sorry for any confusion, but "Pyridines" is not a medical term. It is a chemical term that refers to a class of organic compounds with the chemical structure of a six-membered ring containing one nitrogen atom and five carbon atoms (heterocyclic aromatic compound).

In a biological or medical context, pyridine derivatives can be found in various natural and synthetic substances. For example, some medications contain pyridine rings as part of their chemical structure. However, "Pyridines" itself is not a medical term or condition.

A cohort study is a type of observational study in which a group of individuals who share a common characteristic or exposure are followed up over time to determine the incidence of a specific outcome or outcomes. The cohort, or group, is defined based on the exposure status (e.g., exposed vs. unexposed) and then monitored prospectively to assess for the development of new health events or conditions.

Cohort studies can be either prospective or retrospective in design. In a prospective cohort study, participants are enrolled and followed forward in time from the beginning of the study. In contrast, in a retrospective cohort study, researchers identify a cohort that has already been assembled through medical records, insurance claims, or other sources and then look back in time to assess exposure status and health outcomes.

Cohort studies are useful for establishing causality between an exposure and an outcome because they allow researchers to observe the temporal relationship between the two. They can also provide information on the incidence of a disease or condition in different populations, which can be used to inform public health policy and interventions. However, cohort studies can be expensive and time-consuming to conduct, and they may be subject to bias if participants are not representative of the population or if there is loss to follow-up.

Psychometrics is a branch of psychology that deals with the theory and technique of psychological measurement, such as the development and standardization of tests used to measure intelligence, aptitude, personality, attitudes, and other mental abilities or traits. It involves the construction and validation of measurement instruments, including the determination of their reliability and validity, and the application of statistical methods to analyze test data and interpret results. The ultimate goal of psychometrics is to provide accurate, objective, and meaningful measurements that can be used to understand individual differences and make informed decisions in educational, clinical, and organizational settings.

I'm sorry for any confusion, but "Pennsylvania" is not a medical term or concept. It is a state located in the Northeastern and Mid-Atlantic regions of the United States. If you have any questions related to medical topics, I would be happy to help answer those!

Acupressure is a complementary therapy based on the concept of acupuncture, which involves applying pressure (usually with fingers, hands, or elbow) to specific points on the body (known as acupoints). The goal of acupressure is to stimulate and balance the flow of energy (chi or qi) through the body's meridians or channels. This practice is believed to help promote relaxation, reduce stress, relieve pain, improve sleep, and enhance overall well-being.

It is important to note that while acupressure has been used for thousands of years in traditional Chinese medicine, its effectiveness is not consistently supported by scientific research. Some studies suggest potential benefits, but more rigorous, high-quality research is needed to confirm these findings. As with any therapy, it's recommended to consult a healthcare professional before starting an acupressure practice, especially if you have any health conditions or are taking medications.

Computer-assisted therapy, also known as computerized cognitive behavioral therapy (CCBT), refers to the use of computer programs or digital platforms to deliver therapeutic interventions that are typically guided by a trained professional. This approach often involves interactive activities and exercises designed to help individuals develop skills and strategies for managing various psychological, emotional, or behavioral issues.

The goal of computer-assisted therapy is to increase accessibility, affordability, and convenience of mental health services while maintaining the effectiveness of traditional face-to-face therapy. It can be used as a standalone treatment or as an adjunct to traditional therapy, depending on the individual's needs and preferences. Common applications of computer-assisted therapy include treating anxiety disorders, depression, post-traumatic stress disorder (PTSD), insomnia, and substance use disorders.

Analysis of Variance (ANOVA) is a statistical technique used to compare the means of two or more groups and determine whether there are any significant differences between them. It is a way to analyze the variance in a dataset to determine whether the variability between groups is greater than the variability within groups, which can indicate that the groups are significantly different from one another.

ANOVA is based on the concept of partitioning the total variance in a dataset into two components: variance due to differences between group means (also known as "between-group variance") and variance due to differences within each group (also known as "within-group variance"). By comparing these two sources of variance, ANOVA can help researchers determine whether any observed differences between groups are statistically significant, or whether they could have occurred by chance.

ANOVA is a widely used technique in many areas of research, including biology, psychology, engineering, and business. It is often used to compare the means of two or more experimental groups, such as a treatment group and a control group, to determine whether the treatment had a significant effect. ANOVA can also be used to compare the means of different populations or subgroups within a population, to identify any differences that may exist between them.

Acupuncture points, also known as "acupoints," are specific locations on the body that are used in acupuncture therapy. These points are believed to correspond to underlying pathways, or meridians, through which vital energy, or "qi" (pronounced "chee"), flows.

Acupuncture points are typically found along these meridians and are thought to have specific therapeutic properties. According to traditional Chinese medicine (TCM) theory, stimulating these points with needles, heat, pressure, or electrical impulses can help restore the balance of qi and promote healing in the body.

There are over 360 acupuncture points identified in TCM, each with its own name, location, and set of indications for use. Modern research has attempted to identify the anatomical structures underlying these points, with some studies suggesting that they may correspond to nerve bundles, blood vessels, or other physiological features. However, the exact mechanisms by which acupuncture works remain a topic of ongoing scientific investigation and debate.

"Age factors" refer to the effects, changes, or differences that age can have on various aspects of health, disease, and medical care. These factors can encompass a wide range of issues, including:

1. Physiological changes: As people age, their bodies undergo numerous physical changes that can affect how they respond to medications, illnesses, and medical procedures. For example, older adults may be more sensitive to certain drugs or have weaker immune systems, making them more susceptible to infections.
2. Chronic conditions: Age is a significant risk factor for many chronic diseases, such as heart disease, diabetes, cancer, and arthritis. As a result, age-related medical issues are common and can impact treatment decisions and outcomes.
3. Cognitive decline: Aging can also lead to cognitive changes, including memory loss and decreased decision-making abilities. These changes can affect a person's ability to understand and comply with medical instructions, leading to potential complications in their care.
4. Functional limitations: Older adults may experience physical limitations that impact their mobility, strength, and balance, increasing the risk of falls and other injuries. These limitations can also make it more challenging for them to perform daily activities, such as bathing, dressing, or cooking.
5. Social determinants: Age-related factors, such as social isolation, poverty, and lack of access to transportation, can impact a person's ability to obtain necessary medical care and affect their overall health outcomes.

Understanding age factors is critical for healthcare providers to deliver high-quality, patient-centered care that addresses the unique needs and challenges of older adults. By taking these factors into account, healthcare providers can develop personalized treatment plans that consider a person's age, physical condition, cognitive abilities, and social circumstances.

In epidemiology, the incidence of a disease is defined as the number of new cases of that disease within a specific population over a certain period of time. It is typically expressed as a rate, with the number of new cases in the numerator and the size of the population at risk in the denominator. Incidence provides information about the risk of developing a disease during a given time period and can be used to compare disease rates between different populations or to monitor trends in disease occurrence over time.

I'm sorry for any confusion, but "Norway" is not a medical term or concept. It is a country in Northern Europe, known officially as the Kingdom of Norway. If you have any questions about medical topics or definitions, I would be happy to help!

I'm sorry for any confusion, but "United States" is a geopolitical entity, specifically the name of the country consisting of 50 states, and it is not a medical term or concept. Therefore, I can't provide a medical definition for it. If you have any questions related to health, medicine, or biology, I would be happy to try to help answer those!

Pain is an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage. It is a complex phenomenon that can result from various stimuli, such as thermal, mechanical, or chemical irritation, and it can be acute or chronic. The perception of pain involves the activation of specialized nerve cells called nociceptors, which transmit signals to the brain via the spinal cord. These signals are then processed in different regions of the brain, leading to the conscious experience of pain. It's important to note that pain is a highly individual and subjective experience, and its perception can vary widely among individuals.

Chamomile is a common name for several daisy-like plants that belong to the family Asteraceae, and more specifically to the genus Matricaria or Chamaemelum. The two most commonly used varieties are Matricaria recutita, also known as German chamomile, and Chamaemelum nobile, or Roman chamomile.

Chamomile has been used traditionally for medicinal purposes due to its rich phytochemistry, which includes various terpenoids, flavonoids, and other compounds. The most well-known active constituents are the volatile oils (including alpha-bisabolol, chamazulene, and farnesene) and the flavonoid apigenin.

Chamomile is often used in herbal teas, essential oils, and various dietary supplements for its calming, anti-inflammatory, analgesic, spasmolytic, and mild sedative properties. Some of its applications include:

1. Treatment of anxiety and insomnia: Chamomile is known to help promote relaxation and sleep, making it a popular natural remedy for people suffering from anxiety or insomnia.
2. Digestive health: Chamomile has been used traditionally to treat various gastrointestinal disorders, such as indigestion, bloating, gastritis, and irritable bowel syndrome (IBS), due to its antispasmodic and anti-inflammatory effects on the digestive tract.
3. Skin conditions: Chamomile is often found in skincare products and topical treatments for its soothing, anti-inflammatory, and vulnerary properties, which can help alleviate skin irritations, rashes, and inflammation.
4. Menstrual discomfort: Chamomile's antispasmodic and analgesic effects may provide relief from menstrual cramps and pain.
5. Respiratory health: Chamomile has been used to treat respiratory conditions, such as coughs, colds, bronchitis, and asthma, due to its anti-inflammatory and expectorant properties.
6. Oral health: The antibacterial and anti-inflammatory properties of chamomile make it useful for maintaining oral hygiene and treating conditions like mouth ulcers, gum inflammation, and plaque buildup.

It is important to note that while chamomile has many potential health benefits, it may cause allergic reactions in some individuals, particularly those with sensitivities to ragweed, chrysanthemums, or daisies. Additionally, chamomile should not be consumed in large quantities during pregnancy, as it may stimulate uterine contractions and potentially lead to premature labor. Always consult a healthcare professional before starting any new herbal remedy, especially if you have pre-existing medical conditions or are taking medications.

Melatonin receptors are a type of G protein-coupled receptor (GPCR) that bind to the hormone melatonin in animals. These receptors play a crucial role in regulating various physiological functions, including sleep-wake cycles, circadian rhythms, and seasonal reproduction.

There are two main types of melatonin receptors: MT1 (also known as Mel1a) and MT2 (Mel1b). Both receptor subtypes are widely expressed in the central nervous system, retina, and peripheral tissues. The activation of these receptors by melatonin leads to a range of downstream signaling events that ultimately result in changes in gene expression, cellular responses, and physiological processes.

MT1 receptors are involved in regulating sleep onset and promoting non-rapid eye movement (NREM) sleep. They have also been implicated in the regulation of mood, anxiety, and cognitive function. MT2 receptors play a role in regulating circadian rhythms and the timing of sleep-wake cycles. They are also involved in the regulation of pupillary light reflex, body temperature, and blood pressure.

Dysregulation of melatonin receptor signaling has been implicated in various sleep disorders, mood disorders, and neurodegenerative diseases. Therefore, understanding the function and regulation of melatonin receptors is an important area of research for developing novel therapeutic strategies for these conditions.

A delusion is a fixed, false belief that is firmly held despite evidence to the contrary and is not shared by others who hold similar cultural or religious beliefs. Delusions are a key symptom of certain psychiatric disorders, such as schizophrenia and delusional disorder. They can also be seen in other medical conditions, such as dementia, brain injury, or substance abuse.

Delusions can take many forms, but some common types include:

* Persecutory delusions: the belief that one is being targeted or harmed by others
* Grandiose delusions: the belief that one has special powers, talents, or importance
* Erotomanic delusions: the belief that someone, often of higher social status, is in love with the individual
* Somatic delusions: the belief that one's body is abnormal or has been altered in some way
* Religious or spiritual delusions: the belief that one has a special relationship with a deity or religious figure

Delusions should not be confused with overvalued ideas, which are strongly held beliefs based on subjective interpretation of experiences or evidence. Overvalued ideas may be shared by others and can sometimes develop into delusions if they become fixed and firmly held despite contradictory evidence.

Mood disorders are a category of mental health disorders characterized by significant and persistent changes in mood, affect, and emotional state. These disorders can cause disturbances in normal functioning and significantly impair an individual's ability to carry out their daily activities. The two primary types of mood disorders are depressive disorders (such as major depressive disorder or persistent depressive disorder) and bipolar disorders (which include bipolar I disorder, bipolar II disorder, and cyclothymic disorder).

Depressive disorders involve prolonged periods of low mood, sadness, hopelessness, and a lack of interest in activities. Individuals with these disorders may also experience changes in sleep patterns, appetite, energy levels, concentration, and self-esteem. In severe cases, they might have thoughts of death or suicide.

Bipolar disorders involve alternating episodes of mania (or hypomania) and depression. During a manic episode, individuals may feel extremely elated, energetic, or irritable, with racing thoughts, rapid speech, and impulsive behavior. They might engage in risky activities, have decreased sleep needs, and display poor judgment. In contrast, depressive episodes involve the same symptoms as depressive disorders.

Mood disorders can be caused by a combination of genetic, biological, environmental, and psychological factors. Proper diagnosis and treatment, which may include psychotherapy, medication, or a combination of both, are essential for managing these conditions and improving quality of life.

Nitrazepam is a benzodiazepine drug primarily used for the treatment of severe insomnia and sometimes for managing certain types of epilepsy. It works by increasing the activity of gamma-aminobutyric acid (GABA), a neurotransmitter that inhibits central nervous system activity, thereby producing calming effects.

According to the World Health Organization's (WHO) Anatomical Therapeutic Chemical (ATC) classification system, Nitrazepam falls under the category of "N05CD - Benzodiazepine derivatives" and has the ATC code "N05CD02".

It is essential to note that Nitrazepam should only be used under medical supervision due to its potential for dependence, addiction, and other side effects. It is also not recommended for long-term use or in pregnant or breastfeeding women without consulting a healthcare professional first.

Medical records are organized, detailed collections of information about a patient's health history, including their symptoms, diagnoses, treatments, medications, test results, and any other relevant data. These records are created and maintained by healthcare professionals during the course of providing medical care and serve as an essential tool for continuity, communication, and decision-making in healthcare. They may exist in paper form, electronic health records (EHRs), or a combination of both. Medical records also play a critical role in research, quality improvement, public health, reimbursement, and legal proceedings.

I couldn't find a medical definition specifically for "delayed-action preparations." However, in the context of pharmacology, it may refer to medications or treatments that have a delayed onset of action. These are designed to release the active drug slowly over an extended period, which can help to maintain a consistent level of the medication in the body and reduce the frequency of dosing.

Examples of delayed-action preparations include:

1. Extended-release (ER) or controlled-release (CR) formulations: These are designed to release the drug slowly over several hours, reducing the need for frequent dosing. Examples include extended-release tablets and capsules.
2. Transdermal patches: These deliver medication through the skin and can provide a steady rate of drug delivery over several days. Examples include nicotine patches for smoking cessation or fentanyl patches for pain management.
3. Injectable depots: These are long-acting injectable formulations that slowly release the drug into the body over weeks to months. An example is the use of long-acting antipsychotic injections for the treatment of schizophrenia.
4. Implantable devices: These are small, biocompatible devices placed under the skin or within a body cavity that release a steady dose of medication over an extended period. Examples include hormonal implants for birth control or drug-eluting stents used in cardiovascular procedures.

Delayed-action preparations can improve patient compliance and quality of life by reducing dosing frequency, minimizing side effects, and maintaining consistent therapeutic levels.

An "Employee Performance Appraisal" is a systematic and periodic process in which an organization evaluates the job performance of its employees. The purpose of this process is to provide feedback to employees about their strengths and areas for improvement, as well as to set goals and development plans for their future growth and performance enhancement.

The appraisal typically involves a review of the employee's job responsibilities, objectives, and achievements during a specific period, along with an assessment of their skills, behaviors, and competencies. The evaluation may be based on various factors such as job knowledge, productivity, quality of work, communication skills, teamwork, leadership, and attendance.

The performance appraisal is usually conducted by the employee's supervisor or manager, but it can also involve self-evaluation, peer review, or 360-degree feedback from multiple sources. The results of the appraisal are used to inform decisions about promotions, salary increases, training and development opportunities, and corrective actions when necessary.

Overall, the employee performance appraisal is a critical tool for organizations to manage their workforce effectively, improve productivity, and promote a culture of continuous learning and development.

Alcoholism is a chronic and often relapsing brain disorder characterized by the excessive and compulsive consumption of alcohol despite negative consequences to one's health, relationships, and daily life. It is also commonly referred to as alcohol use disorder (AUD) or alcohol dependence.

The diagnostic criteria for AUD include a pattern of alcohol use that includes problems controlling intake, continued use despite problems resulting from drinking, development of a tolerance, drinking that leads to risky behaviors or situations, and withdrawal symptoms when not drinking.

Alcoholism can cause a wide range of physical and psychological health problems, including liver disease, heart disease, neurological damage, mental health disorders, and increased risk of accidents and injuries. Treatment for alcoholism typically involves a combination of behavioral therapies, medications, and support groups to help individuals achieve and maintain sobriety.

Sleep phase chronotherapy is a specialized treatment approach in sleep medicine that involves systematically adjusting a person's sleep and wake times to realign their circadian rhythm (internal biological clock) with their desired sleep-wake schedule. This technique is often used to treat circadian rhythm sleep disorders, such as delayed sleep phase disorder (DSPD), advanced sleep phase disorder (ASPD), and irregular sleep-wake rhythm disorder.

The process of sleep phase chronotherapy typically involves gradually shifting the sleep onset time earlier or later in small increments (usually 15-60 minutes) every one to three days until the desired sleep schedule is achieved. This adjustment can be done over a period of several weeks, depending on the severity and nature of the sleep disorder.

It's important to note that sleep phase chronotherapy should be conducted under the supervision of a qualified healthcare professional or sleep specialist, as improper implementation may lead to further disruption of the circadian rhythm and exacerbate existing sleep problems.

Desensitization, psychologic, also known as psychological desensitization or systematic desensitization, is a therapeutic technique used in behavioral therapy to reduce or eliminate fear, anxiety, or other negative emotional responses associated with specific stimuli or situations. This process involves gradually and systematically exposing the individual to the feared stimulus or situation, beginning with less threatening versions and progressively increasing the level of exposure until the anxiety response is significantly reduced or eliminated. The technique is often used in conjunction with relaxation training and cognitive restructuring to help the person develop more adaptive responses to the previously distressing stimuli.

Phytotherapy is the use of extracts of natural origin, especially plants or plant parts, for therapeutic purposes. It is also known as herbal medicine and is a traditional practice in many cultures. The active compounds in these plant extracts are believed to have various medicinal properties, such as anti-inflammatory, analgesic, or sedative effects. Practitioners of phytotherapy may use the whole plant, dried parts, or concentrated extracts to prepare teas, capsules, tinctures, or ointments for therapeutic use. It is important to note that the effectiveness and safety of phytotherapy are not always supported by scientific evidence, and it should be used with caution and preferably under the guidance of a healthcare professional.

A cross-over study is a type of experimental design in which participants receive two or more interventions in a specific order. After a washout period, each participant receives the opposite intervention(s). The primary advantage of this design is that it controls for individual variability by allowing each participant to act as their own control.

In medical research, cross-over studies are often used to compare the efficacy or safety of two treatments. For example, a researcher might conduct a cross-over study to compare the effectiveness of two different medications for treating high blood pressure. Half of the participants would be randomly assigned to receive one medication first and then switch to the other medication after a washout period. The other half of the participants would receive the opposite order of treatments.

Cross-over studies can provide valuable insights into the relative merits of different interventions, but they also have some limitations. For example, they may not be suitable for studying conditions that are chronic or irreversible, as it may not be possible to completely reverse the effects of the first intervention before administering the second one. Additionally, carryover effects from the first intervention can confound the results if they persist into the second treatment period.

Overall, cross-over studies are a useful tool in medical research when used appropriately and with careful consideration of their limitations.

Nocturia is a common symptom characterized by the need to wake up during the night one or more times to urinate. While it's normal to urinate a few times during the night, nocturia is defined as having to urinate more than twice per night, which can disrupt sleep and lead to daytime fatigue and sleepiness.

Nocturia can be caused by various factors, including underlying medical conditions such as diabetes, bladder infections, enlarged prostate, or sleep disorders like sleep apnea. It can also be a side effect of certain medications. In some cases, nocturia may be a symptom of more serious conditions, so it's important to speak with a healthcare provider if you experience frequent nighttime urination.

Prion diseases, also known as transmissible spongiform encephalopathies (TSEs), are a group of progressive neurodegenerative disorders that affect both humans and animals. They are unique in that they are caused by prions, which are misfolded proteins rather than infectious agents like bacteria or viruses. These abnormal prions can cause other normal proteins to misfold and accumulate in the brain, leading to brain damage and neurodegeneration.

Prion diseases can be sporadic, inherited, or acquired. Sporadic forms occur without a known cause and are the most common type. Inherited prion diseases are caused by mutations in the PRNP gene and are often associated with a family history of the disease. Acquired prion diseases can result from exposure to contaminated food (as in variant Creutzfeldt-Jakob disease), medical procedures (iatrogenic Creutzfeldt-Jakob disease), or inherited forms of the disease that cause abnormal prions to be secreted in body fluids (like kuru).

Common prion diseases in humans include:

1. Creutzfeldt-Jakob disease (CJD) - sporadic, inherited, and acquired forms
2. Variant Creutzfeldt-Jakob disease (vCJD) - acquired form linked to consumption of contaminated beef products
3. Gerstmann-Sträussler-Scheinker syndrome (GSS) - inherited form
4. Fatal familial insomnia (FFI) - inherited form
5. Kuru - an acquired form that occurred in a isolated tribe due to cannibalistic practices, now eradicated

Prion diseases are characterized by rapidly progressing dementia, neurological symptoms, and motor dysfunction. There is no known cure for these diseases, and they are universally fatal.

Piperazines are a class of heterocyclic organic compounds that contain a seven-membered ring with two nitrogen atoms at positions 1 and 4. They have the molecular formula N-NRR' where R and R' can be alkyl or aryl groups. Piperazines have a wide range of uses in pharmaceuticals, agrochemicals, and as building blocks in organic synthesis.

In a medical context, piperazines are used in the manufacture of various drugs, including some antipsychotics, antidepressants, antihistamines, and anti-worm medications. For example, the antipsychotic drug trifluoperazine and the antidepressant drug nefazodone both contain a piperazine ring in their chemical structure.

However, it's important to note that some piperazines are also used as recreational drugs due to their stimulant and euphoric effects. These include compounds such as BZP (benzylpiperazine) and TFMPP (trifluoromethylphenylpiperazine), which have been linked to serious health risks, including addiction, seizures, and death. Therefore, the use of these substances should be avoided.

Traditional Chinese Medicine (TCM) is a system of medicine that has been developed in China over thousands of years. It is based on the philosophy that the body's vital energy (Qi) circulates through a network of channels called meridians, and that disease results from an imbalance or blockage in this flow of Qi.

TCM uses a variety of treatments to restore balance and promote health, including acupuncture, herbal medicine, moxibustion (the burning of herbs near the skin), cupping, dietary therapy, and tuina (Chinese massage). The use of Chinese herbal medicines is a major component of TCM, with formulas often consisting of combinations of several different herbs tailored to the individual patient's needs.

In addition to these treatments, TCM practitioners may also use diagnostic techniques such as pulse diagnosis and tongue examination to assess a person's overall health and determine the underlying cause of their symptoms. The goal of TCM is not only to treat specific symptoms or diseases but to address the root causes of illness and promote overall wellness.

Chronic pain is defined as pain that persists or recurs for a period of 3 months or longer, beyond the normal healing time for an injury or illness. It can be continuous or intermittent and range from mild to severe. Chronic pain can have various causes, such as nerve damage, musculoskeletal conditions, or chronic diseases like cancer. It can significantly impact a person's quality of life, causing limitations in mobility, sleep disturbances, mood changes, and decreased overall well-being. Effective management of chronic pain often involves a multidisciplinary approach, including medications, physical therapy, psychological interventions, and complementary therapies.

In medical terms, "Radio" generally refers to the use of radiation in the diagnosis and treatment of various medical conditions. This can include:

1. Diagnostic Radiology: This is the use of various imaging techniques that utilize different types of radiation to create detailed images of the internal structures of the body. Examples include X-rays, CT scans, and mammography.

2. Interventional Radiology: This is a medical subspecialty that uses minimally invasive image-guided procedures to diagnose and treat various diseases. These procedures often involve the use of radiological imaging techniques to guide catheters or other small instruments through the body to the site of the disease.

3. Radiation Therapy: This is a type of cancer treatment that uses high-energy radiation to kill cancer cells and shrink tumors.

Remember, while radiation is a valuable tool in medicine, it must be used carefully to minimize potential risks such as damage to healthy tissues and the potential for developing secondary cancers.

A "self-report" in a medical context refers to the information or data provided by an individual about their own symptoms, experiences, behaviors, or health status. This can be collected through various methods such as questionnaires, surveys, interviews, or diaries. Self-reports are commonly used in research and clinical settings to assess various aspects of health, including physical and mental health symptoms, quality of life, treatment adherence, and substance use.

While self-reports can be a valuable source of information, they may also be subject to biases such as recall bias, social desirability bias, or response distortion. Therefore, it is important to consider the potential limitations and validity of self-reported data in interpreting the results. In some cases, self-reports may be supplemented with other sources of information, such as medical records, physiological measures, or observer ratings.

GABA (gamma-aminobutyric acid) agents are pharmaceutical drugs that act as agonists at the GABA receptors in the brain. GABA is the primary inhibitory neurotransmitter in the central nervous system, and it plays a crucial role in regulating neuronal excitability.

GABA agents can enhance the activity of GABA by increasing the frequency or duration of GABA-mediated chloride currents at the GABA receptors. These drugs are often used as anticonvulsants, anxiolytics, muscle relaxants, and sedatives due to their ability to reduce neuronal excitability and promote relaxation.

Examples of GABA agents include benzodiazepines, barbiturates, non-benzodiazepine hypnotics, and certain anticonvulsant drugs such as gabapentin and pregabalin. It is important to note that while these drugs can be effective in treating various medical conditions, they also carry the risk of dependence, tolerance, and adverse effects, particularly when used at high doses or for prolonged periods.

Logistic models, specifically logistic regression models, are a type of statistical analysis used in medical and epidemiological research to identify the relationship between the risk of a certain health outcome or disease (dependent variable) and one or more independent variables, such as demographic factors, exposure variables, or other clinical measurements.

In contrast to linear regression models, logistic regression models are used when the dependent variable is binary or dichotomous in nature, meaning it can only take on two values, such as "disease present" or "disease absent." The model uses a logistic function to estimate the probability of the outcome based on the independent variables.

Logistic regression models are useful for identifying risk factors and estimating the strength of associations between exposures and health outcomes, adjusting for potential confounders, and predicting the probability of an outcome given certain values of the independent variables. They can also be used to develop clinical prediction rules or scores that can aid in decision-making and patient care.

Patient education, as defined by the US National Library of Medicine's Medical Subject Headings (MeSH), is "the teaching or training of patients concerning their own health needs. It includes the patient's understanding of his or her condition and the necessary procedures for self, assisted, or professional care." This encompasses a wide range of activities and interventions aimed at helping patients and their families understand their medical conditions, treatment options, self-care skills, and overall health management. Effective patient education can lead to improved health outcomes, increased patient satisfaction, and better use of healthcare resources.

The odds ratio (OR) is a statistical measure used in epidemiology and research to estimate the association between an exposure and an outcome. It represents the odds that an event will occur in one group versus the odds that it will occur in another group, assuming that all other factors are held constant.

In medical research, the odds ratio is often used to quantify the strength of the relationship between a risk factor (exposure) and a disease outcome. An OR of 1 indicates no association between the exposure and the outcome, while an OR greater than 1 suggests that there is a positive association between the two. Conversely, an OR less than 1 implies a negative association.

It's important to note that the odds ratio is not the same as the relative risk (RR), which compares the incidence rates of an outcome in two groups. While the OR can approximate the RR when the outcome is rare, they are not interchangeable and can lead to different conclusions about the association between an exposure and an outcome.

"Qi" is a concept in traditional Chinese medicine (TCM) and martial arts that refers to a vital energy or life force that is believed to flow through the body. It is considered to be essential for maintaining good health and can be influenced by various factors such as diet, exercise, emotions, and environment. However, it's important to note that "Qi" is not a term recognized in modern Western medicine and its definition and significance are based on cultural and philosophical beliefs rather than scientific evidence.

A mental disorder is a syndrome characterized by clinically significant disturbance in an individual's cognition, emotion regulation, or behavior. It's associated with distress and/or impaired functioning in social, occupational, or other important areas of life, often leading to a decrease in quality of life. These disorders are typically persistent and can be severe and disabling. They may be related to factors such as genetics, early childhood experiences, or trauma. Examples include depression, anxiety disorders, bipolar disorder, schizophrenia, and personality disorders. It's important to note that a diagnosis should be made by a qualified mental health professional.

Creutzfeldt-Jakob syndrome (CJD) is a rare, degenerative, and fatal brain disorder. It is caused by an abnormal form of protein called prion that can cause normal proteins in the brain to fold into abnormal shapes and accumulate, leading to damage and death of brain cells.

The symptoms of CJD usually develop over a period of several months and include rapidly progressing dementia, memory loss, confusion, coordination problems, muscle stiffness, twitching, and shaking. Some people may also experience visual hallucinations, changes in personality, or depression.

There are three main types of CJD: sporadic, inherited, and acquired. Sporadic CJD is the most common form and accounts for about 85% of all cases. It occurs spontaneously with no known cause. Inherited CJD is caused by a genetic mutation that is passed down from parents to their children. Acquired CJD is caused by exposure to contaminated tissue or bodily fluids, such as through a medical procedure or eating contaminated beef (variant CJD).

There is no cure for Creutzfeldt-Jakob syndrome and it is fatal, usually within a year of onset of symptoms. Treatment focuses on managing the symptoms and making the patient as comfortable as possible.

"Sex factors" is a term used in medicine and epidemiology to refer to the differences in disease incidence, prevalence, or response to treatment that are observed between males and females. These differences can be attributed to biological differences such as genetics, hormones, and anatomy, as well as social and cultural factors related to gender.

For example, some conditions such as autoimmune diseases, depression, and osteoporosis are more common in women, while others such as cardiovascular disease and certain types of cancer are more prevalent in men. Additionally, sex differences have been observed in the effectiveness and side effects of various medications and treatments.

It is important to consider sex factors in medical research and clinical practice to ensure that patients receive appropriate and effective care.

Health status is a term used to describe the overall condition of an individual's health, including physical, mental, and social well-being. It is often assessed through various measures such as medical history, physical examination, laboratory tests, and self-reported health assessments. Health status can be used to identify health disparities, track changes in population health over time, and evaluate the effectiveness of healthcare interventions.

Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) medication that is primarily used to treat major depressive disorder, obsessive-compulsive disorder, bulimia nervosa, panic disorder, and premenstrual dysphoric disorder. It works by increasing the levels of serotonin, a neurotransmitter in the brain that helps maintain mental balance.

Fluoxetine is available under the brand name Prozac and is also available as a generic medication. It comes in various forms, including capsules, tablets, delayed-release capsules, and liquid solution. The typical starting dose for adults with depression is 20 mg per day, but the dosage may be adjusted based on individual patient needs and response to treatment.

Fluoxetine has a relatively long half-life, which means it stays in the body for an extended period of time. This can be beneficial for patients who may have difficulty remembering to take their medication daily, as they may only need to take it once or twice a week. However, it also means that it may take several weeks for the full effects of the medication to become apparent.

As with any medication, fluoxetine can cause side effects, including nausea, dry mouth, sleepiness, insomnia, dizziness, and headache. In some cases, it may also increase the risk of suicidal thoughts or behavior in children, adolescents, and young adults, particularly during the initial stages of treatment. It is important for patients to discuss any concerns about side effects with their healthcare provider.

A placebo is a substance or treatment that has no inherent therapeutic effect. It is often used in clinical trials as a control against which the effects of a new drug or therapy can be compared. Placebos are typically made to resemble the active treatment, such as a sugar pill for a medication trial, so that participants cannot tell the difference between what they are receiving and the actual treatment.

The placebo effect refers to the phenomenon where patients experience real improvements in their symptoms or conditions even when given a placebo. This may be due to psychological factors such as belief in the effectiveness of the treatment, suggestion, or conditioning. The placebo effect is often used as a comparison group in clinical trials to help determine if the active treatment has a greater effect than no treatment at all.

In the context of medical science, culture refers to the growth of microorganisms, such as bacteria or fungi, under controlled conditions in a laboratory setting. This process is used to identify and study the characteristics of these microorganisms, including their growth patterns, metabolic activities, and sensitivity to various antibiotics or other treatments.

The culture medium, which provides nutrients for the microorganisms to grow, can be modified to mimic the environment in which the organism is typically found. This helps researchers to better understand how the organism behaves in its natural habitat.

In addition to its use in diagnosis and research, culture is also an important tool in monitoring the effectiveness of treatments and tracking the spread of infectious diseases.

Secobarbital is a barbiturate medication that is primarily used for the treatment of short-term insomnia and as a preoperative sedative. It works by depressing the central nervous system, producing a calming effect and helping to induce sleep. Secobarbital has a rapid onset of action and a relatively short duration of effect.

It is available in various forms, including capsules and injectable solutions, and is typically prescribed for use on an as-needed basis rather than as a regular medication. Secobarbital can be habit-forming and carries a risk of dependence and withdrawal, so it should only be used under the close supervision of a healthcare provider.

It's important to note that Secobarbital is not commonly prescribed in modern medical practice due to its high potential for abuse and the availability of safer and more effective sleep aids.

Prions are misfolded proteins that can induce other normal proteins to also adopt the misfolded shape, leading to the formation of aggregates. These abnormal prion protein aggregates are associated with a group of progressive neurodegenerative diseases known as transmissible spongiform encephalopathies (TSEs). Examples of TSEs include bovine spongiform encephalopathy (BSE or "mad cow disease") in cattle, variant Creutzfeldt-Jakob disease (vCJD) in humans, and scrapie in sheep. The misfolded prion proteins are resistant to degradation by proteases, which contributes to their accumulation and subsequent neuronal damage, ultimately resulting in spongiform degeneration of the brain and other neurological symptoms associated with TSEs.

I'm sorry for any confusion, but the term "Mid-Atlantic Region" is geographical and does not have a medical definition. It generally refers to a region of the United States that includes the states of New York, Pennsylvania, New Jersey, Delaware, Maryland, Washington D.C., Virginia, and West Virginia. However, in some contexts, the term may also include parts of southern New England, Ohio, Kentucky, and North Carolina. If you're looking for medical information related to a specific region or location, I'd be happy to help if you could provide more details.

The placebo effect is a psychological or psychophysiological phenomenon in which a person's symptoms improve following a treatment but this improvement is not attributable to the properties of the treatment itself. Instead, it is believed to be due to the mind's belief in the effectiveness of the treatment, often influenced by positive expectations and the ritualistic aspects of the therapy itself.

Placebos are often used in clinical trials as a control group to compare against the actual treatment. The placebo effect can make it challenging to determine whether an observed improvement is truly due to the treatment or other factors.

I'm sorry for any confusion, but "Information Science" is not a term that has a specific medical definition. Information science is a multidisciplinary field that deals with the study, management, and analysis of information, its representation, processing, dissemination, and retrieval in various contexts, including libraries, databases, data analytics, knowledge management, and intellectual property rights.

While information science may not have a direct medical definition, it does have important applications in healthcare and medicine, such as in the areas of clinical decision support systems, electronic health records, biomedical informatics, public health surveillance, and evidence-based medicine. These applications involve the use of advanced technologies and methods to analyze large volumes of data, extract meaningful insights, and support better clinical outcomes.

Patient compliance, also known as medication adherence or patient adherence, refers to the degree to which a patient's behavior matches the agreed-upon recommendations from their healthcare provider. This includes taking medications as prescribed (including the correct dosage, frequency, and duration), following dietary restrictions, making lifestyle changes, and attending follow-up appointments. Poor patient compliance can negatively impact treatment outcomes and lead to worsening of symptoms, increased healthcare costs, and development of drug-resistant strains in the case of antibiotics. It is a significant challenge in healthcare and efforts are being made to improve patient education, communication, and support to enhance compliance.

I'm sorry for any confusion, but "Hong Kong" is not a medical term or concept. It is a region located on the southeastern coast of China. If you have any questions about a medical topic, please provide more details so I can try to help you.

Hong Kong is a Special Administrative Region (SAR) of the People's Republic of China (PRC). It was a British colony from 1842 until it was returned to China in 1997. As a SAR, Hong Kong maintains separate governing and economic systems from those of mainland China under the principle of "one country, two systems."

The region is known for its impressive skyline, deep natural harbor, and bustling urban center. It is a major port and global financial hub, and it has a high degree of autonomy in administration, legislation, and economic policies. Hong Kong's legal system is based on English common law, and it has its own currency, the Hong Kong dollar.

I hope this clarifies any confusion regarding the term "Hong Kong." If you have any medical questions, please let me know!

A tension-type headache (TTH) is a common primary headache disorder characterized by mild to moderate, non-throbbing head pain, often described as a tight band or pressure surrounding the head. The pain typically occurs on both sides of the head and may be accompanied by symptoms such as scalp tenderness, neck stiffness, and light or sound sensitivity.

TTHs are classified into two main categories: episodic and chronic. Episodic TTHs occur less than 15 days per month, while chronic TTHs occur 15 or more days per month for at least three months. The exact cause of tension-type headaches is not fully understood, but they are believed to be related to muscle tension, stress, anxiety, and poor posture.

Treatment options for TTHs include over-the-counter pain relievers such as ibuprofen or acetaminophen, relaxation techniques, stress management, physical therapy, and lifestyle modifications. In some cases, prescription medications may be necessary to manage chronic TTHs.

The International Classification of Diseases (ICD) is a standardized system for classifying and coding mortality and morbidity data, established by the World Health Organization (WHO). It provides a common language and framework for health professionals, researchers, and policymakers to share and compare health-related information across countries and regions.

The ICD codes are used to identify diseases, injuries, causes of death, and other health conditions. The classification includes categories for various body systems, mental disorders, external causes of injury and poisoning, and factors influencing health status. It also includes a section for symptoms, signs, and abnormal clinical and laboratory findings.

The ICD is regularly updated to incorporate new scientific knowledge and changing health needs. The most recent version, ICD-11, was adopted by the World Health Assembly in May 2019 and will come into effect on January 1, 2022. It includes significant revisions and expansions in several areas, such as mental, behavioral, neurological disorders, and conditions related to sexual health.

In summary, the International Classification of Diseases (ICD) is a globally recognized system for classifying and coding diseases, injuries, causes of death, and other health-related information, enabling standardized data collection, comparison, and analysis across countries and regions.

Electrooculography (EOG) is a technique for measuring the resting potential of the eye and the changes in this potential that occur with eye movements. It involves placing electrodes near the eyes to detect the small electric fields generated by the movement of the eyeball within the surrounding socket. This technique is used in research and clinical settings to study eye movements and their control, as well as in certain diagnostic applications such as assessing the function of the oculomotor system in patients with neurological disorders.

Reproducibility of results in a medical context refers to the ability to obtain consistent and comparable findings when a particular experiment or study is repeated, either by the same researcher or by different researchers, following the same experimental protocol. It is an essential principle in scientific research that helps to ensure the validity and reliability of research findings.

In medical research, reproducibility of results is crucial for establishing the effectiveness and safety of new treatments, interventions, or diagnostic tools. It involves conducting well-designed studies with adequate sample sizes, appropriate statistical analyses, and transparent reporting of methods and findings to allow other researchers to replicate the study and confirm or refute the results.

The lack of reproducibility in medical research has become a significant concern in recent years, as several high-profile studies have failed to produce consistent findings when replicated by other researchers. This has led to increased scrutiny of research practices and a call for greater transparency, rigor, and standardization in the conduct and reporting of medical research.

Psychological adaptation refers to the process by which individuals adjust and cope with stressors, challenges, or changes in their environment or circumstances. It involves modifying thoughts, feelings, behaviors, and copabilities to reduce the negative impact of these stressors and promote well-being. Psychological adaptation can occur at different levels, including intrapersonal (within the individual), interpersonal (between individuals), and cultural (within a group or society).

Examples of psychological adaptation include:

* Cognitive restructuring: changing negative thoughts and beliefs to more positive or adaptive ones
* Emotion regulation: managing and reducing intense or distressing emotions
* Problem-solving: finding solutions to practical challenges or obstacles
* Seeking social support: reaching out to others for help, advice, or comfort
* Developing coping strategies: using effective ways to deal with stressors or difficulties
* Cultivating resilience: bouncing back from adversity and learning from negative experiences.

Psychological adaptation is an important aspect of mental health and well-being, as it helps individuals adapt to new situations, overcome challenges, and maintain a sense of control and optimism in the face of stressors or changes.

Hydroxyzine is an antihistamine medication that is primarily used to treat symptoms of allergies such as itching, hives, and swelling. It works by blocking the effects of histamine, a substance in the body that causes allergic reactions. In addition to its antihistaminic properties, hydroxyzine also has sedative and anxiety-reducing effects, which make it useful in treating anxiety disorders, symptoms of alcohol withdrawal, and as a sleep aid. It is available in both oral and injectable forms and is usually taken orally in the form of tablets, capsules, or syrup. As with any medication, hydroxyzine should be used under the supervision of a healthcare provider, and its use may be subject to certain precautions and contraindications depending on the individual's medical history and current health status.

Electroacupuncture is a form of acupuncture where a small electric current is passed between pairs of acupuncture needles. This technique is used to stimulate the acupoints more strongly and consistently than with manual acupuncture. The intensity of the electrical impulses can be adjusted depending on the patient's comfort level and the desired therapeutic effect. Electroacupuncture is often used to treat conditions such as chronic pain, muscle spasms, and paralysis. It may also be used in the treatment of addiction, weight loss, and stroke rehabilitation.

Mental health is a state of well-being in which an individual realizes his or her own abilities, can cope with the normal stresses of life, can work productively and fruitfully, and is able to make a contribution to his or her community. It involves the emotional, psychological, and social aspects of an individual's health. Mental health is not just the absence of mental illness, it also includes positive characteristics such as resilience, happiness, and having a sense of purpose in life.

It is important to note that mental health can change over time, and it is possible for an individual to experience periods of good mental health as well as periods of poor mental health. Factors such as genetics, trauma, stress, and physical illness can all contribute to the development of mental health problems. Additionally, cultural and societal factors, such as discrimination and poverty, can also impact an individual's mental health.

Mental Health professionals like psychiatrists, psychologists, social workers and other mental health counselors use different tools and techniques to evaluate, diagnose and treat mental health conditions. These include therapy or counseling, medication, and self-help strategies.

Pain measurement, in a medical context, refers to the quantification or evaluation of the intensity and/or unpleasantness of a patient's subjective pain experience. This is typically accomplished through the use of standardized self-report measures such as numerical rating scales (NRS), visual analog scales (VAS), or categorical scales (mild, moderate, severe). In some cases, physiological measures like heart rate, blood pressure, and facial expressions may also be used to supplement self-reported pain ratings. The goal of pain measurement is to help healthcare providers better understand the nature and severity of a patient's pain in order to develop an effective treatment plan.

Chinese herbal drugs, also known as traditional Chinese medicine (TCM), refer to a system of medicine that has been practiced in China for thousands of years. It is based on the belief that the body's vital energy, called Qi, must be balanced and flowing freely for good health. TCM uses various techniques such as herbal therapy, acupuncture, dietary therapy, and exercise to restore balance and promote healing.

Chinese herbal drugs are usually prescribed in the form of teas, powders, pills, or tinctures and may contain one or a combination of herbs. The herbs used in Chinese medicine are typically derived from plants, minerals, or animal products. Some commonly used Chinese herbs include ginseng, astragalus, licorice root, and cinnamon bark.

It is important to note that the use of Chinese herbal drugs should be under the guidance of a qualified practitioner, as some herbs can interact with prescription medications or have side effects. Additionally, the quality and safety of Chinese herbal products can vary widely depending on the source and manufacturing process.

A Receiver Operating Characteristic (ROC) curve is a graphical representation used in medical decision-making and statistical analysis to illustrate the performance of a binary classifier system, such as a diagnostic test or a machine learning algorithm. It's a plot that shows the tradeoff between the true positive rate (sensitivity) and the false positive rate (1 - specificity) for different threshold settings.

The x-axis of an ROC curve represents the false positive rate (the proportion of negative cases incorrectly classified as positive), while the y-axis represents the true positive rate (the proportion of positive cases correctly classified as positive). Each point on the curve corresponds to a specific decision threshold, with higher points indicating better performance.

The area under the ROC curve (AUC) is a commonly used summary measure that reflects the overall performance of the classifier. An AUC value of 1 indicates perfect discrimination between positive and negative cases, while an AUC value of 0.5 suggests that the classifier performs no better than chance.

ROC curves are widely used in healthcare to evaluate diagnostic tests, predictive models, and screening tools for various medical conditions, helping clinicians make informed decisions about patient care based on the balance between sensitivity and specificity.

I'm sorry for any confusion, but "Taiwan" is not a medical term or concept. It is the name of an island nation located in East Asia. The official name of the country is the Republic of China (ROC). If you have any medical questions or inquiries, I would be happy to help answer those for you!

Mind-body therapies refer to a group of interventions that aim to facilitate the connection between the mind and body, with the goal of enhancing mental, emotional, and physical well-being. These therapies are based on the understanding that our thoughts, emotions, and beliefs can significantly impact our physical health.

Examples of mind-body therapies include:

1. Meditation: Focused concentration to achieve a mentally clear and emotionally calm state.
2. Yoga: A practice that combines physical postures, breathing exercises, meditation, and a distinct philosophy.
3. Guided imagery: Deliberate mental visualization of a peaceful setting or situation to promote relaxation and stress reduction.
4. Progressive muscle relaxation: Systematically tensing and then releasing various muscle groups to promote relaxation and stress reduction.
5. Biofeedback: A technique that uses electronic devices to help individuals learn to control physiological responses, such as heart rate or blood pressure.
6. Hypnotherapy: The use of hypnosis to facilitate therapeutic change by accessing the subconscious mind.
7. Tai Chi and Qigong: Ancient Chinese practices that involve slow, gentle movements, deep breathing, and meditation.
8. Mindfulness-based stress reduction (MBSR): A structured program that combines mindfulness meditation, yoga, and cognitive therapy to help manage stress and improve overall well-being.
9. Acupuncture and acupressure: Traditional Chinese medicine practices that involve the stimulation of specific points on the body using needles or pressure, respectively, to promote healing and balance.
10. Prayer and spiritual practices: Engaging in religious or spiritual activities to foster a sense of connection, meaning, and purpose.

These therapies can be used as complementary approaches alongside conventional medical treatments or as standalone interventions for various health conditions, such as stress management, pain relief, anxiety reduction, and overall wellness promotion.

Socioeconomic factors are a range of interconnected conditions and influences that affect the opportunities and resources a person or group has to maintain and improve their health and well-being. These factors include:

1. Economic stability: This includes employment status, job security, income level, and poverty status. Lower income and lack of employment are associated with poorer health outcomes.
2. Education: Higher levels of education are generally associated with better health outcomes. Education can affect a person's ability to access and understand health information, as well as their ability to navigate the healthcare system.
3. Social and community context: This includes factors such as social support networks, discrimination, and community safety. Strong social supports and positive community connections are associated with better health outcomes, while discrimination and lack of safety can negatively impact health.
4. Healthcare access and quality: Access to affordable, high-quality healthcare is an important socioeconomic factor that can significantly impact a person's health. Factors such as insurance status, availability of providers, and cultural competency of healthcare systems can all affect healthcare access and quality.
5. Neighborhood and built environment: The physical conditions in which people live, work, and play can also impact their health. Factors such as housing quality, transportation options, availability of healthy foods, and exposure to environmental hazards can all influence health outcomes.

Socioeconomic factors are often interrelated and can have a cumulative effect on health outcomes. For example, someone who lives in a low-income neighborhood with limited access to healthy foods and safe parks may also face challenges related to employment, education, and healthcare access that further impact their health. Addressing socioeconomic factors is an important part of promoting health equity and reducing health disparities.

Orexin receptors are a type of G protein-coupled receptor found in the central nervous system that play a crucial role in regulating various physiological functions, including wakefulness, energy balance, and reward processing. There are two subtypes of orexin receptors: OX1R (orexin-1 receptor) and OX2R (orexin-2 receptor). These receptors bind to the neuropeptides orexin A and orexin B, which are synthesized in a small group of neurons located in the hypothalamus. Activation of these receptors leads to increased wakefulness, appetite stimulation, and reward-seeking behavior, among other effects. Dysregulation of the orexin system has been implicated in several neurological disorders, such as narcolepsy, where a loss of orexin-producing neurons results in excessive daytime sleepiness and cataplexy.

Perimenopause is a term used to describe the phase before menopause where the ovaries gradually begin to produce less estrogen. It's also sometimes referred to as the "menopausal transition."

This stage can last for several years, typically starting in a woman's mid-40s, but it can begin in some women as early as their mid-30s or as late as their early 50s. During this time, menstrual cycles may become longer or shorter, and periods may be lighter or heavier.

The most significant sign of perimenopause is the irregularity of periods. However, other symptoms such as hot flashes, sleep disturbances, mood changes, and vaginal dryness can also occur, similar to those experienced during menopause.

Perimenopause ends after a woman has gone 12 months without having a period, which marks the start of menopause.

Home care agencies, also known as home health care agencies, are organizations that provide various health and social services to individuals in their own homes. These services can include skilled nursing care, physical therapy, occupational therapy, speech-language pathology, medical social work, and home health aide services. The goal of home care agencies is to help individuals maintain their independence and quality of life while receiving the necessary care in the comfort of their own homes. Home care agencies must be licensed and regulated by state governments to ensure that they meet certain standards of care.

I'm sorry for any confusion, but "Finland" is not a medical term. It is a country located in Northern Europe, known officially as the Republic of Finland. If you have any questions about medical terminology or health-related topics, I would be happy to try and help answer those for you.

Narcolepsy is a chronic neurological disorder that affects the control of sleep and wakefulness. It's characterized by excessive daytime sleepiness (EDS), where people experience sudden, uncontrollable episodes of falling asleep during the day. These "sleep attacks" can occur at any time - while working, talking, eating, or even driving.

In addition to EDS, narcolepsy often includes cataplexy, a condition that causes loss of muscle tone, leading to weakness and sometimes collapse, often triggered by strong emotions like laughter or surprise. Other common symptoms are sleep paralysis (a temporary inability to move or speak while falling asleep or waking up), vivid hallucinations during the transitions between sleep and wakefulness, and fragmented nighttime sleep.

The exact cause of narcolepsy is not fully understood, but it's believed to involve genetic and environmental factors, as well as problems with certain neurotransmitters in the brain, such as hypocretin/orexin, which regulate sleep-wake cycles. Narcolepsy can significantly impact a person's quality of life, making it essential to seek medical attention for proper diagnosis and management.

Hypnosis is a state of highly focused attention or concentration, often associated with relaxation, and heightened suggestibility. In a clinical context, hypnosis is often used as a tool in hypnotherapy, to help individuals explore unconscious thoughts, feelings, and behaviors, or to make positive changes to their thoughts, behavior, and physical well-being. It's important to note that hypnosis is not a state of unconsciousness or sleep, but rather a state of altered consciousness characterized by increased suggestibility and focused attention.

It's also worth noting that the definition of hypnosis can vary between different fields and perspectives. Some definitions emphasize the role of suggestion in shaping experience during hypnosis, while others focus on the importance of expectancy and belief. Additionally, there is ongoing debate about the precise mechanisms underlying hypnotic phenomena, with some researchers emphasizing social and psychological factors, while others highlight neurological and physiological changes associated with hypnosis.

Musculoskeletal pain is discomfort or pain that affects the muscles, bones, ligaments, tendons, and nerves. It can be caused by injury, overuse, or disease and can affect any part of the body, including the neck, back, shoulders, hips, and extremities. The pain can range from mild to severe and may be accompanied by stiffness, swelling, and decreased range of motion. Common causes of musculoskeletal pain include arthritis, fibromyalgia, tendinitis, bursitis, and muscle or ligament strain. Treatment for musculoskeletal pain depends on the underlying cause and may include physical therapy, medication, and in some cases, surgery.

Barbiturates are a class of drugs that act as central nervous system depressants, which means they slow down the activity of the brain and nerves. They were commonly used in the past to treat conditions such as anxiety, insomnia, and seizures, but their use has declined due to the risk of addiction, abuse, and serious side effects. Barbiturates can also be used for surgical anesthesia and as a treatment for barbiturate or pentobarbital overdose.

Barbiturates work by enhancing the activity of the neurotransmitter gamma-aminobutyric acid (GABA) in the brain, which results in sedation, hypnosis, and anticonvulsant effects. However, at higher doses, barbiturates can cause respiratory depression, coma, and even death.

Some examples of barbiturates include pentobarbital, phenobarbital, secobarbital, and amobarbital. These drugs are usually available in the form of tablets, capsules, or injectable solutions. It is important to note that barbiturates should only be used under the supervision of a healthcare professional, as they carry a high risk of dependence and abuse.

I apologize for any confusion, but "Teaching Materials" is not a medical term or concept. It generally refers to resources and tools used by educators to facilitate learning, which can include textbooks, multimedia presentations, handouts, and other materials used in educational settings. If you have a specific term related to medicine or healthcare in mind, please let me know so I can provide a more accurate definition.

A single-blind method in medical research is a study design where the participants are unaware of the group or intervention they have been assigned to, but the researchers conducting the study know which participant belongs to which group. This is done to prevent bias from the participants' expectations or knowledge of their assignment, while still allowing the researchers to control the study conditions and collect data.

In a single-blind trial, the participants do not know whether they are receiving the active treatment or a placebo (a sham treatment that looks like the real thing but has no therapeutic effect), whereas the researcher knows which participant is receiving which intervention. This design helps to ensure that the participants' responses and outcomes are not influenced by their knowledge of the treatment assignment, while still allowing the researchers to assess the effectiveness or safety of the intervention being studied.

Single-blind methods are commonly used in clinical trials and other medical research studies where it is important to minimize bias and control for confounding variables that could affect the study results.

Serotonin uptake inhibitors (also known as Selective Serotonin Reuptake Inhibitors or SSRIs) are a class of medications primarily used to treat depression and anxiety disorders. They work by increasing the levels of serotonin, a neurotransmitter in the brain that helps regulate mood, appetite, and sleep, among other functions.

SSRIs block the reuptake of serotonin into the presynaptic neuron, allowing more serotonin to be available in the synapse (the space between two neurons) for binding to postsynaptic receptors. This results in increased serotonergic neurotransmission and improved mood regulation.

Examples of SSRIs include fluoxetine (Prozac), sertraline (Zoloft), paroxetine (Paxil), citalopram (Celexa), and escitalopram (Lexapro). These medications are generally well-tolerated, with side effects that may include nausea, headache, insomnia, sexual dysfunction, and increased anxiety or agitation. However, they can have serious interactions with other medications, so it is important to inform your healthcare provider of all medications you are taking before starting an SSRI.

A headache is defined as pain or discomfort in the head, scalp, or neck. It can be a symptom of various underlying conditions such as stress, sinus congestion, migraine, or more serious issues like meningitis or concussion. Headaches can vary in intensity, ranging from mild to severe, and may be accompanied by other symptoms such as nausea, vomiting, or sensitivity to light and sound. There are over 150 different types of headaches, including tension headaches, cluster headaches, and sinus headaches, each with their own specific characteristics and causes.

In a medical context, awareness generally refers to the state of being conscious or cognizant of something. This can include being aware of one's own thoughts, feelings, and experiences, as well as being aware of external events or sensations.

For example, a person who is awake and alert is said to have full awareness, while someone who is in a coma or under general anesthesia may be described as having reduced or absent awareness. Similarly, a person with dementia or Alzheimer's disease may have impaired awareness of their surroundings or of their own memory and cognitive abilities.

In some cases, awareness may also refer to the process of becoming informed or educated about a particular health condition or medical treatment. For example, a patient may be encouraged to increase their awareness of heart disease risk factors or of the potential side effects of a medication. Overall, awareness involves a deep understanding and perception of oneself and one's environment.

Somnambulism is defined as a parasomnia, which is a type of sleep disorder, that involves walking or performing other complex behaviors while asleep. It's more commonly known as sleepwalking. During a sleepwalking episode, a person will have their eyes open and may appear to be awake and aware of their surroundings, but they are actually in a state of low consciousness.

Sleepwalking can range from simply sitting up in bed and looking around, to walking around the house, dressing or undressing, or even leaving the house. Episodes usually occur during deep non-REM sleep early in the night and can last from several minutes to an hour.

Although it is more common in children, especially those between the ages of 3 and 7, somnambulism can also affect adults. Factors that may contribute to sleepwalking include stress, fatigue, fever, certain medications, alcohol consumption, and underlying medical or psychiatric conditions such as sleep apnea, restless leg syndrome, gastroesophageal reflux disease (GERD), post-traumatic stress disorder (PTSD), or dissociative states.

Most of the time, somnambulism is not a cause for concern and does not require treatment. However, if sleepwalking leads to potential harm or injury, or if it frequently disrupts sleep, medical advice should be sought to address any underlying conditions and ensure safety measures are in place during sleep.

Laryngopharyngeal reflux (LPR) is a condition in which the stomach contents, particularly acid, flow backward from the stomach into the larynx (voice box) and pharynx (throat). This is also known as extraesophageal reflux disease (EERD) or supraesophageal reflux disease (SERD). Unlike gastroesophageal reflux disease (GERD), where acid reflux causes symptoms such as heartburn and regurgitation, LPR may not cause classic reflux symptoms, but rather symptoms related to the upper aerodigestive tract. These can include hoarseness, throat clearing, cough, difficulty swallowing, and a sensation of a lump in the throat.

A case-control study is an observational research design used to identify risk factors or causes of a disease or health outcome. In this type of study, individuals with the disease or condition (cases) are compared with similar individuals who do not have the disease or condition (controls). The exposure history or other characteristics of interest are then compared between the two groups to determine if there is an association between the exposure and the disease.

Case-control studies are often used when it is not feasible or ethical to conduct a randomized controlled trial, as they can provide valuable insights into potential causes of diseases or health outcomes in a relatively short period of time and at a lower cost than other study designs. However, because case-control studies rely on retrospective data collection, they are subject to biases such as recall bias and selection bias, which can affect the validity of the results. Therefore, it is important to carefully design and conduct case-control studies to minimize these potential sources of bias.

I apologize for any confusion, but "Arkansas" is a proper noun and refers to a state in the United States. It does not have a medical definition. Arkansas is located in the southern region of the U.S. and is known for its diverse geography, which includes mountains, forests, and lowlands. The capital and largest city of Arkansas is Little Rock.

If you have any questions related to health or medicine, I would be happy to try to help answer them.

Ambulatory monitoring is a medical practice that involves the continuous or intermittent recording of physiological parameters in a patient who is mobile and able to perform their usual activities while outside of a hospital or clinical setting. This type of monitoring allows healthcare professionals to evaluate a patient's condition over an extended period, typically 24 hours or more, in their natural environment.

Ambulatory monitoring can be used to diagnose and manage various medical conditions such as hypertension, cardiac arrhythmias, sleep disorders, and mobility issues. Common methods of ambulatory monitoring include:

1. Holter monitoring: A small, portable device that records the electrical activity of the heart for 24-48 hours or more.
2. Ambulatory blood pressure monitoring (ABPM): A device that measures blood pressure at regular intervals throughout the day and night.
3. Event monitors: Devices that record heart rhythms only when symptoms occur or when activated by the patient.
4. Actigraphy: A non-invasive method of monitoring sleep-wake patterns, physical activity, and circadian rhythms using a wristwatch-like device.
5. Continuous glucose monitoring (CGM): A device that measures blood sugar levels continuously throughout the day and night.

Overall, ambulatory monitoring provides valuable information about a patient's physiological status in their natural environment, allowing healthcare professionals to make informed decisions regarding diagnosis, treatment, and management of medical conditions.

Cyclohexanecarboxylic acids are a type of organic compound that consists of a cyclohexane ring, which is a six-carbon saturated hydrocarbon, substituted with a carboxylic acid group (-COOH). This group contains a carbon atom double bonded to an oxygen atom and single bonded to a hydroxyl group (-OH).

The cyclohexane ring can be in various forms, including the chair, boat, or twist-boat conformations, depending on the orientation of its constituent atoms. The carboxylic acid group can ionize to form a carboxylate anion, which is negatively charged and has a deprotonated hydroxyl group.

Cyclohexanecarboxylic acids have various applications in industry and research, including as intermediates in the synthesis of other chemicals, solvents, and pharmaceuticals. They can also be found naturally in some plants and microorganisms.

Psychological tests are standardized procedures or measures used to assess various aspects of an individual's cognitive functioning, personality traits, emotional status, and behavior. These tests are designed to be reliable and valid tools for evaluating specific psychological constructs such as intelligence, memory, attention, achievement, aptitude, interests, and values. They can be in the form of questionnaires, interviews, observational scales, or performance-based tasks. The results obtained from these tests help mental health professionals make informed decisions about diagnosis, treatment planning, and educational or vocational guidance for their clients. It is important to note that psychological tests should only be administered, scored, and interpreted by trained and qualified professionals to ensure accurate and meaningful results.

Psychotherapy is a type of treatment used primarily to treat mental health disorders and other emotional or behavioral issues. It involves a therapeutic relationship between a trained psychotherapist and a patient, where they work together to understand the patient's thoughts, feelings, and behaviors, identify patterns that may be causing distress, and develop strategies to manage symptoms and improve overall well-being.

There are many different approaches to psychotherapy, including cognitive-behavioral therapy (CBT), psychodynamic therapy, interpersonal therapy, and others. The specific approach used will depend on the individual patient's needs and preferences, as well as the training and expertise of the therapist.

Psychotherapy can be conducted in individual, group, or family sessions, and may be provided in a variety of settings, such as hospitals, clinics, private practices, or online platforms. The goal of psychotherapy is to help patients understand themselves better, develop coping skills, improve their relationships, and enhance their overall quality of life.

Primary health care is defined by the World Health Organization (WHO) as:

"Essential health care that is based on practical, scientifically sound and socially acceptable methods and technology made universally accessible to individuals and families in the community through their full participation and at a cost that the community and country can afford. It forms an integral part both of the country's health system, of which it is the central function and main focus, and of the overall social and economic development of the community. It is the first level of contact of individuals, the family and community with the national health system bringing health care as close as possible to where people live and work, and constitutes the first element of a continuing health care process."

Primary health care includes a range of services such as preventive care, health promotion, curative care, rehabilitation, and palliative care. It is typically provided by a team of health professionals including doctors, nurses, midwives, pharmacists, and other community health workers. The goal of primary health care is to provide comprehensive, continuous, and coordinated care to individuals and families in a way that is accessible, affordable, and culturally sensitive.

Illness behavior is a term used in the field of medicine and psychology to describe the way an individual perceives, experiences, and responds to symptoms or illness. It encompasses the thoughts, feelings, and behaviors that are associated with being sick or experiencing discomfort. This can include seeking medical attention, adhering to treatment plans, and adjusting one's daily activities to accommodate the illness.

Illness behavior is not simply the presence of physical symptoms, but rather it is the way in which an individual interprets and responds to those symptoms. It can be influenced by a variety of factors, including cultural beliefs about health and illness, previous experiences with illness, personality traits, and mental health status.

It's important to note that illness behavior is not necessarily indicative of malingering or fabricating symptoms. Rather, it reflects the complex interplay between an individual's physical health, psychological factors, and social context. Understanding illness behavior can help healthcare providers better assess and manage their patients' symptoms and improve overall care.

Binge drinking is a pattern of alcohol consumption that brings blood alcohol concentration (BAC) levels to 0.08 g/dL or above. For the typical adult, this corresponds to consuming 5 or more drinks (male), or 4 or more drinks (female), in about 2 hours.

It is a serious and dangerous form of alcohol consumption as it can lead to various negative health consequences such as injuries, violence, liver disease, heart disease, and sexually transmitted diseases, among others. Binge drinking is also associated with an increased risk of alcohol dependence.

Isoxazoles are not a medical term, but a chemical compound. They are organic compounds containing a five-membered ring consisting of one nitrogen atom, one oxygen atom, and three carbon atoms. Isoxazoles have various applications in the pharmaceutical industry as they can be used to synthesize different drugs. Some isoxazole derivatives have been studied for their potential medicinal properties, such as anti-inflammatory, analgesic, and antipyretic effects. However, isoxazoles themselves are not a medical diagnosis or treatment.

Complementary therapies refer to a group of diverse medical and health care systems, practices, and products that are not presently considered an integral part of conventional allopathic medicine. They are often used in conjunction with conventional treatments and are intended to facilitate the physical and emotional well-being of the patient. Complementary therapies can include a wide range of interventions such as acupuncture, chiropractic care, massage therapy, herbal medicine, yoga, meditation, guided imagery, hypnotherapy, and homeopathy, among others. It is important to note that while some complementary therapies have been shown to be effective for certain conditions, others lack scientific evidence of their safety and efficacy. Therefore, it is always recommended to consult with a healthcare provider before starting any new complementary therapy.

Perceptual disorders are conditions that affect the way a person perceives or interprets sensory information from their environment. These disorders can involve any of the senses, including sight, sound, touch, taste, and smell. They can cause a person to have difficulty recognizing, interpreting, or responding appropriately to sensory stimuli.

Perceptual disorders can result from damage to the brain or nervous system, such as from a head injury, stroke, or degenerative neurological condition. They can also be caused by certain mental health conditions, such as schizophrenia or severe depression.

Symptoms of perceptual disorders may include:

* Misinterpretations of sensory information, such as seeing things that are not there or hearing voices that are not present
* Difficulty recognizing familiar objects or people
* Problems with depth perception or spatial awareness
* Difficulty judging the size, shape, or distance of objects
* Trouble distinguishing between similar sounds or colors
* Impaired sense of smell or taste

Perceptual disorders can have a significant impact on a person's daily life and functioning. Treatment may involve medication, therapy, or rehabilitation to help the person better cope with their symptoms and improve their ability to interact with their environment.

Acetamides are organic compounds that contain an acetamide functional group, which is a combination of an acetyl group (-COCH3) and an amide functional group (-CONH2). The general structure of an acetamide is R-CO-NH-CH3, where R represents the rest of the molecule.

Acetamides are found in various medications, including some pain relievers, muscle relaxants, and anticonvulsants. They can also be found in certain industrial chemicals and are used as intermediates in the synthesis of other organic compounds.

It is important to note that exposure to high levels of acetamides can be harmful and may cause symptoms such as headache, dizziness, nausea, and vomiting. Chronic exposure has been linked to more serious health effects, including liver and kidney damage. Therefore, handling and use of acetamides should be done with appropriate safety precautions.

Fatal familial insomnia is thought to be the result of a point mutation in PRNP at codon 178, which corroborates PrP's ... Collins S, McLean CA, Masters CL (2001). "Gerstmann-Straussler-Scheinker syndrome, fatal familial insomnia, and kuru: a review ... Montagna P, Gambetti P, Cortelli P, Lugaresi E (2003). "Familial and sporadic fatal insomnia". Lancet Neurol. 2 (3): 167-76. ... "Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene". N. Engl. J. Med. 326 (7): 444 ...
... and Fatal familial insomnia (FFI). Animal pathogens are disease-causing agents of wild and domestic animal species, at times ... It has been found that prions transmit three ways: obtained, familial, and sporadic. It has also been found that plants play ...
... permanent and eventually fatal form of insomnia called fatal familial insomnia Physical exercise: exercise-induced insomnia is ... Acute insomnia is also known as short term insomnia or stress related insomnia. Chronic insomnia lasts for longer than a month ... Schenkein J, Montagna P (September 2006). "Self management of fatal familial insomnia. Part 1: what is FFI?". MedGenMed. 8 (3 ... "Insomnia - sleeplessness, chronic insomnia, acute insomnia, mental ..." Archived from the original on 29 March 2008. Retrieved ...
Khan, Z.; Bollu, P. C. (2021). "Fatal Familial Insomnia". Zalan Khan; Pradeep C. Bollu, Fatal Familial Insomnia. PMID 29489284 ... "Fatal Insomnia". Merck Manual. Retrieved 4 May 2018. Turner, Rebecca. "Dying To Sleep: Fatal Familial Insomnia (FFI)". www. ... "Fatal Familial Insomnia". NORD (National Organization for Rare Disorders). Retrieved 21 September 2022. "Fatal Insomnia - ... "Fatal familial insomnia". Genetic and Rare Diseases Information Center (GARD) - an NCATS Program. Retrieved 17 May 2019. "Fatal ...
Miska, Brad (2020-04-28). "'Awoken': Vertical Suffers From Fatal Familial Insomnia [Exclusive]". Bloody Disgusting!. Retrieved ... Fatal Famial Insomnia (FFI), after witnessing their parents die in a murder-suicide. She is also suffering from insomnia. Not ... The film stars Sara West as a young medical student trying to save her insomnia plagued brother from sinister forces. Karla is ... Once there they are introduced to the two other participants Chris and Angela, who also suffer from insomnia due to their own ...
"Sleep-wake cycle abnormalities in fatal familial insomnia. Evidence of the role of the thalamus in sleep regulation". ... A clinico-pathological study in fatal familial thalamic degeneration". Electroencephalography and Clinical Neurophysiology. 73 ... Sallanon M, Denoyer M, Kitahama K, Aubert C, Gay N, Jouvet M (1989). "Long-lasting insomnia induced by preoptic neuron lesions ... According to a recent sleep disruption and insomnia review study, there are short-term and long-term negative consequences on ...
Oxford Journals Familial prion diseases: Creutzfeldt-Jakob disease and fatal insomnia F. Flugel. In memoriam Friedrich ... Sporadic and familial CJD: classification and characterisation. Br Med Bull. 2003;66:213-39. doi:10.1093/bmb/66.1.213. PMID ... In 1930 he provided an early description of familial Creutzfeldt-Jakob disease in the "Backer family" of northern Germany. The ...
Patients with Fatal familial insomnia, an extremely rare and strictly hereditary disorder, also presents with hypermetabolism; ... Fatal familial insomnia: Manifestation: Hypermetabolism in the thalamus occurs and disrupts sleep spindle formation that occurs ... "Pre-symptomatic diagnosis in fatal familial insomnia: serial neurophysiological and FDG-PET studies" (PDF). Brain. Oxford ... Outward symptoms of hypermetabolism may include: Weight loss Anemia Fatigue Elevated heart rate Irregular heartbeat Insomnia ...
Loss of sleep spindles are also a feature of familial fatal insomnia, a prion disease. Changes in spindle density are observed ...
... fatal familial insomnia (FFI), and kuru. There is also evidence suggesting prions may play a part in the process of Alzheimer's ... Lay summary: "BSE proteins may cause fatal insomnia". BBC News. May 28, 1999. Nitrini R, Rosemberg S, Passos-Bueno MR, da Silva ... "Prion protein conformation in a patient with sporadic fatal insomnia". The New England Journal of Medicine. 340 (21): 1630-1638 ... All known prion diseases are untreatable and fatal. However, a vaccine developed in mice may provide insight into providing a ...
Prion diseases comprise Creutzfeldt-Jakob disease (CJD), Gerstmann-Sträussler-Scheinker syndrome, fatal familial insomnia and ... CJD is a degenerative brain disorder that is always fatal. In the 1990s, some people in the United Kingdom developed a variant ... Diagnosis of Gerstmann-Straussler syndrome in familial dementia with prion protein gene analysis. Lancet 1989; 2: 15-7 "Report ...
Fatal familial insomnia, an extremely rare and universally-fatal prion disease that causes a complete cessation of sleep. ... Insomnia: Insomnia may be primary or it may be comorbid with or secondary to another disorder such as a mood disorder (i.e., ... Insomnia can start off at the basic level but about 40% of people who struggle with insomnia have worse symptoms. There are ... Insomnia is a prevalent form of sleep deprivation. Individuals with insomnia may have problems falling asleep, staying asleep, ...
Paradoxical Insomnia Schenkein, Joyce Fatal Familial Insomnia. Part 1: What Is Fatal Familial Insomnia. Medscape. Hauri PJ. " ... Insomnia Information Sleepnet.com - Insomnia Information Conroy, Deirdre A; Culebras, Antonio (2013). "Paradoxical insomnia". ... that have been recorded have predominantly been ascribed to a rare incurable genetic disorder called fatal familial insomnia, ... subjective insomnia complaint without objective findings) or no sleep at all (subjective total insomnia) report excessive ...
... fatal familial insomnia, and kuru: a review of these less common human transmissible spongiform encephalopathies". Journal of ...
Collins S, McLean CA, Masters CL (September 2001). "Gerstmann-Sträussler-Scheinker syndrome,fatal familial insomnia, and kuru: ... Familial cases are associated with autosomal-dominant inheritance. Certain symptoms are common to GSS, such as progressive ... Gerstmann-Sträussler-Scheinker syndrome (GSS) is an extremely rare, always fatal (due to it being caused by prions) ...
Collins, S; McLean CA; Masters CL (2001). "Gerstmann-Straussler-Scheinker syndrome, fatal familial insomnia, and kuru: a review ...
... fatal familial insomnia, and kuru, as well as the recently discovered variably protease-sensitive prionopathy and familial ... Collins S, McLean CA, Masters CL (2001). "Gerstmann-Straussler-Scheinker syndrome, fatal familial insomnia, and kuru: a review ... In some people, familial forms of prion disease are caused by a new mutation in the PRNP gene. Although such people most likely ... Familial forms of prion disease are caused by inherited mutations in the PRNP gene. Only a small percentage of all cases of ...
He is secretly suffering from a degenerative brain disease known as fatal familial insomnia and has only a few months left to ...
... ranging from amyotrophic lateral sclerosis to fatal familial insomnia. Although the mechanisms which lead to astrogliosis are ...
Fatal Familial Insomnia (FFI) is a disorder that results in trouble sleeping, speech and coordination problems, and eventually ... Cortelli P, Gambetti P, Montagna P, Lugaresi E (June 1999). "Fatal familial insomnia: clinical features and molecular genetics ... "Fatal Insomnia - Neurologic Disorders". Merck Manuals Professional Edition. Retrieved 2021-05-06. Burchell JT, Panegyres PK ( ... Familial Delayed Sleep Phase (FDSP), and Familial Natural Short Sleep (FNSS). Some mutations in Mendelian genes that are ...
Hungarian soldier who supposedly never slept after gunshot to the head Sleep state misperception Fatal familial insomnia The ... It was likely that he died for other reasons, not sleep deprivation, as his insomnia did not seem to have any effect on his ... No other person with total insomnia has lived for such a long period of time. ...
... disease Labyrinthitis Otitis media Brain tumor Acoustic neuroma Motion sickness Ramsay Hunt syndrome Fatal Familial Insomnia ...
Fatal familial insomnia is a hereditary prion disease in which degeneration of the thalamus occurs, causing the patient to ... gradually lose their ability to sleep and progressing to a state of total insomnia, which invariably leads to death. In ...
Fatal Familial Insomnia: Inherited Prion Diseases, Sleep and the Thalamus (1994) Obstructive Sleep Apnea Syndrome: Clinical ...
... insomnia, fatal familial MeSH C10.228.228.800.435 - Kuru MeSH C10.228.228.800.717 - scrapie MeSH C10.228.228.800.858 - wasting ... insomnia, fatal familial MeSH C10.574.843.625 - Kuru MeSH C10.574.843.850 - scrapie MeSH C10.574.843.925 - wasting disease, ... insomnia, fatal familial MeSH C10.886.659.618 - nocturnal myoclonus syndrome MeSH C10.886.659.627 - nocturnal paroxysmal ... familial MeSH C10.574.500.497 - huntington disease MeSH C10.574.500.529 - lafora disease MeSH C10.574.500.536 - lesch-nyhan ...
... fatal familial insomnia (FFI), and kuru in humans. While prions are typically viewed as pathogens that cause protein amyloid ... Gambetti, Pierluigi; Kong, Qingzhong; Zou, Wenquan; Parchi, Piero; Chen, Shu G (June 1, 2003). "Sporadic and Familial CJD: ...
In certain ADPs, such as Gerstmann-Straussler or fatal familial insomnia, individuals naturally encode a form of the PrP ... In the case of Kuru, familial and cultural rituals in indigenous peoples of Papua New Guinea promoted the consumption of a ...
Fatal familial insomnia (PrP in thalamus) Bovine spongiform encephalopathy (PrP in cerebrum of cows) Cardiac amyloidosis Senile ...
Martha Stewart Elon Musk Jim Cramer Margaret Thatcher Nikola Tesla Tom Ford Kelly Ripa Sleep apnea Fatal familial insomnia ... While insomnia and FNSS share some common features (late sleep onset, for example), those with insomnia do suffer from the ... Ptacek, Louis J. "Characterization of Familial Advanced Sleep Phase Syndrome". Sutton, Eliza L. (March 2021). "Insomnia". ... "Kegg Disease: Familial advanced sleep phase syndrome". www.genome.jp. Retrieved 2022-10-15. "Orphanet: Familial advanced sleep ...
Hereditary disorders Cluster headaches with ptosis Iridocyclitis Fatal familial insomnia Aphakia Opioids such as fentanyl, ...
Fatal familial insomnia (FFI) is linked to a mutation at codon 178 of the prion protein gene, coupled with the methionine codon ... Molecular pathology of fatal familial insomnia Brain Pathol. 1998 Jul;8(3):539-48. doi: 10.1111/j.1750-3639.1998.tb00176.x. ... Fatal familial insomnia (FFI) is linked to a mutation at codon 178 of the prion protein gene, coupled with the methionine codon ... insomnia more severe and histopathology more restricted to the thalamus in the homozygotes than in the heterozygotes. The ...
Find the facts of fatal familial insomnia including symptoms, causes, treatment & diagnosis. ... How do you Treat Fatal Familial Insomnia?. Currently, there is no cure for fatal familial insomnia or for that matter, any ... What are the Causes of Fatal Familial Insomnia?. Fatal familial insomnia is a genetic condition caused by a mutation in the ... What are the Symptoms and Signs of Fatal Familial Insomnia?. Fatal Familial Insomnia affects several parts of the brain, but ...
Fatal Familial Insomnia (FFI) is inherited. Sporadic Fatal Insomnia (SFI) occurs spontaneously. ... Fatal Insomnia is a prion disease with symptoms including insomnia, mental deterioration, and loss of coordination. It ... Fatal Insomnia, particularly sFI, is confirmed by autopsy. (Contact the CJD Foundation for specifics). ... Typical early symptoms: severe insomnia that continues to worsen, accompanied by ataxia (inability to coordinate movements) and ...
Fatal Familial" OR "familial insomnia" OR "fatal insomnia" OR ((familial insomnia OR fatal insomnia) AND (prion OR PRNP OR ... Fatal familial insomnia and familial creutzfeldt-jakob disease: disease phenotype determined by a DNA polymorphism. Science ... Fatal familial insomnia: a model disease in sleep physiopathology. Sleep Med Rev 2005;9:339-53.doi:10.1016/j.smrv.2005.02.001 ... Fatal familial insomnia: clinical and pathologic study of five new cases. Neurology 1992;42:312-9.doi:10.1212/wnl.42.2.312 pmid ...
Find out more from our sleep team about fatal familial insomnia, its symptoms and how to treat it. ... What is Fatal Familial Insomnia?. Fatal Familial Insomnia[1] (FFI) is a degenerative brain disorder that inhibits a persons ... Home - Sleep Science - Fatal Familial Insomnia: Symptoms, Diagnosis, and Treatment. Fatal Familial Insomnia: Symptoms, ... Insomnia. Insomnia is one of the primary symptoms of this disease. We mentioned earlier that Fatal Familial Insomnia leads to a ...
An introduction to Walker Jacksons fatal familial insomnia knock-in mice. Nov 16, 2012 • ericminikel ... published his creation of fatal familial insomnia knock-in mice [Jackson 2009]. As Prion Alliance has recently decided to make ... insomnia, hyper- or hypothermia, astrogliosis and neuronal loss localized in the thalamus. Skeptics wouldnt be able to argue ...
Fatal familial insomnia is a rare genetic disorder. We take a closer look at this condition and its symptoms, causes, and ... Fatal familial insomnia and sporadic deadly insomnia are the two forms of fatal insomnia. Their causes, symptoms, and expected ... The hereditary kind of fatal insomnia is fatal familial insomnia (FFI). This implies that specific gene alterations linked to ... Causes of Fatal Insomnia. The kind of disease will determine the cause of fatal insomnia. In contrast to sporadic fatal ...
Benefits and effects of Hyperbaric oxygen therapy in Fatal familial insomnia , India ... Fatal familial insomnia is a rare, inheritable neurodegenerative disorder characterized by progressively worsening insomnia ... Hyperbaric oxygen therapy may help alleviate fatigue and cognitive impairment in Fatal Familial Insomnia patients by enhancing ... Fatal familial insomnia , Gerstmann-Straussler-Scheinker syndrome , Herpes simplex virus , Varicella-zoster virus , ...
She had something called Fatal Familial Insomnia (FFI), a rare degenerative brain disorder where the inability to fall asleep ...
As many as 95% of Americans have reported an episode of insomnia at some point during their lives. ... Insomnia is defined as repeated difficulty with sleep initiation, maintenance, consolidation, or quality that occurs despite ... Fatal familial insomnia. Guilleminault C, Montagna P, Lugaresi E, Gambetti P, editors. Fatal Familial Insomnia: Inherited Prion ... Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science. ...
Fatal familial insomnia is thought to be the result of a point mutation in PRNP at codon 178, which corroborates PrPs ... Collins S, McLean CA, Masters CL (2001). "Gerstmann-Straussler-Scheinker syndrome, fatal familial insomnia, and kuru: a review ... Montagna P, Gambetti P, Cortelli P, Lugaresi E (2003). "Familial and sporadic fatal insomnia". Lancet Neurol. 2 (3): 167-76. ... "Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene". N. Engl. J. Med. 326 (7): 444 ...
Familial fatal insomnia. Discovered only recently, fatal familial insomnia presents initially with sleeping difficulties and ... Gerstmann-Sträussler-Scheinker disease is believed to be a familial disease with hereditary predisposition. It differs from ... disturbance of the autonomic nervous system, followed by insomnia and dementia.. Recent developments. During 1995, the ...
Fatal Insomnia - Etiology, pathophysiology, symptoms, signs, diagnosis & prognosis from the Merck Manuals - Medical ... Fatal insomnia, which includes fatal familial insomnia and sporadic fatal insomnia, are rare hereditary or sporadic prion ... Fatal familial insomnia (FFI) results from an autosomal dominant mutation in the PRNP gene. Average age at onset is 40 years ( ... Sporadic fatal insomnia (sFI) lacks a PRNP gene mutation. Average age at onset is slightly older and life expectancy is ...
As many as 95% of Americans have reported an episode of insomnia at some point during their lives. ... Insomnia is defined as repeated difficulty with sleep initiation, maintenance, consolidation, or quality that occurs despite ... Fatal familial insomnia. Guilleminault C, Montagna P, Lugaresi E, Gambetti P, editors. Fatal Familial Insomnia: Inherited Prion ... Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science. ...
Others suffer from Fatal Familial Insomnia, which - after months without sleep - leads to brain deterioration and death.. ...
Fatal familial insomnia. (2016).. https://rarediseases.info.nih.gov/diseases/6429/fatal-familial-insomnia. ... Fatal Familial insomnia (FFI). FFI affects the thalamus, which is the part of your brain that manages sleeping and waking ... One of the main symptoms of this condition is worsening insomnia. The mutation is inherited in a dominant manner, meaning an ... Prion diseases are rare, fatal neurodegenerative disorders caused by misfolded prion proteins (PrP) in the brain. This can lead ...
... including Creutzfeld-Jakob disease and familial fatal insomnia; Renner et al., 2004; Victoroff et al., 1994), and so-called ...
A subtype of sporadic prion disease mimicking fatal familial insomnia. Neurology. 1999;52:1757-63. DOIPubMedGoogle Scholar ... Prion diseases are fatal, transmissible neurodegenerative disorders characterized by deposition of abnormal prion protein (PrP ...
And this fatal familial insomnia sounds like a horrible disease:. The main symptom of FFI, as the disease is often called, is ... When Sonia Vallabh lost her mother to a rare disease called fatal familial insomnia, she soon found out that she had inherited ... found a 2010 post on a National Geographic article Max wrote about sleep that specifically referenced fatal familial insomnia: ...
Fatal Familial Insomnia. The whole story is crazy and perhaps the most terrifying Wikipedia rabbit hole Ive ever gone down. ... It starts off like regular insomnia, but progresses over a few years until you legit go insane and finally shut down. NOTHING, ...
Somethings Killing Me on HLN examines the rare and deadly disease Fatal Familial Insomnia - which stops you ever sleeping ... who inherited Fatal Familial Insomnia, on Somethings Killing Me. Imagine insomnia so bad that you are left delirious from ... On tonights Somethings Killing Me, the deadly inherited sleep disorder Fatal Familial Insomnia (FFI) is examined in several ... with people across the globe telling their stories of this fatal form of insomnia. ...
Spontaneous generation of prion infectivity in fatal familial insomnia knockin mice. Neuron 2009, 63, 438-450. [Google Scholar ... Transmissible spongiform encephalopathies (TSE diseases) or prion diseases are all fatal neurodegenerative conditions that ... familial, and variant forms of Creutzfeldt-Jakob disease (CJD) in humans. The central dogma of prion biology is that the normal ...
Other very rare inherited human diseases, such as Gerstmann-Straussler-Scheinker disease and fatal familial insomnia ... The disorder is fatal in a short time, usually within 8 months. People who have variant CJD get worse more slowly, but the ... Familial CJD occurs when a person inherits the abnormal prion from a parent (this form of CJD is rare). ... condition is still fatal. A few people survive for as long as 1 or 2 years. The cause of death is usually infection, heart ...
re: Insomnia. What can I do about this? Will I die? - Moustache on 10/5/23 at 11:18 am. [quote]Fatal Familial Insomnia? Check ...
fatal familial insomnia - aspartic acid-178 is replaced by asparagine while methionine is present at amino acid 129[45] ... Circadian rhythm is altered in null mice.[7] Fatal familial insomnia is thought to be the result of a point mutation in PRNP at ... Montagna P, Gambetti P, Cortelli P, Lugaresi E (2003). "Familial and sporadic fatal insomnia". Lancet Neurol. 2 (3): 167-76. ... Collins S, McLean CA, Masters CL (2001). "Gerstmann-Straussler-Scheinker syndrome, fatal familial insomnia, and kuru: a review ...
ClinVar Annotator: match by term: Fatal familial insomnia. ClinVar. OMIM. PMID:1351274 PMID:1353341 PMID:1404799 PMID:1439789 ... ClinVar Annotator: match by term: Insomnia. ClinVar. PMID:11742254 PMID:12189488 PMID:25741868 PMID:28492532. NCBI chrNW_ ... ClinVar Annotator: match by term: Insomnia. ClinVar. PMID:25741868 PMID:28492532 PMID:30755392 PMID:31618474. NCBI chrNW_ ... Dyssomnias (i.e., insomnias or hypersomnias) associated with dysfunction of internal sleep mechanisms or secondary to a sleep- ...
1996 -1998: Biomed 2 EU project "Clinico-pathological features and pathogenesis of fatal familial insomnia (FFI)" contract n° ... She has also collected original detailed data on the clinical and neurophysiological features of Fatal Familial Insomnia, ... clinical and neurophysiological characterization of patients affected by Fatal Familial Insomnia (FFI) with short and long ... 2000: "Organic insomnia (agrypnia excitata) associated with motor and autonomic activation: neuro-physico-physiological ...
Fatal familial insomnia and sporadic fatal insomnia. Handbook of Clinical Neurology. 153: 271-299. PMID 29887141 DOI: 10.1016/ ... Fatal familial insomnia and familial Creutzfeldt-Jakob disease: clinical, pathological and molecular features. Brain Pathology ... Fatal familial insomnia in a new Italian kindred. Neurology. 51: 1491-4. PMID 9818894 DOI: 10.1212/Wnl.51.5.1491 0.683. ... Familial and sporadic fatal insomnia. The Lancet. Neurology. 2: 167-76. PMID 12849238 DOI: 10.1016/S1474-4422(03)00323-5 0.56. ...
Infographic Text: How Long Can Someone Go Without Sleep? 6 MONTHS INVOLUNTARILY Fatal Familial Insomnia (FFI) is a genetic ...
... we do have data on people with the rare inherited disease called fatal familial insomnia (FFI). These patients have a genetic ... their lapses in attention rose significantly and were even worse for the participants with chronic insomnia. A study from 2000 ...
  • Sporadic Fatal Insomnia (SFI) occurs spontaneously. (cjdfoundation.org)
  • Specifically, scientists say that sometimes a person can develop a spontaneous genetic mutation affecting the prion protein, known as Sporadic Fatal Insomnia [2] . (sleepadvisor.org)
  • Sporadic fatal insomnia (sFI) results from the spontaneous transformation of normal prion proteins into abnormally structured proteins. (sweetislanddreams.com)
  • Fatal insomnia, which includes fatal familial insomnia and sporadic fatal insomnia, are rare hereditary or sporadic prion disorders causing difficulty sleeping, motor dysfunction, and death. (merckmanuals.com)
  • Sporadic fatal insomnia (sFI) lacks a PRNP gene mutation. (merckmanuals.com)
  • Other related human TSEs include variant CJD (vCJD), Gerstmann-Str ussler-Sheinker disease (GSS), fatal familial insomnia (FFI), sporadic fatal insomnia and kuru. (health.gov.au)
  • 8 The sporadic cases include 4641 cases of sporadic Creutzfeldt-Jakob disease (sCJD), 88 cases of Variably Protease-Sensitive Prionopathy (VPSPr), and 39 cases of sporadic Fatal Insomnia (sFI). (case.edu)
  • Currently, there is no cure for fatal familial insomnia or for that matter, any prion disease. (medindia.net)
  • Unfortunately, at present, there is still no cure for fatal familial insomnia. (bensfriends.org)
  • Codon 129 on the normal allele further modifies the FFI phenotype determining patient subpopulations of 129 homozygotes and heterozygotes: disease duration is generally shorter, insomnia more severe and histopathology more restricted to the thalamus in the homozygotes than in the heterozygotes. (nih.gov)
  • Fatal Familial Insomnia affects several parts of the brain, but mainly the thalamus. (medindia.net)
  • Thus, FFI's effect on the thalamus is what ultimately causes people to experience this extreme insomnia. (sleepadvisor.org)
  • That need motivated two decisions about the mouse model he generated: first, he chose FFI as the disease to study because FFI (in humans) was known to have phenotypes distinct from CJD and other prion diseases: insomnia, hyper- or hypothermia, astrogliosis and neuronal loss localized in the thalamus. (cureffi.org)
  • Individuals who satisfy the above three steps of diagnosis could be diagnosed as suffering from fatal familial insomnia. (medindia.net)
  • Genetic testing can confirm the diagnosis of the familial form. (merckmanuals.com)
  • In 1993, using genetic linkage, the gene for familial dysautonomia was localized to the distal long arm of chromosome 9(q31) with sufficient DNA markers to permit prenatal diagnosis and carrier identification for families in which an individual had been affected. (medscape.com)
  • Doctors consider fatal insomnia as a rare possible diagnosis when people have typical symptoms, such as rapidly deteriorating mental function, loss of coordination, and/or sleep problems. (msdmanuals.com)
  • The diagnosis of fatal familial insomnia is confirmed by genetic testing. (msdmanuals.com)
  • Insomnia is a clinical diagnosis. (medscape.com)
  • Fatal Familial Insomnia [1] (FFI) is a degenerative brain disorder that inhibits a person's ability to fall asleep. (sleepadvisor.org)
  • She had something called Fatal Familial Insomnia (FFI), a rare degenerative brain disorder where the inability to fall asleep is just the start of what many describe to be a living nightmare. (nine.com.au)
  • Overview of Prion Diseases Prion diseases are progressive, fatal, and untreatable degenerative brain disorders. (merckmanuals.com)
  • Overview of Prion Diseases Prion diseases are rare progressive, fatal, and currently untreatable degenerative disorders of the brain (and rarely of other organs) that result when a protein changes into an abnormal form. (msdmanuals.com)
  • Fatal familial insomnia is a rare genetic degenerative brain disorder wherein the affected individual is unable to sleep. (barnorama.com)
  • Though considered a fatal disorder, it must be noted that in the paper by Pasquale Montagna and colleagues, mentions that a few unreported cases of FFI carriers who are still leading a healthy life at the age of 74. (medindia.net)
  • The sleep disorder known as fatal insomnia is a kind of prion disease. (sweetislanddreams.com)
  • Fatal familial insomnia is a rare, inheritable neurodegenerative disorder characterized by progressively worsening insomnia leading to severe cognitive impairment, physical deterioration, and eventually death. (hbot-india.com)
  • 58% women) with confirmed insomnia disorder and no major depression within the previous 12 months found CBT significantly reduced risk of depression in patients with insomnia. (medscape.com)
  • On tonight's Something's Killing Me, the deadly inherited sleep disorder Fatal Familial Insomnia (FFI) is examined in several specific cases. (monstersandcritics.com)
  • The disorder is fatal in a short time, usually within 8 months. (medlineplus.gov)
  • Dyssomnias (i.e., insomnias or hypersomnias) associated with dysfunction of internal sleep mechanisms or secondary to a sleep-related medical disorder (e.g., sleep apnea, post-traumatic sleep disorders, etc. (mcw.edu)
  • Familial dysautonomia (FD) is an inherited disorder of the nervous system that affects the development and survival of autonomic and some sensory neurons. (medscape.com)
  • Familial dysautonomia is an autosomal recessive disorder with complete penetrance but variable expression. (medscape.com)
  • Fatal familial insomnia is a rare disorder that usually manifests in middle age, with mild difficulty sleeping at first, but worsens eventually. (bensfriends.org)
  • However, it was Elio Lugaresi s group that first reported the condition of fatal familial insomnia in a patient in 1986. (medindia.net)
  • Scientists officially named this rare disease Fatal Familial Insomnia in 1986. (sleepadvisor.org)
  • and in humans: Creutzfeldt-Jakob disease (CJD), fatal familial insomnia (FFI), Gerstmann-Sträussler-Scheinker syndrome (GSS), kuru, and variant Creutzfeldt-Jakob disease (vCJD). (wikipedia.org)
  • The hereditary kind of fatal insomnia is fatal familial insomnia (FFI). (sweetislanddreams.com)
  • [ 5 ] familial dysautonomia is now recognized as one of several hereditary sensory and autonomic neuropathies. (medscape.com)
  • Typical early symptoms: severe insomnia that continues to worsen, accompanied by ataxia (inability to coordinate movements) and mental confusion. (cjdfoundation.org)
  • Fatal familial insomnia is a rare brain disease characterized by insomnia or sleeplessness and hallucinations, among other symptoms. (medindia.net)
  • Fatal familial insomnia (FFI) is a rare and intractable inherited prion-based disease reported first by Lugaresi et al . (bmj.com)
  • However, a rare and serious condition known as Fatal Familial Insomnia causes people to lose the ability to sleep over a period of time. (sleepadvisor.org)
  • Both the sporadic form and familial insomnia are rare human prion diseases. (sleepadvisor.org)
  • Fatal familial insomnia is a rare condition that causes early death if contracted. (sweetislanddreams.com)
  • However, knowing the specifics of fatal insomnia, including its symptoms, causes, and treatment, will help you better grasp this rare condition and its differences from more common sleep issues. (sweetislanddreams.com)
  • Fatal insomnia should be considered as a rare possibility when patients have rapidly progressive cognitive impairment accompanied by behavioral or mood changes, ataxia, and sleep disturbances. (merckmanuals.com)
  • Prion diseases are rare, fatal neurodegenerative disorders caused by misfolded prion proteins (PrP) in the brain. (healthline.com)
  • Familial CJD occurs when a person inherits the abnormal prion from a parent (this form of CJD is rare). (medlineplus.gov)
  • Though prolonged sleep deprivation can't be studied, we do have data on people with the rare inherited disease called fatal familial insomnia (FFI). (livescience.com)
  • This Discovery documentary deals with a very rare and unusual prion disease called Fatal Familial Insomnia or FFI for short. (topdocumentaryfilms.com)
  • Fatal insomnia is a rare prion disease that interferes with sleep and leads to deterioration of mental function and loss of coordination. (msdmanuals.com)
  • Symptoms include persistent insomnia, paranoia, hallucinations, panic attacks, memory loss, rapidly progressive dementia leading to a complete loss of motor control and speech, then coma and death. (yahoo.com)
  • Fatal familial insomnia (FFI) is linked to a mutation at codon 178 of the prion protein gene, coupled with the methionine codon at position 129, the site of a methionine/valine polymorphism. (nih.gov)
  • Fatal familial insomnia is a genetic condition caused by a mutation in the prion gene ( PRNP ) is located on chromosome 20. (medindia.net)
  • Fatal familial insomnia (FFI) results from an autosomal dominant mutation in the PRNP gene. (merckmanuals.com)
  • Fatal insomnia also affects the autonomic nervous system, which controls involuntary body activities. (sweetislanddreams.com)
  • 6 MONTHS INVOLUNTARILY Fatal Familial Insomnia (FFI) is a genetic disease that affects a person's sleep-wake cycles. (goodtherapy.org)
  • Much like regular insomnia, Fatal Familial Insomnia is linked to diminished cognitive abilities, including difficulty thinking and concentrating. (sleepadvisor.org)
  • Hyperbaric oxygen therapy may help alleviate fatigue and cognitive impairment in Fatal Familial Insomnia patients by enhancing oxygen supply to the brain and promoting neural repair. (hbot-india.com)
  • The AASM guideline recommends psychological and behavioral interventions (including, but not limited to, cognitive-behavioral therapy [CBT]) as effective in the treatment of chronic comorbid insomnia as well as primary insomnia. (medscape.com)
  • Cognitive-behavioral therapy (CBT) can be used to ameliorate factors that perpetuate or exacerbate chronic insomnia, such as poor sleep habits, hyperarousal, irregular sleep schedules, inadequate sleep hygiene, and misconceptions about sleep. (medscape.com)
  • The initial symptoms of this condition are most commonly epileptic seizures, but the disease progresses rapidly with dementia, neuropsychiatric symptoms, and cognitive deterioration and has a fatal outcome within 5-10 years after onset. (ibecbarcelona.eu)
  • Cognitive-behavioral therapy (CBT) is considered the most appropriate treatment for patients with primary insomnia, though it is also effective for comorbid insomnia as adjunctive therapy. (medscape.com)
  • Fatal familial insomnia (FFI) is an inherited disease that belongs to a group of diseases called prion diseases. (medindia.net)
  • Insomnia may not be the predominant symptom in those whose disease is a slow-progressing disease. (medindia.net)
  • Fatal Insomnia is a prion disease with symptoms including insomnia, mental deterioration, and loss of coordination. (cjdfoundation.org)
  • Insomnia is one of the primary symptoms of this disease. (sleepadvisor.org)
  • It's a living nightmare for those afflicted - and worse still, the disease is fatal and there is no known cure. (monstersandcritics.com)
  • It was only after my dad's symptoms started that we learned the true cause: an ultrarare disease called fatal familial insomnia (FFI). (yahoo.com)
  • Genetic prion diseases include familial Creutzfeldt-Jakob disease (CJD), Gerstmann-Sträussler-Scheinker syndrome (GSS), fatal familial insomnia (FFI) and other related conditions. (ucsf.edu)
  • Prion diseases include Creuzfeldt-Jakob disease and fatal familial insomnia. (case.edu)
  • Prion diseases, such as Creutzfeldt-Jakob Disease (CJD), are fast-moving, fatal dementia syndromes associated with the formation of aggregates of the prion protein, PrP. (medicalxpress.com)
  • PRNP ( PRioN Protein (Creutzfeld-Jakob disease, Gerstmann-Sträussler-Scheinker syndrome, fatal familial insomnia) ) is a gene that codes for a protein called the prion protein (PrP), which is expressed in the brain and several other tissues. (medicalxpress.com)
  • Prion diseases are fatal, transmissible neurodegenerative disorders characterized by deposition of abnormal prion protein (PrP Sc ) in the brain ( 1 ). (cdc.gov)
  • When you think of common sleep disorders, you may think of insomnia or sleepwalking. (shortform.com)
  • Prion diseases are a group of rapidly progressive, fatal and infectious neurodegenerative disorders affecting both humans and animals. (medicalxpress.com)
  • Physical examination may offer clues to underlying medical disorders predisposing to insomnia. (medscape.com)
  • People with Fatal Familial Insomnia can also experience impairments with their autonomic nervous system, which is responsible for automatic bodily functions such as your heartbeat, breathing, or sweating. (sleepadvisor.org)
  • In 2017, the AASM released an updated guideline for the pharmacologic treatment of chronic insomnia in adults. (medscape.com)
  • But after 16 hours, their lapses in attention rose significantly and were even worse for the participants with chronic insomnia. (livescience.com)
  • Fatal familial insomnia is inherited in an autosomal dominant pattern. (medindia.net)
  • In fatal familial insomnia, symptoms may begin in a person's late 20s to the early 70s (average is 40 years). (msdmanuals.com)
  • Conclusions Insomnia, RPD and hypertension are representative key clinical presentations of FFI. (bmj.com)
  • In particular, adequate pain control can greatly relieve the insomnia associated with pain syndromes. (medscape.com)
  • This results in the signs and symptoms observed in fatal familial insomnia. (medindia.net)
  • What are the Symptoms and Signs of Fatal Familial Insomnia? (medindia.net)
  • According to the National Center for Advancing Translational Sciences, the following symptoms are common signs of Fatal Familial Insomnia. (sleepadvisor.org)
  • Sleep disruptions, alterations in mood or behavior, abnormal bodily processes, and a loss of physical power are all signs of fatal insomnia. (sweetislanddreams.com)
  • In the familial form, early symptoms include minor difficulties falling and staying asleep and occasional muscle twitching, spasms, and stiffness. (msdmanuals.com)
  • Fatal familial insomnia and sporadic deadly insomnia are the two forms of fatal insomnia. (sweetislanddreams.com)
  • Medications used in the treatment of insomnia include nonbenzodiazepine receptor agonists, benzodiazepine receptor agonists, the selective melatonin receptor agonist ramelteon, and sedating antidepressants. (medscape.com)
  • 9 Total does not include 312 Familial cases diagnosed by blood test only. (case.edu)
  • The annual incidence of CJD is approximately one case per million population, and is invariably fatal, usually within a year of onset of symptoms. (health.gov.au)
  • The course of the illness is generally longer than that of cCJD, but is invariably fatal. (health.gov.au)
  • Selective melatonin agonists are indicated for insomnia characterized by difficulty with sleep onset, particularly for individuals who lack dim-light melatonin-onset stimulation. (medscape.com)
  • Insomnia is defined as repeated difficulty with sleep initiation, maintenance, consolidation, or quality that occurs despite adequate time and opportunity for sleep and that results in some form of daytime impairment. (medscape.com)
  • Well, in certain cases, insomnia is an inherited condition that occurs due to brain abnormalities. (medindia.net)
  • If it is a rapidly progressing condition, then insomnia is a predominant feature. (medindia.net)
  • Every fourth adult under- anxiety, insomnia, low self-esteem, social isolation and went at least one form of violence during childhood, and panic attacks ( 9 ). (who.int)
  • The most common triggers of insomnia are emotional concerns or distress. (shortform.com)
  • The treatment of primary (psychophysiologic) insomnia begins with education about the sleep problem and appropriate sleep hygiene measures (elements of good sleep hygiene are described in Patient Education). (medscape.com)
  • They are excellent choices for treatment of sleep-onset insomnia. (medscape.com)
  • Melatonin itself is not regulated by the US Food and Drug Administration (FDA) and is thus not approved for treatment of insomnia. (medscape.com)
  • Currently, ramelteon is the only melatonin receptor agonist approved by the FDA for treatment of insomnia and is available by prescription. (medscape.com)
  • A sedative-hypnotic of the pyrazolopyrimidine class, zaleplon has a rapid onset of action and an ultra-short duration of action, making it a good choice for treatment of sleep-onset insomnia. (medscape.com)
  • It is a good first choice for treatment of sleep-onset insomnia and produces no significant residual sedation in the morning. (medscape.com)
  • Treatment of fatal insomnia focuses on relieving symptoms and making the person as comfortable as possible. (msdmanuals.com)
  • People who have variant CJD get worse more slowly, but the condition is still fatal. (medlineplus.gov)
  • Fatal Insomnia symptoms usually begin between the ages of 40 and 60. (sleepadvisor.org)
  • Both eszopiclone and sustained-release zolpidem are effective for both sleep-onset and sleep-maintenance insomnia, with a reduced abuse potential and long-term efficacy of up to 6 months as compared with nonselective benzodiazepine receptor agonists. (medscape.com)
  • Short-acting (eg, triazolam) and intermediate-acting (eg, estazolam, temazepam) benzodiazepine receptor agonists are useful for sleep-onset insomnia. (medscape.com)
  • The extended-release product (Ambien CR) consists of a coated 2-layer tablet and is useful for insomnia characterized by difficulties with sleep onset and/or sleep maintenance. (medscape.com)
  • an oral spray (Zolpimist) is also available for sleep-onset and/or sleep-maintenance insomnia. (medscape.com)
  • Objective Elucidate the core clinical and genetic characteristics and identify the phenotypic variation between different regions and genotypes of fatal familial insomnia (FFI). (bmj.com)
  • We mentioned earlier that Fatal Familial Insomnia leads to a loss of nerve cells - or neurons - in the brain. (sleepadvisor.org)
  • People with fatal insomnia may abruptly enter a dream-like phase while awake due to inadequate sleep. (sweetislanddreams.com)
  • Nevertheless, most people with fatal insomnia continue to function cognitively throughout most of the illness. (sweetislanddreams.com)
  • This week's one-hour episode of Something's Killing Me is a tense journey, with people across the globe telling their stories of this fatal form of insomnia. (monstersandcritics.com)
  • Many adults with familial dysautonomia have been able to achieve independent function. (medscape.com)